CHILDRENS HOSPITAL MEDICAL CENTER
Reduce your risk when donating: see where the money actually goes.
Reduce your risk when donating: see where the money actually goes.
Cite this
Plain text CHILDRENS HOSPITAL MEDICAL CENTER. furp.org, nonprofit organization profile, tax years 2009–2024. https://furp.org/org/childrens-hospital-medical-center-310833936. Retrieved 2026-11-09.
APA furp.org. (n.d.). CHILDRENS HOSPITAL MEDICAL CENTER [Nonprofit organization profile; tax years 2009–2024]. Retrieved November 9, 2026, from https://furp.org/org/childrens-hospital-medical-center-310833936
MLA “CHILDRENS HOSPITAL MEDICAL CENTER.” furp.org, tax years 2009–2024, https://furp.org/org/childrens-hospital-medical-center-310833936. Accessed 9 Nov. 2026.
Retrieved 2026-11-09; covers tax years 2009–2024. Data: furp.org (index © the FURP Alliance; the records are public domain).
2024 · Form 990 · revenue $3.57B · expenses $3.36B · assets $10.71B
- EIN
- 31-0833936
- Address
- 3333 BURNET AVE, CINCINNATI, OH 45229-3026
- Website
- WWW.CINCINNATICHILDRENS.ORG
- NTEE code
- E24 Hospital, Specialty (Health Care) published (IRS Business Master File, as E240)
- FURP topic
- abuse: child · abuse: sexual · abuse: substance · science: research education (from its 990 text; the topic index)
- Exempt type
- 501(c)(3): charitable, religious, educational, scientific or literary (corporation)
- Ruling date
- November 1973 (when the IRS recognized its exemption)
- IRS status
- Exempt (unconditional) (IRS Business Master File) IRS data ↗
- Tax-deductible donations
- Yes: listed in IRS Publication 78 (public charity) Pub 78 ↗
- Foundation status
- Hospital or medical research organization
- Cross-check
- ProPublica Nonprofit Explorer
Mission
CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER WILL BE THE LEADER IN IMPROVING CHILD HEALTH. CINCINNATI CHILDREN'S WILL PROVIDE CHILD HEALTH AND TRANSFORM DELIVERY OF CARE THROUGH FULLY INTEGRATED, GLOBALLY RECOGNIZED RESEARCH, EDUCATION, AND INNOVATION. FOR PATIENTS AND OUR COMMUNITY, THE NATION AND THE WORLD, THE CARE WE PROVIDE WILL ACHIEVE THE BEST MEDICAL AND QUALITY OF LIFE OUTCOMES, PATIENT AND FAMILY EXPERIENCES, AND VALUE, TODAY AND IN THE FUTURE.
Each tax year counts once: when a return was amended, only the latest return for that period is used below (superseded returns stay listed, greyed, under Finances).
People paid by the organization
56 people paid across every filing: current people first, then by total pay from this organization. Organizations counts every nonprofit each person appears on.
| Name | Latest title | Years | Latest year pay | Total pay from here | Organizations |
|---|---|---|---|---|---|
| David Morales Md | DIV. DIR, CARDIOLOGY | 2012-2024 | $3,370,355 | $25,026,950 | 1 |
| Andrew Redington Md | FMR. INSTITUTE DIRECTOR | 2015-2024 | $1,230,795 | $16,955,444 | 1 |
| Daniel Von Allmen Md | SURGEON-IN-CHIEF (THROUGH 6/25) | 2015-2024 | $1,945,395 | $16,914,196 | 1 |
| Steve Davis | PRESIDENT & CEO | 2015-2024 | $2,814,850 | $15,321,091 | 13 |
| Brian Coley | RADIOLOGIST-IN-CHIEF | 2015-2024 | $1,234,818 | $11,517,058 | 1 |
| John Mcauliffe Md | FMR. KEY EMPLOYEE | 2016-2024 | $573,209 | $7,385,665 | 1 |
| Carl Backer | FACULTY PROFESSOR | 2021-2024 | $1,718,212 | $6,827,874 | 1 |
| Tina Cheng | CHAIR, PEDIATRICS | 2020-2024 | $1,343,265 | $5,065,043 | 2 |
| Paul Jenny | CFO & TREASURER | 2020-2024 | $1,470,070 | $5,010,872 | 4 |
| Barbara Tofani | SVP-PATIENT SERVICES | 2018-2024 | $793,838 | $4,839,136 | 5 |
| Evaline Alessandrini | COO | 2022-2024 | $1,445,167 | $3,844,831 | 3 |
| Robert Carpenter | SECRETARY, SVP & CLO | 2021-2024 | $1,052,419 | $2,996,957 | 1 |
| Rosland Mcleod | FORMER OFFICER | 2022-2024 | $1,009,577 | $2,339,714 | 1 |
| Stephanie Ebken | SVP & CHIEF MARKETING OFFICER | 2022-2024 | $722,557 | $1,908,032 | 2 |
| Tony Johnston | SVP & CIA | 2023-2024 | $821,380 | $1,529,174 | 1 |
| Marco Ricci Md | FACULTY PROFESSOR | 2024 | $1,506,288 | $1,506,288 | 1 |
| Oliver Rhine | SVP & CSO | 2022-2024 | $662,901 | $1,484,447 | 1 |
| Peter Adebi | SVP & CHRO | 2024 | $996,188 | $996,188 | 1 |
| Karen Foos | INTERIM SVP, CHRO | 2023-2024 | $506,347 | $958,068 | 1 |
| Michael Fisher (former) | FMR. PRESIDENT & CEO | 2010-2022 | $1,052,710 | $21,814,246 | 18 |
| James Tweddell Md (former) | INSTIT DIR, CARDIOTHOR SURG | 2015-2022 | $2,096,360 | $20,843,794 | 1 |
| Richard Azizkhan (former) | Former Surgeon-in-Chief | 2009-2015 | $3,201,099 | $12,831,399 | 1 |
| Beth Stautberg (former) | FMR. SEC., SR. VP & CLO | 2010-2022 | $1,034,585 | $11,306,935 | 4 |
| Eric J Wall Md (former) | FACULTY PROFESSOR | 2009-2020 | $1,121,322 | $9,934,556 | 1 |
| Scott Hamlin (former) | COO (through 4/15) | 2009-2017 | $500,000 | $9,397,810 | 8 |
| Mark Mumford (former) | FORMER SVP & CFO, TREAS. (THRU 08/20) | 2013-2021 | $259,294 | $9,169,590 | 4 |
| Dean Kurth (former) | Anesthesiologist-in-Chief | 2009-2014 | $1,222,595 | $6,804,198 | 1 |
| Margaret Hostetter (former) | Chair, Pediatrics (through 02/20) | 2013-2019 | $1,304,101 | $6,416,249 | 1 |
| Charles Myer Iii (former) | FACULTY PROFESSOR | 2009-2020 | $1,100,276 | $6,292,564 | 1 |
| Arnold Strauss (former) | CHAIR, PEDIATRICS | 2009-2013 | $1,223,072 | $4,946,129 | 1 |
| James M Anderson (former) | RETIRED FORMER EXECUTIVE | 2010-2011 | $650,830 | $4,879,011 | 5 |
| Nerissa Morris (former) | SVP & CHRO (THROUGH 7/23) | 2018-2023 | $1,019,688 | $4,598,621 | 2 |
| David Winlaw (former) | FACULTY PROFESSOR | 2021-2023 | $1,181,874 | $4,570,186 | 1 |
| James Anthony Quintessenza MD (former) | Cardiothoracic Surgery | 2017-2019 | $1,457,708 | $4,376,268 | 1 |
| Jennifer Dauer (former) | Former Key Employee | 2015-2019 | $175,604 | $3,515,384 | 6 |
| Charles Mehlman (former) | Professor - Orthopaedic | 2009-2014 | $938,630 | $2,808,099 | 1 |
| Cheryl Hoying (former) | Former Key Employee | 2015-2018 | $125,274 | $2,529,858 | 1 |
| Francesco Mangano DO (former) | Div. Dir, Neurosurgery | 2016-2017 | $1,259,285 | $2,393,486 | 1 |
| Lane Donnelly (former) | Former Highest Comp | 2010-2014 | $1,236,059 | $2,258,553 | 1 |
| Francesco Mangano (former) | Prof/Div Dir, Neurosurgery | 2013-2015 | $1,128,453 | $2,109,590 | 1 |
| James Anderson - Ceo (former) | PRES (7/1/09-12/31/09) | 2009 | $1,894,782 | $1,894,782 | 1 |
| Jay Paul Willging (former) | PROFESSOR - FACULTY | 2011-2012 | $959,065 | $1,893,335 | 1 |
| Jeffrey Towbin (former) | PROF/DIV DIR, CARDIOLOGY | 2011-2012 | $923,306 | $1,833,722 | 1 |
| Fred Ryckman (former) | Sr. VP, Medical Operations | 2014 | $1,683,346 | $1,683,346 | 1 |
| Marianne James (former) | FMR. SVP & CIO | 2022-2023 | $760,338 | $1,562,072 | 1 |
| Frederick Ryckman (former) | Sr. VP Medical Operations | 2015 | $1,328,682 | $1,328,682 | 1 |
| Jana Bazzoli (former) | FRMR. INT. CFO & TREAS. (THRU 01/21) | 2020-2021 | $591,212 | $1,173,496 | 4 |
| Dean Kurth through 616 (former) | Anesthesiologist-in-Chief | 2015 | $1,158,050 | $1,158,050 | 1 |
| Vicki Davies (former) | Treasurer (through 6/15) | 2011-2015 | $166,069 | $1,146,498 | 4 |
| Thomas F Boat (former) | RETIRED FORMER EXECUTIVE | 2009-2011 | $24,333 | $975,851 | 1 |
| Jeff Robbins (former) | CO-DIRECTOR HEART INSTITUTE | 2009 | $929,463 | $929,463 | 1 |
| Charles Dean Kurth MD (former) | Former Key Employee (Through 6/16) | 2016 | $845,503 | $845,503 | 1 |
| Diane White (former) | SECRETARY | 2009 | $96,671 | $96,671 | 1 |
| Michael Fisher - Ceo (former) | PRES. (1/1/10-6/30/10) | 2009 | $89,968 | $89,968 | 1 |
| William K Schubert Md (former) | TRUSTEE | 2009-2010 | $0 | $25,000 | 5 |
| Alicia Bond-Lewis (former) | TRUSTEE (THROUGH 10/23) | 2019-2023 | $15,376 | $15,376 | 6 |
Officers and directors, no compensation reported
65 people listed on the returns with $0 (or no amount) in every compensation column: current people first. Hours are as filed on the latest return each person appears on.
| Name | Latest title | Years | Hrs/wk (latest) | Compensation | Organizations |
|---|---|---|---|---|---|
| Andrew Quinn | TRUSTEE | 2020-2024 | 1 | $0 reported | 7 |
| Liza Smitherman | TRUSTEE, CHAIR | 2014-2024 | 4 | $0 reported | 7 |
| Beth Guttman | TRUSTEE (THROUGH 10/24) | 2012-2024 | 1 | $0 reported | 9 |
| Chiquita White | TRUSTEE | 2017-2024 | 1 | $0 reported | 1 |
| Christine Browner | TRUSTEE | 2017-2024 | 1 | $0 reported | 2 |
| Darin Hall | TRUSTEE | 2022-2024 | 1 | $0 reported | 4 |
| David Cassady | TRUSTEE | 2019-2024 | 4 | $0 reported | 2 |
| David Osborn | TRUSTEE | 2015-2024 | 1 | $0 reported | 4 |
| Gary Huffman | TRUSTEE | 2014-2024 | 1 | $0 reported | 8 |
| Hillary Weidner | TRUSTEE | 2017-2024 | 1 | $0 reported | 3 |
| Holly Collinsworth | TRUSTEE | 2022-2024 | 1 | $0 reported | 1 |
| Jim Vance | TRUSTEE | 2018-2024 | 4 | $0 reported | 2 |
| Joel Stone | TRUSTEE | 2021-2024 | 1 | $0 reported | 10 |
| Kate White | TRUSTEE | 2023-2024 | 1 | $0 reported | 1 |
| Kay Geiger | TRUSTEE | 2014-2024 | 1 | $0 reported | 10 |
| Laura Tomlin | TRUSTEE | 2021-2024 | 4 | $0 reported | 2 |
| Mark Biegger | TRUSTEE / VICE CHAIR | 2015-2024 | 1 | $0 reported | 3 |
| Michael Hirschfeld Esq | TRUSTEE / VICE CHAIR (THROUGH 10/24) | 2009-2024 | 1 | $0 reported | 2 |
| Pamela Brailsford | TRUSTEE | 2021-2024 | 1 | $0 reported | 1 |
| Rebecca Wood | TRUSTEE / VICE CHAIR (EFF. 10/24) | 2021-2024 | 4 | $0 reported | 1 |
| Robert Taylor | TRUSTEE | 2022-2024 | 1 | $0 reported | 4 |
| Stacey Browning | TRUSTEE / VICE CHAIR | 2021-2024 | 1 | $0 reported | 6 |
| Stuart Aitken | TRUSTEE | 2023-2024 | 1 | $0 reported | 5 |
| Susan Shelton | TRUSTEE | 2017-2024 | 4 | $0 reported | 4 |
| Susan Street Whaley | TRUSTEE | 2022-2024 | 1 | $0 reported | 1 |
| Tom Finn | TRUSTEE | 2018-2024 | 4 | $0 reported | 3 |
| Vada Hill | TRUSTEE | 2020-2024 | 1 | $0 reported | 5 |
| Dan Ostilie | SURGEON-IN-CHIEF (EFF. 6/25) | 2024 | 50 | $0 reported | 1 |
| Craig Young (former) | TRUSTEE (THROUGH 10/23) | 2010-2023 | 1 | $0 reported | 8 |
| Joyce J Keeshin (former) | TRUSTEE (THROUGH 10/23) | 2009-2023 | 1 | $0 reported | 1 |
| Nancy Krieger Eddy Phd (former) | TRUSTEE (THROUGH 10/23) | 2009-2023 | 1 | $0 reported | 1 |
| Sharry Addison (former) | TRUSTEE (THRU 10/22) | 2009-2022 | 1 | $0 reported | 2 |
| Mark Jahnke (former) | TRUSTEE, CHAIR (THRU 11/22) | 2012-2022 | 4 | $0 reported | 4 |
| Jane Portman (former) | TRUSTEE (THRU 10/22) | 2009-2022 | 1 | $0 reported | 2 |
| Timothy Schroeder (former) | TRUSTEE (THRU 11/22) | 2020-2022 | 1 | $0 reported | 4 |
| Felicia Williams (former) | TRUSTEE (THRU 5/22) | 2009-2021 | 1 | $0 reported | 4 |
| John Steinman (former) | TRUSTEE (THRU 10/21) | 2009-2021 | 1 | $0 reported | 2 |
| Lynwood Battle (former) | TRUSTEE (THRU 8/21) | 2009-2021 | 1 | $0 reported | 1 |
| Robert D H Anning (former) | TRUSTEE (THROUGH 10/20) | 2017-2020 | 1 | $0 reported | 3 |
| Carol Armstrong (former) | TRUSTEE (THROUGH 1/21) | 2009-2020 | 1 | $0 reported | 1 |
| Thomas G Cody (former) | Trustee (through 10/19) | 2009-2019 | 1 | $0 reported | 7 |
| Dave Dougherty (former) | Trustee (through 01/20) | 2012-2019 | 2 | $0 reported | 4 |
| Maureen Bisognano (former) | Trustee (through 01/20) | 2013-2019 | 1 | $0 reported | 1 |
| Lee A Carter (former) | Trustee (through 10/18) | 2009-2018 | 1 | $0 reported | 6 |
| Michael S Cambron (former) | Trustee (through 10/18) | 2009-2018 | 1 | $0 reported | 2 |
| Pamela Terp (former) | Trustee (through 10/17) | 2009-2017 | 1 | $0 reported | 4 |
| Louis D George through 1017 (former) | Trustee | 2017 | 1 | $0 reported | 1 |
| Robert DH Anning (former) | Trustee | 2009-2016 | 1 | $0 reported | 3 |
| Louis D George (former) | Trustee | 2009-2016 | 1 | $0 reported | 1 |
| Deb Henretta through 1016 (former) | Trustee | 2016 | 1 | $0 reported | 1 |
| M Denise Kuprionis (former) | Trustee (through 10/16) | 2009-2016 | 1 | $0 reported | 2 |
| Deb Henretta (former) | Trustee | 2013-2015 | 1 | $0 reported | 1 |
| Vallie Geier (former) | Trustee | 2009-2014 | 1 | $0 reported | 3 |
| Willie F Carden Jr (former) | Trustee (Through 10/14) | 2009-2014 | 1 | $0 reported | 1 |
| Peggy Mathile (former) | Trustee (Through 07/14) | 2009-2014 | 1 | $0 reported | 3 |
| Katharine Dewitt (former) | TRUSTEE | 2009-2011 | 1 | $0 reported | 3 |
| Mr Manuel D Mayerson (former) | TRUSTEE | 2009-2010 | 1 | $0 reported | 2 |
| Deborah A Henretta (former) | TRUSTEE | 2009 | 1 | $0 reported | 2 |
| Mrs Barbara Fitch (former) | TRUSTEE | 2009 | 4 | $0 reported | 2 |
| Mrs Mardie Off (former) | TRUSTEE | 2009 | 1 | $0 reported | 2 |
| Mr Geoffrey Place (former) | TRUSTEE | 2009 | 1 | $0 reported | 2 |
| Todd M Duncan (former) | TRUSTEE | 2009 | 1 | $0 reported | 1 |
| Camille C Graham Md (former) | TRUSTEE | 2009 | 1 | $0 reported | 1 |
| John Sawyer (former) | TRUSTEE | 2009 | 1 | $0 reported | 1 |
| John P Zanotti (former) | TRUSTEE | 2009 | 1 | $0 reported | 1 |
People by year
2024 · 47 people listed · 19 paid, $25.2M · 22,512 employees · 465 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| DAVID MORALES MD | DIV. DIR, CARDIOLOGY | 50 | $2,968,640 | $0 | $401,715 | $3,370,355 | 1 |
| STEVE DAVIS MD | PRESIDENT & CEO | 50 | $2,737,353 | $0 | $77,497 | $2,814,850 | 13 |
| DANIEL VON ALLMEN MD | SURGEON-IN-CHIEF (THROUGH 6/25) | 50 | $1,878,397 | $0 | $66,998 | $1,945,395 | 1 |
| CARL BACKER | FACULTY PROFESSOR | 50 | $1,644,536 | $0 | $73,676 | $1,718,212 | 1 |
| MARCO RICCI MD | FACULTY PROFESSOR | 50 | $1,452,298 | $0 | $53,990 | $1,506,288 | 1 |
| PAUL JENNY | CFO & TREASURER | 49 | $1,262,048 | $0 | $208,022 | $1,470,070 | 4 |
| EVALINE ALESSANDRINI | COO | 49 | $1,372,157 | $0 | $73,010 | $1,445,167 | 3 |
| TINA CHENG | CHAIR, PEDIATRICS | 50 | $1,296,408 | $0 | $46,857 | $1,343,265 | 2 |
| BRIAN COLEY | RADIOLOGIST-IN-CHIEF | 50 | $1,168,527 | $0 | $66,291 | $1,234,818 | 1 |
| ANDREW REDINGTON MD | FMR. INSTITUTE DIRECTOR | 50 | $1,194,241 | $0 | $36,554 | $1,230,795 | 1 |
| ROBERT CARPENTER | SECRETARY, SVP & CLO | 50 | $923,502 | $0 | $128,917 | $1,052,419 | 1 |
| ROSLAND MCLEOD | FORMER OFFICER | 50 | $997,081 | $0 | $12,496 | $1,009,577 | 1 |
| PETER ADEBI | SVP & CHRO | 50 | $894,831 | $0 | $101,357 | $996,188 | 1 |
| TONY JOHNSTON | SVP & CIA | 50 | $760,145 | $0 | $61,235 | $821,380 | 1 |
| BARBARA TOFANI | SVP-PATIENT SERVICES | 49 | $737,959 | $0 | $55,879 | $793,838 | 5 |
| STEPHANIE EBKEN | SVP & CHIEF MARKETING OFFICER | 50 | $597,979 | $0 | $124,578 | $722,557 | 2 |
| OLIVER RHINE | SVP & CSO | 50 | $553,693 | $0 | $109,208 | $662,901 | 1 |
| JOHN MCAULIFFE MD | FMR. KEY EMPLOYEE | 50 | $537,935 | $0 | $35,274 | $573,209 | 1 |
| KAREN FOOS | INTERIM SVP, CHRO | 50 | $428,904 | $0 | $77,443 | $506,347 | 1 |
| LIZA SMITHERMAN | TRUSTEE, CHAIR | 4 | $0 | $0 | $0 | $0 | 7 |
| MARK BIEGGER | TRUSTEE / VICE CHAIR | 1 | $0 | $0 | $0 | $0 | 3 |
| MICHAEL HIRSCHFELD ESQ | TRUSTEE / VICE CHAIR (THROUGH 10/24) | 1 | $0 | $0 | $0 | $0 | 2 |
| STACEY BROWNING | TRUSTEE / VICE CHAIR | 1 | $0 | $0 | $0 | $0 | 6 |
| ANDREW QUINN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 7 |
| BETH GUTTMAN | TRUSTEE (THROUGH 10/24) | 1 | $0 | $0 | $0 | $0 | 9 |
| CHIQUITA WHITE | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| CHRISTINE BROWNER | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| DAN OSTILIE | SURGEON-IN-CHIEF (EFF. 6/25) | 50 | $0 | $0 | $0 | $0 | 1 |
| DARIN HALL | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 4 |
| DAVID CASSADY | TRUSTEE | 4 | $0 | $0 | $0 | $0 | 2 |
| DAVID OSBORN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 4 |
| GARY HUFFMAN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 8 |
| HILLARY WEIDNER | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 3 |
| HOLLY COLLINSWORTH | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| JIM VANCE | TRUSTEE | 4 | $0 | $0 | $0 | $0 | 2 |
| JOEL STONE | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 10 |
| KATE WHITE | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| KAY GEIGER | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 10 |
| LAURA TOMLIN | TRUSTEE | 4 | $0 | $0 | $0 | $0 | 2 |
| PAMELA BRAILSFORD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| REBECCA WOOD | TRUSTEE / VICE CHAIR (EFF. 10/24) | 4 | $0 | $0 | $0 | $0 | 1 |
| ROBERT TAYLOR | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 4 |
| STUART AITKEN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 5 |
| SUSAN SHELTON | TRUSTEE | 4 | $0 | $0 | $0 | $0 | 4 |
| SUSAN STREET WHALEY | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| TOM FINN | TRUSTEE | 4 | $0 | $0 | $0 | $0 | 3 |
| VADA HILL | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 5 |
2023 · 51 people listed · 21 paid, $25.0M · 21,943 employees · 450 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| DAVID MORALES MD | DIV. DIR, CARDIOLOGY | 50 | $2,680,412 | $0 | $360,619 | $3,041,031 | 1 |
| STEVE DAVIS MD | PRESIDENT & CEO | 50 | $2,504,416 | $0 | $72,328 | $2,576,744 | 13 |
| DANIEL VON ALLMEN MD | SURGEON-IN-CHIEF | 50 | $1,822,227 | $0 | $62,857 | $1,885,084 | 1 |
| CARL BACKER | FACULTY PROFESSOR | 50 | $1,645,422 | $0 | $68,753 | $1,714,175 | 1 |
| ANDREW REDINGTON MD | INSTIT DIR, CARDIOLOGY | 50 | $1,507,735 | $0 | $59,117 | $1,566,852 | 1 |
| EVALINE ALESSANDRINI | COO | 49 | $1,319,326 | $0 | $71,443 | $1,390,769 | 3 |
| PAUL JENNY | CFO & TREASURER | 49 | $1,115,505 | $0 | $198,766 | $1,314,271 | 4 |
| TINA CHENG | CHAIR, PEDIATRICS | 50 | $1,249,336 | $0 | $44,349 | $1,293,685 | 2 |
| DAVID WINLAW | FACULTY PROFESSOR | 50 | $1,120,096 | $0 | $61,778 | $1,181,874 | 1 |
| BRIAN COLEY | RADIOLOGIST-IN-CHIEF | 50 | $1,099,650 | $0 | $67,181 | $1,166,831 | 1 |
| BARBARA TOFANI | SVP-PATIENT SERVICES | 49 | $996,766 | $0 | $52,001 | $1,048,767 | 5 |
| NERISSA MORRIS | SVP & CHRO (THROUGH 7/23) | 50 | $975,930 | $0 | $43,758 | $1,019,688 | 2 |
| JOHN MCAULIFFE MD | FMR. KEY EMPLOYEE | 50 | $976,953 | $0 | $34,598 | $1,011,551 | 1 |
| ROSLAND MCLEOD | SECRETARY, SVP & CLO (THROUGH 2/24) | 50 | $849,965 | $0 | $128,317 | $978,282 | 1 |
| MARIANNE JAMES | FMR. SVP & CIO | 50 | $703,928 | $0 | $56,410 | $760,338 | 1 |
| TONY JOHNSTON | SVP & CIA (EFF. 7/23) | 50 | $616,059 | $0 | $91,735 | $707,794 | 1 |
| ROBERT CARPENTER | SECRETARY, SVP & CLO (EFF. 2/24) | 50 | $553,024 | $0 | $112,278 | $665,302 | 1 |
| STEPHANIE EBKEN | SVP & SENIOR MARKETING OFFICER | 50 | $538,780 | $0 | $111,907 | $650,687 | 2 |
| OLIVER RHINE | SVP & CSO | 50 | $443,277 | $0 | $84,966 | $528,243 | 1 |
| KAREN FOOS | INT. SVP & CHRO (8/23-1/24) | 50 | $379,802 | $0 | $71,919 | $451,721 | 1 |
| ALICIA BOND-LEWIS | TRUSTEE (THROUGH 10/23) | 1 | $13,022 | $0 | $2,354 | $15,376 | 6 |
| LIZA SMITHERMAN | TRUSTEE, CHAIR | 4 | $0 | $0 | $0 | $0 | 7 |
| ANDREW QUINN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 7 |
| BETH GUTTMAN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 9 |
| CHIQUITA WHITE | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| CHRISTINE BROWNER | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| CRAIG YOUNG | TRUSTEE (THROUGH 10/23) | 1 | $0 | $0 | $0 | $0 | 8 |
| DARIN HALL | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 4 |
| DAVID CASSADY | TRUSTEE | 4 | $0 | $0 | $0 | $0 | 2 |
| DAVID OSBORN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 4 |
| GARY HUFFMAN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 8 |
| HILLARY WEIDNER | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 3 |
| HOLLY COLLINSWORTH | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| JIM VANCE | TRUSTEE | 4 | $0 | $0 | $0 | $0 | 2 |
| JOEL STONE | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 10 |
| JOYCE J KEESHIN | TRUSTEE (THROUGH 10/23) | 1 | $0 | $0 | $0 | $0 | 1 |
| KATE WHITE | TRUSTEE (EFF. 4/24) | 1 | $0 | $0 | $0 | $0 | 1 |
| KAY GEIGER | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 10 |
| LAURA TOMLIN | TRUSTEE | 4 | $0 | $0 | $0 | $0 | 2 |
| MARK BIEGGER | TRUSTEE / VICE CHAIR | 1 | $0 | $0 | $0 | $0 | 3 |
| MICHAEL HIRSCHFELD ESQ | TRUSTEE / VICE CHAIR | 1 | $0 | $0 | $0 | $0 | 2 |
| NANCY KRIEGER EDDY PHD | TRUSTEE (THROUGH 10/23) | 1 | $0 | $0 | $0 | $0 | 1 |
| PAMELA BRAILSFORD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| REBECCA WOOD | TRUSTEE | 4 | $0 | $0 | $0 | $0 | 1 |
| ROBERT TAYLOR | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 4 |
| STACEY BROWNING | TRUSTEE / VICE CHAIR (EFF. 10/23) | 1 | $0 | $0 | $0 | $0 | 6 |
| STUART AITKEN | TRUSTEE (EFF. 10/23) | 1 | $0 | $0 | $0 | $0 | 5 |
| SUSAN SHELTON | TRUSTEE | 4 | $0 | $0 | $0 | $0 | 4 |
| SUSAN STREET WHALEY | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| TOM FINN | TRUSTEE / VICE CHAIR (THROUGH 10/23) | 4 | $0 | $0 | $0 | $0 | 3 |
| VADA HILL | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 5 |
2022 · 54 people listed · 21 paid, $25.2M · 20,881 employees · 456 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| STEVE DAVIS MD | PRESIDENT & CEO | 49 | $2,302,891 | $0 | $69,201 | $2,372,092 | 13 |
| DAVID MORALES MD | DIV. DIR, CARDIOLOGY | 50 | $2,076,488 | $0 | $68,591 | $2,145,079 | 1 |
| JAMES TWEDDELL MD | INSTIT DIR, CARDIOTHOR SURG | 50 | $2,054,746 | $0 | $41,614 | $2,096,360 | 1 |
| DANIEL VON ALLMEN MD | SURGEON-IN-CHIEF | 50 | $1,737,434 | $0 | $59,788 | $1,797,222 | 1 |
| CARL BACKER | FACULTY PROFESSOR | 50 | $1,645,627 | $0 | $66,389 | $1,712,016 | 1 |
| DAVID WINLAW | FACULTY PROFESSOR | 50 | $1,570,102 | $0 | $69,204 | $1,639,306 | 1 |
| ANDREW REDINGTON MD | INSTIT DIR, CARDIOLOGY | 50 | $1,456,286 | $0 | $59,398 | $1,515,684 | 1 |
| PAUL JENNY | CFO & TREASURER | 49 | $1,103,457 | $0 | $172,416 | $1,275,873 | 4 |
| TINA CHENG | CHAIR, PEDIATRICS | 49 | $1,197,820 | $0 | $44,022 | $1,241,842 | 2 |
| BRIAN COLEY | FORMER KEY EMPLOYEE | 50 | $1,069,200 | $0 | $59,504 | $1,128,704 | 1 |
| MICHAEL FISHER | FMR. PRESIDENT & CEO | 0 | $996,810 | $0 | $55,900 | $1,052,710 | 18 |
| BETH STAUTBERG | FMR. SEC., SR. VP & CLO | 0 | $1,025,814 | $0 | $8,771 | $1,034,585 | 4 |
| EVALINE ALESSANDRINI | COO | 49 | $939,746 | $0 | $69,149 | $1,008,895 | 3 |
| JOHN MCAULIFFE MD | FORMER KEY EMPLOYEE | 50 | $955,746 | $0 | $32,098 | $987,844 | 1 |
| NERISSA MORRIS | SVP & CHRO | 50 | $808,423 | $0 | $46,007 | $854,430 | 2 |
| MARIANNE JAMES | SVP & CIO | 50 | $742,076 | $0 | $59,658 | $801,734 | 1 |
| ROBERT CARPENTER | INT. SECRETARY & CLO (THRU 9/22) | 50 | $594,191 | $0 | $106,500 | $700,691 | 1 |
| BARBARA TOFANI | SVP-PATIENT SERVICES | 49 | $597,411 | $0 | $49,589 | $647,000 | 5 |
| STEPHANIE EBKEN | SVP & CMO (EFF. 8/22) | 50 | $439,818 | $0 | $94,970 | $534,788 | 2 |
| ROSLAND MCLEOD | SECRETARY, SVP & CLO (EFF. 9/22) | 50 | $315,406 | $0 | $36,449 | $351,855 | 1 |
| OLIVER RHINE | SVP & CSO (EFF. 1/23) | 50 | $250,180 | $0 | $43,123 | $293,303 | 1 |
| ALICIA BOND-LEWIS | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 6 |
| LIZA SMITHERMAN | TRUSTEE, CHAIR (EFF. 11/22) | 4 | $0 | $0 | $0 | $0 | 7 |
| MARK JAHNKE | TRUSTEE, CHAIR (THRU 11/22) | 4 | $0 | $0 | $0 | $0 | 4 |
| ANDREW QUINN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 7 |
| BETH GUTTMAN | TRUSTEE | 4 | $0 | $0 | $0 | $0 | 9 |
| CHIQUITA WHITE | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| CHRISTINE BROWNER | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| CRAIG YOUNG | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 8 |
| DARIN HALL | TRUSTEE (EFF. 11/22) | 1 | $0 | $0 | $0 | $0 | 4 |
| DAVID CASSADY | TRUSTEE | 4 | $0 | $0 | $0 | $0 | 2 |
| DAVID OSBORN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 4 |
| GARY HUFFMAN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 8 |
| HILLARY WEIDNER | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 3 |
| HOLLY COLLINSWORTH | TRUSTEE (EFF. 11/22) | 1 | $0 | $0 | $0 | $0 | 1 |
| JANE PORTMAN | TRUSTEE (THRU 10/22) | 1 | $0 | $0 | $0 | $0 | 2 |
| JIM VANCE | TRUSTEE | 4 | $0 | $0 | $0 | $0 | 2 |
| JOEL STONE | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 10 |
| JOYCE J KEESHIN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| KAY GEIGER | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 10 |
| LAURA TOMLIN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| MARK BIEGGER | TRUSTEE | 4 | $0 | $0 | $0 | $0 | 3 |
| MICHAEL HIRSCHFELD ESQ | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| NANCY KRIEGER EDDY PHD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| PAMELA BRAILSFORD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| REBECCA WOOD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| ROBERT TAYLOR | TRUSTEE (EFF. 11/22) | 1 | $0 | $0 | $0 | $0 | 4 |
| SHARRY ADDISON | TRUSTEE (THRU 10/22) | 1 | $0 | $0 | $0 | $0 | 2 |
| STACEY BROWNING | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 6 |
| SUSAN SHELTON | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 4 |
| SUSAN STREET WHALEY | TRUSTEE (EFF. 11/22) | 1 | $0 | $0 | $0 | $0 | 1 |
| TIMOTHY SCHROEDER | TRUSTEE (THRU 11/22) | 1 | $0 | $0 | $0 | $0 | 4 |
| TOM FINN | TRUSTEE | 4 | $0 | $0 | $0 | $0 | 3 |
| VADA HILL | TRUSTEE | 4 | $0 | $0 | $0 | $0 | 5 |
2021 · 50 people listed · 18 paid, $23.6M · 19,987 employees · 400 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| JAMES TWEDDELL MD | INSTIT DIR, CARDIOTHOR SURG | 50 | $2,712,040 | $0 | $56,289 | $2,768,329 | 1 |
| MICHAEL FISHER | PRESIDENT & CEO (THRU 11/21) | 49 | $2,134,467 | $0 | $64,915 | $2,199,382 | 18 |
| DAVID MORALES MD | DIV. DIR, CARDIOLOGY | 50 | $1,934,340 | $0 | $65,375 | $1,999,715 | 1 |
| DAVID WINLAW | FACULTY PROFESSOR | 50 | $1,683,154 | $0 | $65,852 | $1,749,006 | 1 |
| STEVE DAVIS MD | PRESIDENT & CEO (EFF. 11/21) | 49 | $1,536,234 | $0 | $190,573 | $1,726,807 | 13 |
| DANIEL VON ALLMEN MD | SURGEON-IN-CHIEF | 50 | $1,668,378 | $0 | $56,437 | $1,724,815 | 1 |
| CARL BACKER | FACULTY PROFESSOR | 50 | $1,620,311 | $0 | $63,160 | $1,683,471 | 1 |
| ANDREW REDINGTON MD | INSTIT DIR, CARDIOLOGY | 50 | $1,428,472 | $0 | $56,721 | $1,485,193 | 1 |
| BRIAN COLEY | RADIOLOGIST-IN-CHIEF | 50 | $1,300,198 | $0 | $52,105 | $1,352,303 | 1 |
| TINA CHENG | CHAIR, PEDIATRICS | 49 | $1,012,450 | $0 | $39,881 | $1,052,331 | 2 |
| BETH STAUTBERG | SEC., SR. VP & COL (THRU 1/22) | 50 | $919,558 | $0 | $129,228 | $1,048,786 | 4 |
| PAUL JENNY | CFO & TREASURER | 49 | $887,433 | $0 | $63,225 | $950,658 | 4 |
| JOHN MCAULIFFE MD | ANESTHESIOLOGIST-IN-CHIEF | 50 | $882,567 | $0 | $30,598 | $913,165 | 1 |
| NERISSA MORRIS | SVP AND CHRO | 50 | $848,895 | $0 | $43,978 | $892,873 | 2 |
| BARBARA TOFANI | SVP-PATIENT SERVICES | 49 | $572,210 | $0 | $47,530 | $619,740 | 5 |
| JANA BAZZOLI | FRMR. INT. CFO & TREAS. (THRU 01/21) | 49 | $500,885 | $0 | $90,327 | $591,212 | 4 |
| ROBERT CARPENTER | INT. SECRETARY & CLO (EFF. 1/22) | 50 | $482,467 | $0 | $96,078 | $578,545 | 1 |
| MARK MUMFORD | FORMER SVP & CFO, TREAS. (THRU 08/20) | 0 | $259,294 | $0 | $0 | $259,294 | 4 |
| ALICIA BOND-LEWIS | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 6 |
| MARK JAHNKE | TRUSTEE, CHAIR | 4 | $0 | $0 | $0 | $0 | 4 |
| ANDREW QUINN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 7 |
| BETH GUTTMAN | TRUSTEE | 4 | $0 | $0 | $0 | $0 | 9 |
| CHIQUITA WHITE | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| CHRISTINE BROWNER | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| CRAIG YOUNG | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 8 |
| DAVID CASSADY | TRUSTEE | 4 | $0 | $0 | $0 | $0 | 2 |
| DAVID OSBORN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 4 |
| FELICIA WILLIAMS | TRUSTEE (THRU 5/22) | 1 | $0 | $0 | $0 | $0 | 4 |
| GARY HUFFMAN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 8 |
| HILLARY WEIDNER | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 3 |
| JANE PORTMAN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| JIM VANCE | TRUSTEE | 4 | $0 | $0 | $0 | $0 | 2 |
| JOEL STONE | TRUSTEE (EFF. 10/21) | 1 | $0 | $0 | $0 | $0 | 10 |
| JOHN STEINMAN | TRUSTEE (THRU 10/21) | 1 | $0 | $0 | $0 | $0 | 2 |
| JOYCE J KEESHIN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| KAY GEIGER | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 10 |
| LAURA TOMLIN | TRUSTEE (EFF. 10/21) | 1 | $0 | $0 | $0 | $0 | 2 |
| LIZA SMITHERMAN | TRUSTEE | 4 | $0 | $0 | $0 | $0 | 7 |
| LYNWOOD BATTLE | TRUSTEE (THRU 8/21) | 1 | $0 | $0 | $0 | $0 | 1 |
| MARK BIEGGER | TRUSTEE | 4 | $0 | $0 | $0 | $0 | 3 |
| MICHAEL HIRSCHFELD ESQ | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| NANCY KRIEGER EDDY PHD | TRUSTEE | 4 | $0 | $0 | $0 | $0 | 1 |
| PAMELA BRAILSFORD | TRUSTEE (EFF. 10/21) | 1 | $0 | $0 | $0 | $0 | 1 |
| REBECCA WOOD | TRUSTEE (EFF. 10/21) | 1 | $0 | $0 | $0 | $0 | 1 |
| SHARRY ADDISON | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| STACEY BROWNING | TRUSTEE (EFF. 10/21) | 1 | $0 | $0 | $0 | $0 | 6 |
| SUSAN SHELTON | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 4 |
| TIMOTHY SCHROEDER | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 4 |
| TOM FINN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 3 |
| VADA HILL | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 5 |
2020 · 46 people listed · 16 paid, $21.4M · 18,712 employees · 400 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| JAMES TWEDDELL MD | INSTIT DIR, CARDIOTHOR SURG | 50 | $2,999,392 | $0 | $63,076 | $3,062,468 | 1 |
| MICHAEL FISHER | PRESIDENT & CEO | 49 | $2,119,784 | $0 | $64,515 | $2,184,299 | 18 |
| ANDREW REDINGTON MD | INSTIT DIR, CARDIOLOGY | 50 | $2,032,662 | $0 | $55,282 | $2,087,944 | 1 |
| DANIEL VON ALLMEN MD | SURGEON-IN-CHIEF | 50 | $1,827,140 | $0 | $55,347 | $1,882,487 | 1 |
| DAVID MORALES MD | DIV. DIR, CARDIOLOGY | 50 | $1,741,529 | $0 | $64,865 | $1,806,394 | 1 |
| MARK MUMFORD | SVP & CFO, TREASURER (THROUGH 08/20) | 49 | $1,485,152 | $0 | $161,099 | $1,646,251 | 4 |
| STEVE DAVIS MD | COO | 49 | $1,132,109 | $0 | $187,766 | $1,319,875 | 13 |
| BRIAN COLEY | RADIOLOGIST-IN-CHIEF | 50 | $1,018,630 | $0 | $159,539 | $1,178,169 | 1 |
| ERIC J WALL MD | FACULTY PROFESSOR | 50 | $1,066,706 | $0 | $54,616 | $1,121,322 | 1 |
| CHARLES MYER III | FACULTY PROFESSOR | 50 | $1,071,152 | $0 | $29,124 | $1,100,276 | 1 |
| BETH STAUTBERG | SECRETARY, SR. VP & COUNSEL | 50 | $869,240 | $0 | $126,913 | $996,153 | 4 |
| JOHN MCAULIFFE MD | ANESTHESIOLOGIST-IN-CHIEF | 50 | $859,890 | $0 | $30,132 | $890,022 | 1 |
| NERISSA MORRIS | SVP AND CHRO | 50 | $630,485 | $0 | $105,161 | $735,646 | 2 |
| BARBARA TOFANI | SVP-PATIENT SERVICES | 50 | $602,550 | $0 | $47,004 | $649,554 | 5 |
| JANA BAZZOLI | INT. CFO & TREAS. (9/20 - 01/21) | 49 | $495,064 | $0 | $87,220 | $582,284 | 4 |
| TINA CHENG | CHAIR, PEDIATRICS (EFFECTIVE 10/20) | 50 | $120,536 | $0 | $13,384 | $133,920 | 2 |
| JANE PORTMAN | TRUSTEE, CHAIR (THRU 9/20) | 4 | $0 | $0 | $0 | $0 | 2 |
| MARK JAHNKE | TRUSTEE, CHAIR (EFF 10/20) | 4 | $0 | $0 | $0 | $0 | 4 |
| ALICIA BOND-LEWIS | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 6 |
| ANDREW QUINN | TRUSTEE (EFFECTIVE 10/20) | 1 | $0 | $0 | $0 | $0 | 7 |
| BETH GUTTMAN | TRUSTEE | 4 | $0 | $0 | $0 | $0 | 9 |
| CAROL ARMSTRONG | TRUSTEE (THROUGH 1/21) | 1 | $0 | $0 | $0 | $0 | 1 |
| CHIQUITA WHITE | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| CHRISTINE BROWNER | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| CRAIG YOUNG | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 8 |
| DAVID CASSADY | TRUSTEE | 4 | $0 | $0 | $0 | $0 | 2 |
| DAVID OSBORN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 4 |
| FELICIA WILLIAMS | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 4 |
| GARY HUFFMAN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 8 |
| HILLARY WEIDNER | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 3 |
| JIM VANCE | TRUSTEE | 4 | $0 | $0 | $0 | $0 | 2 |
| JOHN STEINMAN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| JOYCE J KEESHIN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| KAY GEIGER | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 10 |
| LIZA SMITHERMAN | TRUSTEE | 4 | $0 | $0 | $0 | $0 | 7 |
| LYNWOOD BATTLE | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| MARK BIEGGER | TRUSTEE | 4 | $0 | $0 | $0 | $0 | 3 |
| MICHAEL HIRSCHFELD ESQ | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| NANCY KRIEGER EDDY PHD | TRUSTEE | 4 | $0 | $0 | $0 | $0 | 1 |
| ROBERT D H ANNING | TRUSTEE (THROUGH 10/20) | 1 | $0 | $0 | $0 | $0 | 3 |
| SHARRY ADDISON | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| SUSAN SHELTON | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 4 |
| TIMOTHY SCHROEDER | TRUSTEE (EFFECTIVE 10/20) | 1 | $0 | $0 | $0 | $0 | 4 |
| TOM FINN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 3 |
| VADA HILL | TRUSTEE (EFFECTIVE 10/20) | 1 | $0 | $0 | $0 | $0 | 5 |
| PAUL JENNY | CFO & TREASURER (EFF 1/21) | 50 | $0 | $0 | $0 | $0 | 4 |
2019 · 45 people listed · 16 paid, $22.9M · 18,848 employees · 610 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| James Tweddell MD | Instit Dir, Cardiothor Surg | 50 | $3,427,566 | $0 | $70,518 | $3,498,084 | 1 |
| Michael Fisher | President & CEO | 50 | $2,284,860 | $0 | $69,995 | $2,354,855 | 18 |
| David Morales MD | Div. Dir, Cardiology | 50 | $2,103,643 | $0 | $64,032 | $2,167,675 | 1 |
| Andrew Redington MD | Instit Dir, Cardiology | 50 | $2,023,168 | $0 | $59,724 | $2,082,892 | 1 |
| Daniel von Allmen MD | Surgeon-in-Chief | 50 | $1,803,821 | $0 | $66,280 | $1,870,101 | 1 |
| James Anthony Quintessenza MD | Cardiothoracic Surgery | 50 | $1,410,922 | $0 | $46,786 | $1,457,708 | 1 |
| Margaret Hostetter | Chair, Pediatrics (through 02/20) | 50 | $1,259,998 | $0 | $44,103 | $1,304,101 | 1 |
| Steve Davis MD | COO | 50 | $1,097,796 | $0 | $177,300 | $1,275,096 | 13 |
| Brian Coley | Radiologist-in-Chief | 50 | $1,097,300 | $0 | $155,345 | $1,252,645 | 1 |
| Mark Mumford | SVP & CFO, Treasurer | 50 | $973,455 | $0 | $262,917 | $1,236,372 | 4 |
| Eric J Wall MD | Faculty Professor | 50 | $1,050,292 | $0 | $53,135 | $1,103,427 | 1 |
| Beth Stautberg | Secretary, Sr. VP & Counsel | 50 | $828,701 | $0 | $120,736 | $949,437 | 4 |
| John McAuliffe MD | Anesthesiologist-in-Chief | 50 | $828,539 | $0 | $33,275 | $861,814 | 1 |
| Nerissa Morris | SVP and CHRO | 50 | $605,526 | $0 | $95,687 | $701,213 | 2 |
| Barbara Tofani | SVP-Patient Services | 50 | $544,428 | $0 | $46,949 | $591,377 | 5 |
| Jennifer Dauer | Former Key Employee | 0 | $167,243 | $0 | $8,361 | $175,604 | 6 |
| Sharry Addison | Trustee | 1 | $0 | $0 | $0 | $0 | 2 |
| Robert D H Anning | Trustee | 1 | $0 | $0 | $0 | $0 | 3 |
| Carol Armstrong | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Lynwood Battle | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Mark Biegger | Trustee | 4 | $0 | $0 | $0 | $0 | 3 |
| Maureen Bisognano | Trustee (through 01/20) | 1 | $0 | $0 | $0 | $0 | 1 |
| Alicia Bond-Lewis | Trustee (effective 10/19) | 1 | $0 | $0 | $0 | $0 | 6 |
| Christine Browner | Trustee | 1 | $0 | $0 | $0 | $0 | 2 |
| David Cassady | Trustee (effective 10/19) | 1 | $0 | $0 | $0 | $0 | 2 |
| Thomas G Cody | Trustee (through 10/19) | 1 | $0 | $0 | $0 | $0 | 7 |
| Dave Dougherty | Trustee (through 01/20) | 2 | $0 | $0 | $0 | $0 | 4 |
| Nancy Krieger Eddy PhD | Trustee | 4 | $0 | $0 | $0 | $0 | 1 |
| Tom Finn | Trustee | 1 | $0 | $0 | $0 | $0 | 3 |
| Kay Geiger | Trustee | 1 | $0 | $0 | $0 | $0 | 10 |
| Beth Guttman | Trustee | 4 | $0 | $0 | $0 | $0 | 9 |
| Michael Hirschfeld Esq | Trustee | 1 | $0 | $0 | $0 | $0 | 2 |
| Gary Huffman | Trustee | 1 | $0 | $0 | $0 | $0 | 8 |
| Mark Jahnke | Trustee | 4 | $0 | $0 | $0 | $0 | 4 |
| Joyce J Keeshin | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| David Osborn | Trustee | 1 | $0 | $0 | $0 | $0 | 4 |
| Jane Portman | Chair | 4 | $0 | $0 | $0 | $0 | 2 |
| Liza Smitherman | Trustee | 1 | $0 | $0 | $0 | $0 | 7 |
| John Steinman | Trustee | 1 | $0 | $0 | $0 | $0 | 2 |
| Susan Shelton | Trustee | 1 | $0 | $0 | $0 | $0 | 4 |
| Jim Vance | Trustee | 4 | $0 | $0 | $0 | $0 | 2 |
| Hillary Weidner | Trustee | 1 | $0 | $0 | $0 | $0 | 3 |
| Chiquita White | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Felicia Williams | Trustee | 2 | $0 | $0 | $0 | $0 | 4 |
| Craig Young | Trustee | 1 | $0 | $0 | $0 | $0 | 8 |
2018 · 46 people listed · 17 paid, $20.7M · 18,318 employees · 690 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| James Tweddell MD | Instit Dir, Cardiothor Surg | 50 | $2,658,105 | $0 | $189,750 | $2,847,855 | 1 |
| Michael Fisher | President & CEO | 50 | $2,011,839 | $0 | $151,850 | $2,163,689 | 18 |
| Daniel von Allmen MD | Surgeon-in-Chief | 50 | $1,564,008 | $0 | $141,741 | $1,705,749 | 1 |
| David Morales MD | Div. Dir, Cardiology | 50 | $1,551,606 | $0 | $134,880 | $1,686,486 | 1 |
| Andrew Redington MD | Instit Dir, Cardiology | 50 | $1,471,731 | $0 | $100,907 | $1,572,638 | 1 |
| James Anthony Quintessenza MD | Cardiothoracic Surgery | 50 | $1,404,341 | $0 | $49,856 | $1,454,197 | 1 |
| Mark Mumford | SVP & CFO, Treasurer | 50 | $1,234,913 | $0 | $140,997 | $1,375,910 | 4 |
| Steve Davis MD | COO | 50 | $1,023,636 | $0 | $111,284 | $1,134,920 | 13 |
| Eric J Wall MD | Faculty Professor | 50 | $1,076,774 | $0 | $53,425 | $1,130,199 | 1 |
| Brian Coley | Radiologist-in-Chief | 50 | $991,642 | $0 | $96,716 | $1,088,358 | 1 |
| Margaret Hostetter | Chair, Pediatrics | 50 | $910,490 | $0 | $37,530 | $948,020 | 1 |
| Beth Stautberg | Secretary, Sr. VP & Counsel | 50 | $843,895 | $0 | $76,966 | $920,861 | 4 |
| Jennifer Dauer | Former Key Employee | 50 | $832,138 | $0 | $65,249 | $897,387 | 6 |
| John McAuliffe MD | Anesthesiologist-in-Chief | 50 | $762,954 | $0 | $29,207 | $792,161 | 1 |
| Barbara Tofani | SVP-Patient Services | 50 | $428,820 | $0 | $60,040 | $488,860 | 5 |
| Nerissa Morris | SVP and CHRO (effective 3/18) | 50 | $352,402 | $0 | $42,369 | $394,771 | 2 |
| Cheryl Hoying | Former Key Employee | 50 | $111,921 | $0 | $13,353 | $125,274 | 1 |
| Sharry Addison | Trustee | 1 | $0 | $0 | $0 | $0 | 2 |
| Robert D H Anning | Trustee | 1 | $0 | $0 | $0 | $0 | 3 |
| Carol Armstrong | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Lynwood Battle | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Mark Biegger | Trustee | 4 | $0 | $0 | $0 | $0 | 3 |
| Maureen Bisognano | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Christine Browner | Trustee | 1 | $0 | $0 | $0 | $0 | 2 |
| Michael S Cambron | Trustee (through 10/18) | 1 | $0 | $0 | $0 | $0 | 2 |
| Lee A Carter | Trustee (through 10/18) | 1 | $0 | $0 | $0 | $0 | 6 |
| Thomas G Cody | Trustee | 1 | $0 | $0 | $0 | $0 | 7 |
| Dave Dougherty | Trustee | 4 | $0 | $0 | $0 | $0 | 4 |
| Nancy Krieger Eddy PhD | Trustee | 4 | $0 | $0 | $0 | $0 | 1 |
| Tom Finn | Trustee (effective 10/18) | 1 | $0 | $0 | $0 | $0 | 3 |
| Kay Geiger | Trustee | 1 | $0 | $0 | $0 | $0 | 10 |
| Beth Guttman | Trustee | 4 | $0 | $0 | $0 | $0 | 9 |
| Michael Hirschfeld Esq | Trustee | 1 | $0 | $0 | $0 | $0 | 2 |
| Gary Huffman | Trustee | 1 | $0 | $0 | $0 | $0 | 8 |
| Mark Jahnke | Trustee | 4 | $0 | $0 | $0 | $0 | 4 |
| Joyce J Keeshin | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| David Osborn | Trustee | 1 | $0 | $0 | $0 | $0 | 4 |
| Jane Portman | Chair | 4 | $0 | $0 | $0 | $0 | 2 |
| Liza Smitherman | Trustee | 1 | $0 | $0 | $0 | $0 | 7 |
| John Steinman | Trustee | 1 | $0 | $0 | $0 | $0 | 2 |
| Susan Shelton | Trustee | 1 | $0 | $0 | $0 | $0 | 4 |
| Jim Vance | Trustee (effective 10/18) | 4 | $0 | $0 | $0 | $0 | 2 |
| Hillary Weidner | Trustee | 1 | $0 | $0 | $0 | $0 | 3 |
| Chiquita White | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Felicia Williams | Trustee | 1 | $0 | $0 | $0 | $0 | 4 |
| Craig Young | Trustee | 1 | $0 | $0 | $0 | $0 | 8 |
2017 · 45 people listed · 16 paid, $20.6M · 17,946 employees · 720 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| James Tweddell MD | Instit Dir, Cardiothor Surg | 50 | $2,319,752 | $0 | $320,141 | $2,639,893 | 1 |
| Michael Fisher | President & CEO | 50 | $2,161,175 | $0 | $237,395 | $2,398,570 | 18 |
| Daniel von Allmen MD | Surgeon-in-Chief | 50 | $1,377,689 | $0 | $226,933 | $1,604,622 | 1 |
| David Morales MD | Div. Dir, Cardiology | 50 | $1,486,462 | $0 | $56,694 | $1,543,156 | 1 |
| Andrew Redington MD | Instit Dir, Cardiology | 50 | $1,378,676 | $0 | $149,339 | $1,528,015 | 1 |
| James Anthony Quintessenza MD | Cardiothoracic Surgery | 50 | $1,414,917 | $0 | $49,446 | $1,464,363 | 1 |
| Francesco Mangano DO | Div. Dir, Neurosurgery | 50 | $1,207,766 | $0 | $51,519 | $1,259,285 | 1 |
| Mark Mumford | SVP & CFO, Treasurer | 50 | $874,224 | $0 | $274,175 | $1,148,399 | 4 |
| Brian Coley | Radiologist-in-Chief | 50 | $964,955 | $0 | $146,685 | $1,111,640 | 1 |
| Margaret Hostetter | Chair, Pediatrics | 50 | $1,034,616 | $0 | $37,133 | $1,071,749 | 1 |
| Steve Davis MD | COO | 50 | $818,376 | $0 | $154,903 | $973,279 | 13 |
| Beth Stautberg | Secretary, Sr. VP & Counsel | 50 | $764,258 | $0 | $113,541 | $877,799 | 4 |
| Jennifer Dauer | SVP Strat & Grwth (thru 4/18) | 50 | $717,897 | $0 | $129,966 | $847,863 | 6 |
| John McAuliffe MD | Anesthesiologist-in-Chief | 50 | $785,839 | $0 | $28,529 | $814,368 | 1 |
| Cheryl Hoying | SVP Patient Svcs (thru 3/18) | 50 | $678,890 | $0 | $115,013 | $793,903 | 1 |
| Scott Hamlin | COO (through 4/15) | 0 | $500,000 | $0 | $0 | $500,000 | 8 |
| Sharry Addison | Trustee | 1 | $0 | $0 | $0 | $0 | 2 |
| Robert D H Anning | Trustee | 1 | $0 | $0 | $0 | $0 | 3 |
| Carol Armstrong | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Lynwood Battle | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Mark Biegger | Trustee | 4 | $0 | $0 | $0 | $0 | 3 |
| Maureen Bisognano | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Michael S Cambron | Trustee | 1 | $0 | $0 | $0 | $0 | 2 |
| Lee A Carter | Trustee | 1 | $0 | $0 | $0 | $0 | 6 |
| Thomas G Cody | Chair (through 10/17) | 1 | $0 | $0 | $0 | $0 | 7 |
| Dave Dougherty | Trustee | 4 | $0 | $0 | $0 | $0 | 4 |
| Nancy Krieger Eddy PhD | Trustee | 4 | $0 | $0 | $0 | $0 | 1 |
| Kay Geiger | Trustee | 1 | $0 | $0 | $0 | $0 | 10 |
| Louis D George through 1017 | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Beth Guttman | Trustee | 4 | $0 | $0 | $0 | $0 | 9 |
| Michael Hirschfeld Esq | Trustee | 1 | $0 | $0 | $0 | $0 | 2 |
| Felicia Williams | Trustee | 4 | $0 | $0 | $0 | $0 | 4 |
| Craig Young | Trustee | 1 | $0 | $0 | $0 | $0 | 8 |
| Susan Shelton | Trustee | 1 | $0 | $0 | $0 | $0 | 4 |
| Christine Browner | Trustee | 1 | $0 | $0 | $0 | $0 | 2 |
| Hillary Weidner | Trustee | 1 | $0 | $0 | $0 | $0 | 3 |
| Chiquita White | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Gary Huffman | Trustee | 1 | $0 | $0 | $0 | $0 | 8 |
| Mark Jahnke | Trustee | 4 | $0 | $0 | $0 | $0 | 4 |
| Joyce J Keeshin | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| David Osborn | Trustee | 1 | $0 | $0 | $0 | $0 | 4 |
| Jane Portman | Chair (effective 10/17) | 4 | $0 | $0 | $0 | $0 | 2 |
| Liza Smitherman | Trustee | 1 | $0 | $0 | $0 | $0 | 7 |
| John Steinman | Trustee | 1 | $0 | $0 | $0 | $0 | 2 |
| Pamela Terp | Trustee (through 10/17) | 1 | $0 | $0 | $0 | $0 | 4 |
2016 · 44 people listed · 17 paid, $19.7M · 17,771 employees · 780 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| James Tweddell MD | Institute Director - Cardiothoracic | 50 | $2,184,170 | $0 | $310,030 | $2,494,200 | 1 |
| Michael Fisher | President & CEO | 50 | $1,752,026 | $0 | $227,782 | $1,979,808 | 18 |
| David Morales MD | Director, Cardiology | 50 | $1,706,160 | $0 | $53,890 | $1,760,050 | 1 |
| Daniel von Allmen MD | Surgeon-in-Chief | 50 | $1,242,111 | $0 | $212,750 | $1,454,861 | 1 |
| Andrew Redington MD | Institute Director - Cardiology | 50 | $1,268,658 | $0 | $146,222 | $1,414,880 | 1 |
| Eric Wall MD | Director, Sports Medicine & Orthopedic Fellowship | 50 | $1,101,909 | $0 | $54,079 | $1,155,988 | 1 |
| Francesco Mangano DO | Director, Neurosurgery | 50 | $1,081,670 | $0 | $52,531 | $1,134,201 | 1 |
| Brian Coley MD | Radiologist-in-Chief | 50 | $826,082 | $0 | $143,608 | $969,690 | 1 |
| Mark Mumford | SVP & CFO, Treasurer | 50 | $823,328 | $0 | $141,094 | $964,422 | 4 |
| Margaret Hostetter | Chair, Pediatrics | 50 | $880,532 | $0 | $35,913 | $916,445 | 1 |
| Jennifer Dauer | SVP Strategy & Growth | 50 | $752,924 | $0 | $125,064 | $877,988 | 6 |
| Cheryl Hoying RN-PhD | SVP Patient Services | 50 | $767,075 | $0 | $108,724 | $875,799 | 1 |
| Beth Stautberg | Secretary, Sr VP & Counsel | 50 | $765,983 | $0 | $109,125 | $875,108 | 4 |
| Steve Davis MD | COO | 50 | $730,701 | $0 | $129,836 | $860,537 | 13 |
| Charles Dean Kurth MD | Former Key Employee (Through 6/16) | 50 | $752,124 | $0 | $93,379 | $845,503 | 1 |
| John McAuliffe | Anesthesiologist-in-Chief | 50 | $514,515 | $0 | $27,016 | $541,531 | 1 |
| Scott Hamlin | Former COO (through 4/15) | 50 | $530,755 | $0 | $0 | $530,755 | 8 |
| Sharry Addison | Trustee | 1 | $0 | $0 | $0 | $0 | 2 |
| Robert DH Anning | Trustee | 1 | $0 | $0 | $0 | $0 | 3 |
| Carol Armstrong | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Lynwood Battle | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Mark Biegger | Trustee | 1 | $0 | $0 | $0 | $0 | 3 |
| Maureen Bisognano | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Michael S Cambron | Trustee | 1 | $0 | $0 | $0 | $0 | 2 |
| Lee A Carter | Trustee | 1 | $0 | $0 | $0 | $0 | 6 |
| Thomas G Cody | Chairman | 4 | $0 | $0 | $0 | $0 | 7 |
| Dave Dougherty | Trustee | 4 | $0 | $0 | $0 | $0 | 4 |
| Nancy Krieger Eddy PhD | Trustee | 4 | $0 | $0 | $0 | $0 | 1 |
| Kay Geiger | Trustee | 1 | $0 | $0 | $0 | $0 | 10 |
| Louis D George | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Beth Guttman | Trustee | 1 | $0 | $0 | $0 | $0 | 9 |
| Deb Henretta through 1016 | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Michael Hirschfeld Esq | Trustee | 4 | $0 | $0 | $0 | $0 | 2 |
| Gary Huffman | Trustee | 1 | $0 | $0 | $0 | $0 | 8 |
| Mark Jahnke | Trustee | 4 | $0 | $0 | $0 | $0 | 4 |
| Joyce J Keeshin | Trustee | 4 | $0 | $0 | $0 | $0 | 1 |
| M Denise Kuprionis | Trustee (through 10/16) | 1 | $0 | $0 | $0 | $0 | 2 |
| David Osborn | Trustee | 1 | $0 | $0 | $0 | $0 | 4 |
| Jane Portman | Trustee | 4 | $0 | $0 | $0 | $0 | 2 |
| Liza Smitherman | Trustee | 1 | $0 | $0 | $0 | $0 | 7 |
| John Steinman | Trustee | 4 | $0 | $0 | $0 | $0 | 2 |
| Pamela Terp | Trustee | 1 | $0 | $0 | $0 | $0 | 4 |
| Felicia Williams | Trustee | 4 | $0 | $0 | $0 | $0 | 4 |
| Craig Young | Trustee | 4 | $0 | $0 | $0 | $0 | 8 |
2015 · 45 people listed · 18 paid, $22.9M · 17,604 employees · 803 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| Richard Azizkhan | Former Surgeon-in-Chief | 50 | $3,084,594 | $0 | $116,505 | $3,201,099 | 1 |
| Andrew Redington | Institute Director - Cardiology | 50 | $2,336,164 | $0 | $134,387 | $2,470,551 | 1 |
| Scott Hamlin | Former COO (through 4/15) | 49 | $1,786,337 | $0 | $73,210 | $1,859,547 | 8 |
| Michael Fisher | President & CEO | 50 | $1,534,986 | $0 | $222,297 | $1,757,283 | 18 |
| David Morales | Prof/Div Dir, Cardiology | 50 | $1,614,809 | $0 | $52,101 | $1,666,910 | 1 |
| James Tweddell | Institute Director - Cardiothoracic Surgery | 50 | $1,272,276 | $0 | $164,329 | $1,436,605 | 1 |
| Frederick Ryckman | Sr. VP Medical Operations | 50 | $1,238,563 | $0 | $90,119 | $1,328,682 | 1 |
| Margaret Hostetter | Chair, Pediatrics | 50 | $1,119,203 | $0 | $83,020 | $1,202,223 | 1 |
| Dean Kurth through 616 | Anesthesiologist-in-Chief | 50 | $1,002,256 | $0 | $155,794 | $1,158,050 | 1 |
| Francesco Mangano | Prof/Div Dir, Neurosurgery | 50 | $1,065,874 | $0 | $62,579 | $1,128,453 | 1 |
| Daniel von Allmen MD | Surgeon-in-Chief | 50 | $916,104 | $0 | $127,756 | $1,043,860 | 1 |
| Brian Coley | Radiologist-in-Chief | 50 | $889,875 | $0 | $144,025 | $1,033,900 | 1 |
| Mark Mumford | SVP & CFO, Treasurer | 50 | $742,180 | $0 | $137,611 | $879,791 | 4 |
| Beth Stautberg | Secretary, Sr VP & Counsel | 50 | $729,598 | $0 | $107,605 | $837,203 | 4 |
| Cheryl Hoying RN-PhD | SVP Patient Services | 50 | $632,233 | $0 | $102,649 | $734,882 | 1 |
| Jennifer Dauer | SVP Strategy & Growth | 50 | $594,593 | $0 | $121,949 | $716,542 | 6 |
| Steve Davis | COO (Start 9/15) | 50 | $207,092 | $0 | $59,799 | $266,891 | 13 |
| Vicki Davies | Treasurer (through 6/15) | 49 | $156,676 | $0 | $9,393 | $166,069 | 4 |
| Sharry Addison | Trustee | 1 | $0 | $0 | $0 | $0 | 2 |
| Robert DH Anning | Trustee | 4 | $0 | $0 | $0 | $0 | 3 |
| Carol Armstrong | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Lynwood Battle | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Mark Biegger | Trustee | 1 | $0 | $0 | $0 | $0 | 3 |
| Maureen Bisognano | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Michael S Cambron | Trustee | 1 | $0 | $0 | $0 | $0 | 2 |
| Lee A Carter | Trustee | 1 | $0 | $0 | $0 | $0 | 6 |
| Thomas G Cody | Chairman | 4 | $0 | $0 | $0 | $0 | 7 |
| Dave Dougherty | Trustee | 4 | $0 | $0 | $0 | $0 | 4 |
| Nancy Krieger Eddy PhD | Trustee | 4 | $0 | $0 | $0 | $0 | 1 |
| Kay Geiger | Trustee | 1 | $0 | $0 | $0 | $0 | 10 |
| Louis D George | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Beth Guttman | Trustee | 1 | $0 | $0 | $0 | $0 | 9 |
| Deb Henretta | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Michael Hirschfeld Esq | Trustee | 4 | $0 | $0 | $0 | $0 | 2 |
| Gary Huffman | Trustee | 1 | $0 | $0 | $0 | $0 | 8 |
| Mark Jahnke | Trustee | 4 | $0 | $0 | $0 | $0 | 4 |
| Joyce J Keeshin | Trustee | 4 | $0 | $0 | $0 | $0 | 1 |
| M Denise Kuprionis | Trustee | 1 | $0 | $0 | $0 | $0 | 2 |
| David Osborn | Trustee | 1 | $0 | $0 | $0 | $0 | 4 |
| Jane Portman | Trustee | 4 | $0 | $0 | $0 | $0 | 2 |
| Liza Smitherman | Trustee | 1 | $0 | $0 | $0 | $0 | 7 |
| John Steinman | Trustee | 4 | $0 | $0 | $0 | $0 | 2 |
| Pamela Terp | Trustee | 1 | $0 | $0 | $0 | $0 | 4 |
| Felicia Williams | Trustee | 4 | $0 | $0 | $0 | $0 | 4 |
| Craig Young | Trustee | 4 | $0 | $0 | $0 | $0 | 8 |
2014 · 41 people listed · 13 paid, $14.5M · 16,766 employees · 775 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| Richard Azizkhan | Surgeon-in-Chief | 50 | $1,570,952 | $0 | $198,912 | $1,769,864 | 1 |
| Fred Ryckman | Sr. VP, Medical Operations | 50 | $1,532,217 | $0 | $151,129 | $1,683,346 | 1 |
| David Morales | Prof/Div Dir, Cardiology | 50 | $1,395,375 | $0 | $49,700 | $1,445,075 | 1 |
| Scott Hamlin | Executive VP & COO | 49 | $1,201,344 | $0 | $166,069 | $1,367,413 | 8 |
| Michael Fisher | President & CEO | 50 | $1,041,567 | $0 | $214,263 | $1,255,830 | 18 |
| Lane Donnelly | Former Highest Comp | 1 | $1,236,059 | $0 | $0 | $1,236,059 | 1 |
| Dean Kurth | Anesthesiologist-in-Chief | 50 | $1,069,393 | $0 | $153,202 | $1,222,595 | 1 |
| Eric Wall | Professor - Orthopaedic | 50 | $988,433 | $0 | $53,707 | $1,042,140 | 1 |
| Charles Mehlman | Professor - Orthopaedic | 50 | $912,374 | $0 | $26,256 | $938,630 | 1 |
| Mark Mumford | Chief Financial Officer | 50 | $737,068 | $0 | $135,096 | $872,164 | 4 |
| Beth Stautberg | Secretary, Sr VP & Counsel | 50 | $716,109 | $0 | $106,521 | $822,630 | 4 |
| Margaret Hostetter | Chair, Pediatrics | 50 | $477,057 | $0 | $81,600 | $558,657 | 1 |
| Vicki Davies | Treasurer | 49 | $251,454 | $0 | $15,463 | $266,917 | 4 |
| Sharry Addison | Trustee | 1 | $0 | $0 | $0 | $0 | 2 |
| Robert DH Anning | Trustee | 4 | $0 | $0 | $0 | $0 | 3 |
| Carol Armstrong | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Lynwood Battle | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Maureen Bisognano | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Michael S Cambron | Trustee | 1 | $0 | $0 | $0 | $0 | 2 |
| Willie F Carden Jr | Trustee (Through 10/14) | 1 | $0 | $0 | $0 | $0 | 1 |
| Lee A Carter | Trustee | 4 | $0 | $0 | $0 | $0 | 6 |
| Thomas G Cody | Chairman | 4 | $0 | $0 | $0 | $0 | 7 |
| Dave Dougherty | Trustee | 1 | $0 | $0 | $0 | $0 | 4 |
| Nancy Krieger Eddy PHD | Trustee | 4 | $0 | $0 | $0 | $0 | 1 |
| Vallie Geier | Trustee | 1 | $0 | $0 | $0 | $0 | 3 |
| Kay Geiger | Trustee | 1 | $0 | $0 | $0 | $0 | 10 |
| Louis D George | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Beth Guttman | Trustee | 1 | $0 | $0 | $0 | $0 | 9 |
| Deb Henretta | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Michael Hirschfeld Esq | Trustee | 4 | $0 | $0 | $0 | $0 | 2 |
| Gary Huffman | Trustee | 1 | $0 | $0 | $0 | $0 | 8 |
| Mark Jahnke | Trustee | 1 | $0 | $0 | $0 | $0 | 4 |
| Joyce J Keeshin | Trustee | 4 | $0 | $0 | $0 | $0 | 1 |
| M Denise Kuprionis | Trustee | 4 | $0 | $0 | $0 | $0 | 2 |
| Peggy Mathile | Trustee (Through 07/14) | 1 | $0 | $0 | $0 | $0 | 3 |
| Jane Portman | Trustee | 4 | $0 | $0 | $0 | $0 | 2 |
| Liza Smitherman | Trustee | 1 | $0 | $0 | $0 | $0 | 7 |
| John Steinman | Trustee | 1 | $0 | $0 | $0 | $0 | 2 |
| Pamela Terp | Trustee | 1 | $0 | $0 | $0 | $0 | 4 |
| Felicia Williams | Trustee | 4 | $0 | $0 | $0 | $0 | 4 |
| Craig Young | Trustee | 1 | $0 | $0 | $0 | $0 | 8 |
2013 · 38 people listed · 13 paid, $13.1M · 16,202 employees · 770 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| RICHARD AZIZKHAN | SURGEON-IN-CHIEF | 50 | $1,477,722 | $0 | $188,438 | $1,666,160 | 1 |
| DAVID MORALES | PROF/DIV DIR, CARDIOLOGY | 50 | $1,306,225 | $0 | $48,686 | $1,354,911 | 1 |
| ARNOLD STRAUSS | CHAIR, PEDIATRICS | 50 | $1,158,636 | $0 | $64,436 | $1,223,072 | 1 |
| SCOTT HAMLIN | EXEC VP & COO | 49 | $1,038,937 | $0 | $160,041 | $1,198,978 | 8 |
| DEAN KURTH | ANESTHESIOLOGIST-IN-CHIEF | 50 | $1,038,662 | $0 | $151,507 | $1,190,169 | 1 |
| MICHAEL FISHER | PRESIDENT & CEO | 50 | $985,024 | $0 | $203,166 | $1,188,190 | 18 |
| CHARLES MYER III | PROFESSOR - FACULTY | 50 | $1,003,038 | $0 | $25,756 | $1,028,794 | 1 |
| FRANCESCO MANGANO | PROFESSOR - FACULTY | 50 | $920,218 | $0 | $60,919 | $981,137 | 1 |
| ERIC WALL | PROFESSOR - FACULTY | 50 | $911,018 | $0 | $52,591 | $963,609 | 1 |
| BETH STAUTBERG | SECRETARY, SR VP & COUNSEL | 50 | $723,159 | $0 | $104,921 | $828,080 | 4 |
| MARK MUMFORD | CHIEF FINANCIAL OFFICER | 50 | $676,502 | $0 | $110,485 | $786,987 | 4 |
| MARGARET HOSTETTER | CHAIR, PEDIATRICS | 50 | $380,724 | $0 | $34,330 | $415,054 | 1 |
| VICKI DAVIES | TREASURER | 49 | $230,606 | $0 | $16,717 | $247,323 | 4 |
| SHARRY ADDISON | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| ROBERT DH ANNING | TRUSTEE | 4 | $0 | $0 | $0 | $0 | 3 |
| CAROL ARMSTRONG | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| LYNWOOD BATTLE | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| MAUREEN BISOGNANO | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| MICHAEL S CAMBRON | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| WILLIE F CARDEN JR | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| LEE A CARTER | TRUSTEE | 4 | $0 | $0 | $0 | $0 | 6 |
| THOMAS G CODY | CHAIRMAN | 4 | $0 | $0 | $0 | $0 | 7 |
| DAVE DOUGHERTY | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 4 |
| NANCY KRIEGER EDDY PHD | TRUSTEE | 4 | $0 | $0 | $0 | $0 | 1 |
| VALLIE GEIER | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 3 |
| LOUIS D GEORGE | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| BETH GUTTMAN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 9 |
| DEB HENRETTA | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| MICHAEL HIRSCHFELD ESQ | TRUSTEE | 4 | $0 | $0 | $0 | $0 | 2 |
| MARK JAHNKE | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 4 |
| JOYCE J KEESHIN | TRUSTEE | 4 | $0 | $0 | $0 | $0 | 1 |
| M DENISE KUPRIONIS | TRUSTEE | 4 | $0 | $0 | $0 | $0 | 2 |
| PEGGY MATHILE | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 3 |
| JANE PORTMAN | TRUSTEE | 4 | $0 | $0 | $0 | $0 | 2 |
| JOHN STEINMAN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| PAMELA TERP | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 4 |
| FELICIA WILLIAMS | TRUSTEE | 4 | $0 | $0 | $0 | $0 | 4 |
| CRAIG YOUNG | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 8 |
2012 · 34 people listed · 11 paid, $11.1M · 14,837 employees · 724 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| RICHARD AZIZKHAN | SURGEON-IN-CHIEF | 50 | $1,631,748 | $0 | $209,146 | $1,840,894 | 1 |
| DEAN KURTH | ANESTHESIOLOGIST-IN-CHIEF | 50 | $996,001 | $0 | $148,481 | $1,144,482 | 1 |
| SCOTT HAMLIN | EXEC VP & COO | 49 | $948,827 | $0 | $166,062 | $1,114,889 | 8 |
| MICHAEL FISHER | PRESIDENT & CEO | 49 | $907,237 | $0 | $195,616 | $1,102,853 | 18 |
| CHARLES MYER III | PROFESSOR - FACULTY | 50 | $1,064,155 | $0 | $25,256 | $1,089,411 | 1 |
| DAVID MORALES | PROF/DIV DIR, CARDIOLOGY | 50 | $1,003,231 | $0 | $36,882 | $1,040,113 | 1 |
| JAY PAUL WILLGING | PROFESSOR - FACULTY | 50 | $933,809 | $0 | $25,256 | $959,065 | 1 |
| JEFFREY TOWBIN | PROF/DIV DIR, CARDIOLOGY | 50 | $871,019 | $0 | $52,287 | $923,306 | 1 |
| ARNOLD STRAUSS | PROF/CHAIR, PEDIATRICS | 50 | $834,783 | $0 | $60,723 | $895,506 | 1 |
| BETH STAUTBERG | SECRETARY, SR VP & COUNSEL | 50 | $645,670 | $0 | $100,434 | $746,104 | 4 |
| VICKI DAVIES | TREASURER | 49 | $235,232 | $0 | $14,920 | $250,152 | 4 |
| SHARRY ADDISON | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| ROBERT DH ANNING | TRUSTEE | 4 | $0 | $0 | $0 | $0 | 3 |
| CAROL ARMSTRONG | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| LYNWOOD BATTLE | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| MICHAEL S CAMBRON | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| WILLIE F CARDEN JR | TRUSTEE | 4 | $0 | $0 | $0 | $0 | 1 |
| LEE A CARTER | TRUSTEE | 4 | $0 | $0 | $0 | $0 | 6 |
| THOMAS G CODY | CHAIRMAN | 4 | $0 | $0 | $0 | $0 | 7 |
| DAVE DOUGHERTY | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 4 |
| NANCY KRIEGER EDDY PHD | TRUSTEE | 4 | $0 | $0 | $0 | $0 | 1 |
| VALLIE GEIER | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 3 |
| LOUIS D GEORGE | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| BETH GUTTMAN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 9 |
| MICHAEL HIRSCHFELD ESQ | TRUSTEE | 4 | $0 | $0 | $0 | $0 | 2 |
| MARK JAHNKE | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 4 |
| JOYCE J KEESHIN | TRUSTEE | 4 | $0 | $0 | $0 | $0 | 1 |
| M DENISE KUPRIONIS | TRUSTEE | 4 | $0 | $0 | $0 | $0 | 2 |
| PEGGY MATHILE | TRUSTEE | 4 | $0 | $0 | $0 | $0 | 3 |
| JANE PORTMAN | TRUSTEE | 4 | $0 | $0 | $0 | $0 | 2 |
| JOHN STEINMAN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| PAMELA TERP | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 4 |
| FELICIA WILLIAMS | TRUSTEE | 4 | $0 | $0 | $0 | $0 | 4 |
| CRAIG YOUNG | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 8 |
2011 · 34 people listed · 13 paid, $11.8M · 14,096 employees · 737 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| RICHARD AZIZKHAN | SURGEON-IN-CHIEF | 40 | $1,221,615 | $0 | $256,749 | $1,478,364 | 1 |
| ERIC WALL | ORTHOPAEDIST | 40 | $1,297,999 | $0 | $56,231 | $1,354,230 | 1 |
| DEAN KURTH | ANESTHESIOLOGIST-IN-CHIEF | 40 | $1,140,101 | $0 | $146,276 | $1,286,377 | 1 |
| MICHAEL FISHER | PRESIDENT & CEO | 40 | $831,532 | $0 | $303,809 | $1,135,341 | 18 |
| CHARLES MYER III | OTOLARYNGOLOGIST | 40 | $1,044,688 | $0 | $24,756 | $1,069,444 | 1 |
| ARNOLD STRAUSS | PROF/CHAIR, PEDIATRICS | 40 | $899,960 | $0 | $111,524 | $1,011,484 | 1 |
| SCOTT HAMLIN | EXEC VP & COO | 40 | $821,244 | $0 | $167,463 | $988,707 | 8 |
| JAY PAUL WILLGING | OTOLARYNGOLOGIST | 40 | $909,514 | $0 | $24,756 | $934,270 | 1 |
| JEFFREY TOWBIN | PROF/DIV DIR, CARDIOLOGY | 40 | $860,293 | $0 | $50,123 | $910,416 | 1 |
| BETH STAUTBERG | SECRETARY, SR VP & COUNSEL | 40 | $642,489 | $0 | $98,361 | $740,850 | 4 |
| JAMES M ANDERSON | RETIRED FORMER EXECUTIVE | 40 | $636,894 | $0 | $13,936 | $650,830 | 5 |
| VICKI DAVIES | TREASURER | 40 | $203,830 | $0 | $12,207 | $216,037 | 4 |
| THOMAS F BOAT | RETIRED FORMER EXECUTIVE | 40 | $22,910 | $0 | $1,423 | $24,333 | 1 |
| SHARRY ADDISON | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| ROBERT DH ANNING | TRUSTEE | 4 | $0 | $0 | $0 | $0 | 3 |
| CAROL ARMSTRONG | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| LYNWOOD BATTLE | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| MICHAEL S CAMBRON | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| WILLIE F CARDEN JR | TRUSTEE | 4 | $0 | $0 | $0 | $0 | 1 |
| LEE A CARTER | TRUSTEE | 4 | $0 | $0 | $0 | $0 | 6 |
| THOMAS G CODY | CHAIRMAN | 4 | $0 | $0 | $0 | $0 | 7 |
| KATHARINE DEWITT | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 3 |
| NANCY KRIEGER EDDY PHD | TRUSTEE | 4 | $0 | $0 | $0 | $0 | 1 |
| VALLIE GEIER | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 3 |
| LOUIS D GEORGE | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| MICHAEL HIRSCHFELD ESQ | TRUSTEE | 4 | $0 | $0 | $0 | $0 | 2 |
| JOYCE J KEESHIN | TRUSTEE | 4 | $0 | $0 | $0 | $0 | 1 |
| M DENISE KUPRIONIS | TRUSTEE | 4 | $0 | $0 | $0 | $0 | 2 |
| PEGGY MATHILE | TRUSTEE | 4 | $0 | $0 | $0 | $0 | 3 |
| JANE PORTMAN | TRUSTEE | 4 | $0 | $0 | $0 | $0 | 2 |
| JOHN STEINMAN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| PAMELA TERP | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 4 |
| FELICIA WILLIAMS | TRUSTEE | 4 | $0 | $0 | $0 | $0 | 4 |
| CRAIG YOUNG | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 8 |
2010 · 35 people listed · 12 paid, $14.8M · 13,637 employees · 620 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| JAMES M ANDERSON | RETIRED FORMER EXECUTIVE | 40 | $4,210,454 | $0 | $17,727 | $4,228,181 | 5 |
| RICHARD AZIZKHAN | SURGEON-IN-CHIEF | 40 | $1,218,743 | $0 | $223,985 | $1,442,728 | 1 |
| MICHAEL FISHER | PRESIDENT & CEO | 40 | $865,537 | $0 | $175,899 | $1,041,436 | 18 |
| LANE DONNELLY | RADIOLOGIST-IN-CHIEF | 40 | $868,579 | $0 | $153,915 | $1,022,494 | 1 |
| ERIC WALL | ORTHOPAEDIST | 40 | $955,752 | $0 | $56,057 | $1,011,809 | 1 |
| CHARLES MYER III | OTOLARYNGOLOGIST | 40 | $986,707 | $0 | $24,756 | $1,011,463 | 1 |
| DEAN KURTH | ANESTHESIOLOGIST-IN-CHIEF | 40 | $850,606 | $0 | $144,546 | $995,152 | 1 |
| ARNOLD STRAUSS | PROF/CHAIR, PEDIATRICS | 40 | $804,334 | $0 | $155,340 | $959,674 | 1 |
| CHARLES MEHLMAN | ORTHOPAEDIST | 40 | $893,206 | $0 | $46,266 | $939,472 | 1 |
| SCOTT HAMLIN | TREASURER, CHIEF FIN & ADMIN OFFICER | 40 | $750,409 | $0 | $157,058 | $907,467 | 8 |
| THOMAS F BOAT | RETIRED FORMER EXECUTIVE | 40 | $611,949 | $0 | $34,423 | $646,372 | 1 |
| BETH STAUTBERG | SECRETARY, SR VP & COUNSEL | 40 | $539,478 | $0 | $89,861 | $629,339 | 4 |
| SHARRY ADDISON | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| ROBERT DH ANNING | TRUSTEE | 4 | $0 | $0 | $0 | $0 | 3 |
| CAROL ARMSTRONG | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| LYNWOOD BATTLE | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| MICHAEL S CAMBRON | TRUSTEE | 4 | $0 | $0 | $0 | $0 | 2 |
| WILLIE F CARDEN JR | TRUSTEE | 4 | $0 | $0 | $0 | $0 | 1 |
| LEE A CARTER | TRUSTEE | 4 | $0 | $0 | $0 | $0 | 6 |
| THOMAS G CODY | CHAIRMAN | 4 | $0 | $0 | $0 | $0 | 7 |
| KATHARINE DEWITT | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 3 |
| NANCY KRIEGER EDDY PHD | TRUSTEE | 4 | $0 | $0 | $0 | $0 | 1 |
| VALLIE GEIER | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 3 |
| LOUIS D GEORGE | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| MICHAEL HIRSCHFELD ESQ | TRUSTEE | 4 | $0 | $0 | $0 | $0 | 2 |
| JOYCE J KEESHIN | TRUSTEE | 4 | $0 | $0 | $0 | $0 | 1 |
| M DENISE KUPRIONIS | TRUSTEE | 4 | $0 | $0 | $0 | $0 | 2 |
| PEGGY MATHILE | TRUSTEE | 4 | $0 | $0 | $0 | $0 | 3 |
| MANUEL D MAYERSON | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| JANE PORTMAN | TRUSTEE | 4 | $0 | $0 | $0 | $0 | 2 |
| WILLIAM K SCHUBERT | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 5 |
| JOHN STEINMAN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| PAMELA TERP | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 4 |
| FELICIA WILLIAMS | TRUSTEE | 4 | $0 | $0 | $0 | $0 | 4 |
| CRAIG YOUNG | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 8 |
2009 · 42 people listed · 13 paid, $10.5M · 13,082 employees · 601 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| JAMES ANDERSON - CEO | PRES (7/1/09-12/31/09) | 40 | $1,855,579 | $0 | $39,203 | $1,894,782 | 1 |
| RICHARD AZIZKHAN MD | SURGEON-IN-CHIEF | 40 | $1,221,114 | $0 | $211,176 | $1,432,290 | 1 |
| erIC WALL | ORTHOPAEDIST | 40 | $1,002,368 | $0 | $49,464 | $1,051,832 | 1 |
| CHARLES MYER III | OTOLARYNGOLOGIST | 40 | $968,316 | $0 | $24,860 | $993,176 | 1 |
| DEAN KURTH | CHIEF ANESTHESIOLOGIST | 40 | $822,166 | $0 | $143,257 | $965,423 | 1 |
| SCOTT HAMLIN | SR VP, TREASURER, CFO | 40 | $779,336 | $0 | $150,718 | $930,054 | 8 |
| CHARLES MEHLMAN | ORTHOPAEDIST | 40 | $883,681 | $0 | $46,316 | $929,997 | 1 |
| JEFF ROBBINS | CO-DIRECTOR HEART INSTITUTE | 40 | $884,181 | $0 | $45,282 | $929,463 | 1 |
| ARNOLD STRAUSS MD | PROF/CHAIR, PEDIATRICS | 40 | $707,595 | $0 | $148,798 | $856,393 | 1 |
| THOMAS F BOAT MD | TRUSTEE | 40 | $272,191 | $0 | $32,955 | $305,146 | 1 |
| DIANE WHITE | SECRETARY | 40 | $81,035 | $0 | $15,636 | $96,671 | 1 |
| MICHAEL FISHER - CEO | PRES. (1/1/10-6/30/10) | 40 | $65,907 | $0 | $24,061 | $89,968 | 1 |
| WILLIAM K SCHUBERT MD | TRUSTEE | 20 | $25,000 | $0 | $0 | $25,000 | 5 |
| THOMAS G CODY | CHAIRMAN | 4 | $0 | $0 | $0 | $0 | 7 |
| SHARRY ADDISON | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| ROBERT DH ANNING | TRUSTEE | 4 | $0 | $0 | $0 | $0 | 3 |
| CAROL ARMSTRONG | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| LYNWOOD BATTLE | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| MICHAEL S CAMBRON | TRUSTEE | 4 | $0 | $0 | $0 | $0 | 2 |
| WILLIE F CARDEN JR | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| LEE A CARTER | TRUSTEE | 4 | $0 | $0 | $0 | $0 | 6 |
| KATHARINE DEWITT | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 3 |
| TODD M DUNCAN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| NANCY KRIEGER EDDY PHD | TRUSTEE | 4 | $0 | $0 | $0 | $0 | 1 |
| BARBARA FITCH | TRUSTEE | 4 | $0 | $0 | $0 | $0 | 2 |
| VALLIE GEIER | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 3 |
| LOUIS D GEORGE | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| CAMILLE C GRAHAM MD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| DEBORAH A HENRETTA | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| MICHAEL HIRSCHFELD ESQ | TRUSTEE | 4 | $0 | $0 | $0 | $0 | 2 |
| JOYCE J KEESHIN | TRUSTEE | 4 | $0 | $0 | $0 | $0 | 1 |
| M DENISE KUPRIONIS | TRUSTEE | 4 | $0 | $0 | $0 | $0 | 2 |
| PEGGY MATHILE | TRUSTEE | 4 | $0 | $0 | $0 | $0 | 3 |
| MANUEL D MAYERSON | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| MARDIE OFF | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| GEOFFREY PLACE | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| JANE PORTMAN | TRUSTEE | 4 | $0 | $0 | $0 | $0 | 2 |
| JOHN SAWYER | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| JOHN STEINMAN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| PAMELA TERP | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 4 |
| FELICIA WILLIAMS | TRUSTEE | 4 | $0 | $0 | $0 | $0 | 4 |
| JOHN P ZANOTTI | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
Highest-paid independent contractors
2024 · 5 contractors · $218.7M
| Name | Location | Service | Paid |
|---|---|---|---|
| MESSER CONSTRUCTION CO | CINCINNATI, OH | CONSTRUCTION SERVICES | $86,581,302 |
| TRIVERSITY CONSTRUCTION COMPANY LLC | CINCINNATI, OH | CONSTRUCTION SERVICES | $54,701,607 |
| ENCORE TECHNOLOGIES | CINCINNATI, OH | INFORMATION SERVICES | $31,617,615 |
| CROTHALL HEALTHCARE | WAYNE, PA | HOUSEKEEPING SERVICES | $29,190,743 |
| HURON CONSULTING GROUP | CHICAGO, IL | CONSULTING SERVICES | $16,649,983 |
2023 · 5 contractors · $218.0M
| Name | Location | Service | Paid |
|---|---|---|---|
| MESSER CONSTRUCTION CO | CINCINNATI, OH | CONSTRUCTION SERVICES | $113,109,115 |
| TRIVERSITY CONSTRUCTION COMPANY LLC | CINCINNATI, OH | CONSTRUCTION SERVICES | $46,067,939 |
| CROTHALL HEALTHCARE | WAYNE, PA | HOUSEKEEPING SERVICES | $24,844,603 |
| QUALIVIS LLC | SAN DIEGO, CA | STAFFING SERVICES | $24,336,743 |
| SODEXO | GAITHERSBURG, MD | FOOD SERVICES | $9,653,768 |
2022 · 5 contractors · $202.9M
| Name | Location | Service | Paid |
|---|---|---|---|
| MESSER CONSTRUCTION CO | CINCINNATI, OH | CONSTRUCTION SERVICES | $116,360,905 |
| TRIVERSITY CONSTRUCTION COMPANY LLC | CINCINNATI, OH | CONSTRUCTION SERVICES | $29,949,216 |
| QUALIVIS LLC | SAN DIEGO, CA | STAFFING SERVICES | $24,732,464 |
| CROTHALL HEALTHCARE | WAYNE, PA | HOUSEKEEPING SERVICES | $23,500,578 |
| SODEXO | GAITHERSBURG, MD | FOOD SERVICES | $8,327,994 |
2021 · 5 contractors · $146.0M
| Name | Location | Service | Paid |
|---|---|---|---|
| MESSER CONSTRUCTION CO | CINCINNATI, OH | CONSTRUCTION SERVICES | $95,167,969 |
| CROTHALL HEALTHCARE | WAYNE, PA | HOUSEKEEPING SERVICES | $21,554,533 |
| TRIVERSITY CONSTRUCTION COMPANY LLC | CINCINNATI, OH | CONSTRUCTION SERVICES | $16,500,689 |
| ZGF ARCHITECTS LLC | PORTLAND, OR | CONSTRUCTION SERVICES | $7,490,053 |
| SODEXO | GAITHERSBURG, MD | FOOD SERVICES | $5,296,616 |
2020 · 5 contractors · $170.6M
| Name | Location | Service | Paid |
|---|---|---|---|
| MESSER CONSTRUCTION CO | CINCINNATI, OH | CONSTRUCTION SERVICES | $115,231,040 |
| TRIVERSITY CONSTRUCTION COMPANY LLC | CINCINNATI, OH | CONSTRUCTION SERVICES | $23,195,710 |
| CROTHALL HEALTHCARE | CINCIINNATI, OH | HOUSEKEEPING SERVICES | $21,324,286 |
| ZGF ARCHITECTS LLC | PORTLAND, OR | CONSTRUCTION SERVICES | $6,229,770 |
| BAREFOOT LLC | CINCINNATI, OH | ADVERTISING/MARKETING SERVICES | $4,644,279 |
2019 · 5 contractors · $199.2M
| Name | Location | Service | Paid |
|---|---|---|---|
| Messer Construction Co | Cincinnati, OH | Construction Services | $138,616,633 |
| TriVersity Group LLC | Cincinnati, OH | Construction Services | $22,367,120 |
| Crothall Healthcare | Cincinnati, OH | Housekeeping Services | $20,759,680 |
| McKinsey & Company Inc | Philadelphia, PA | Management Consulting Services | $11,299,160 |
| ZGF Architects LLC | Portland, OR | Construction Services | $6,163,875 |
2018 · 5 contractors · $128.3M
| Name | Location | Service | Paid |
|---|---|---|---|
| Messer Construction Co | Cincinnati, OH | Construction Services | $75,273,051 |
| TriVersity Group LLC | Cincinnati, OH | Construction Services | $23,643,799 |
| Crothall Healthcare | Wayne, PA | Housekeeping Services | $17,721,284 |
| ZGF Architects LLC | Portland, OR | Construction Services | $6,493,916 |
| Barefoot Proximity | Cincinnati, OH | Advertising/Marketing Services | $5,176,309 |
2017 · 5 contractors · $90.2M
| Name | Location | Service | Paid |
|---|---|---|---|
| Messer Construction Co | Cincinnati, OH | Construction Services | $28,337,263 |
| TriVersity Group LLC | Cincinnati, OH | Construction Services | $21,838,481 |
| Crothall Healthcare | Wayne, PA | Housekeeping Services | $17,254,107 |
| ZGF Architects LLC | Portland, OR | Construction Services | $16,285,809 |
| Turner Construction Company | Cincinnati, OH | Construction Services | $6,474,426 |
2016 · 5 contractors · $59.9M
| Name | Location | Service | Paid |
|---|---|---|---|
| Triversity Group LLC | Cincinnati, OH | Construction Services | $20,577,054 |
| Crothall Healthcare | Wayne, PA | Housekeeping Services | $15,577,208 |
| Messer Construction | Cincinnati, OH | Construction Services | $14,035,533 |
| ZGF Architects LLC | Portland, OR | Construction Services | $5,692,491 |
| Huron Consulting Group | Chicago, IL | Consulting Services | $4,041,207 |
2015 · 5 contractors · $101.0M
| Name | Location | Service | Paid |
|---|---|---|---|
| Messer Construction | Cincinnati, OH | Construction Services | $39,071,327 |
| Triversity Group LLC | Cincinnati, OH | Construction Services | $26,777,909 |
| Messer Linbeck | Cincinnati, OH | Construction Services | $17,216,520 |
| Crothall Healthcare | Wayne, PA | Housekeeping Services | $11,169,255 |
| Aramark Corporation | Cincinnati, OH | Housekeeping Services | $6,795,221 |
2014 · 5 contractors · $195.5M
| Name | Location | Service | Paid |
|---|---|---|---|
| Messer Construction | Cincinnati, OH | Construction Services | $112,442,580 |
| Messer Linbeck | Cincinnati, OH | Construction Services | $31,779,132 |
| Triversity Group LLC | Cincinnati, OH | Construction Services | $27,410,704 |
| Aramark Corporation | Cincinnati, OH | Housekeeping Services | $11,986,043 |
| Turner Construction | Cincinnati, OH | Construction Services | $11,924,993 |
2013 · 5 contractors · $144.2M
| Name | Location | Service | Paid |
|---|---|---|---|
| MESSER CONSTRUCTION | CONSTRUCTION SERVICES | $86,026,838 | |
| TRIVERSITY GROUP LLC | CONSTRUCTION SERVICES | $25,944,452 | |
| ARAMARK CORPORATION | ENVIRONMENTAL SERVICES | $12,587,871 | |
| CBT SOLUTIONS | IT CONSULTING | $9,950,342 | |
| MESSER LINBECK | CONSTRUCTION SERVICES | $9,644,482 |
2012 · 5 contractors · $131.1M
| Name | Location | Service | Paid |
|---|---|---|---|
| MESSER CONSTRUCTION | CINCINNATI, OH | CONSTRUCTION SERVICES | $48,542,275 |
| TRIVERSITY GROUP LLC | CINCINNATI, OH | CONSTRUCTION SERVICES | $38,813,233 |
| TURNER CONSTRUCTION COMPANY | CINCINNATI, OH | CONSTRUCTION SERVICES | $20,457,583 |
| ARAMARK CORPORATION | CINCINNATI, OH | ENVIRONMENTAL SERVICES | $13,712,271 |
| POMEROY IT SOLUTIONS | HEBRON, KY | IT EQUIPMENT & SERVICES | $9,530,984 |
2011 · 5 contractors · $75.0M
| Name | Location | Service | Paid |
|---|---|---|---|
| TRIVERSITY GROUP LLC | CINCINNATI, OH | CONSTRUCTION SERVICES | $32,564,324 |
| ARAMARK CORPORATION | CINCINNATI, OH | ENVIRONMENTAL SERVICES | $15,756,470 |
| MESSER CONSTRUCTION | CINCINNATI, OH | CONSTRUCTION SERVICES | $10,205,296 |
| POMEROY IT SOLUTIONS | HEBRON, KY | IT CONSULTING | $8,931,707 |
| MEDICAL RECOVERY SYSTEMS INC | CINCINNATI, OH | AR SERVICES | $7,546,814 |
2010 · 5 contractors · $66.5M
| Name | Location | Service | Paid |
|---|---|---|---|
| TRIVERSITY GROUP LLC | CINCINNATI, OH | CONSTRUCTION SERVICES | $31,063,167 |
| ARAMARK CORPORATION | CINCINNATI, OH | ENVIRONMENTAL SERVICES | $14,639,216 |
| MEDICAL RECOVERY SYSTEMS INC | CINCINNATI, OH | AR SERVICES | $8,221,101 |
| POMEROY IT SOLUTIONS | HEBRON, KY | IT CONSULTING | $8,096,648 |
| CBTS | CINCINNATI, OH | IT CONSULTING | $4,443,578 |
2009 · 5 contractors · $78.2M
| Name | Location | Service | Paid |
|---|---|---|---|
| TRIVERSITY GROUP LLC | CINCINNATI, OH | CONSTRUCTION SERVICES | $27,783,570 |
| AL NEYER LLC | CINCINNATI, OH | CONSTRUCTION SERVICES | $26,610,785 |
| SODEXHO INC | DAYTON, OH | ENVIRONMENTAL AND FOOD SERVICES | $10,476,226 |
| POMEROY IT SOLUTIONS | HEBRON, KY | IT CONSULTING | $8,303,121 |
| EPIC | VERONA, WI | IT CONSULTING | $4,999,275 |
Paid as a vendor by
Other organizations that listed this one among their highest-paid independent contractors. Contractor lists give no EIN, so these are matched on name and address; check the filing.
| Year | Paid by | Service | Paid | Filing |
|---|---|---|---|---|
| 2024 | EVERY CHILD SUCCEEDS INC | Staffing/Support Svcs | $3,038,288 | view vendor page |
| 2023 | EVERY CHILD SUCCEEDS INC | Staffing/Support Svcs | $2,694,928 | view vendor page |
| 2022 | EVERY CHILD SUCCEEDS INC | Staffing/Support Svcs | $2,159,945 | view vendor page |
| 2021 | UC HEALTHCARE SYSTEM | LABORATORY & CLINICAL SERVICES | $9,326,054 | view vendor page |
| 2021 | EVERY CHILD SUCCEEDS INC | Staffing/Support Svcs | $2,017,764 | view vendor page |
| 2020 | UC HEALTHCARE SYSTEM | LABORATORY & CLINICAL SERVICES | $8,486,406 | view vendor page |
| 2020 | EVERY CHILD SUCCEEDS INC | Staffing/Support Svcs | $1,691,058 | view vendor page |
| 2019 | CARESOURCE OHIO INC | Medical Services | $217,476,690 | view vendor page |
| 2019 | UC HEALTHCARE SYSTEM | Laboratory & Clinical Services | $9,086,186 | view vendor page |
| 2019 | EVERY CHILD SUCCEEDS INC | Staffing/Support Svcs | $1,370,000 | view vendor page |
| 2018 | CARESOURCE OHIO INC | Medical Services | $210,714,952 | view vendor page |
| 2018 | UC HEALTHCARE SYSTEM | Laboratory & Clinical Services | $7,874,214 | view vendor page |
| 2018 | EVERY CHILD SUCCEEDS INC | Staffing/Support Svcs | $1,390,249 | view vendor page |
| 2017 | UC HEALTHCARE SYSTEM | Laboratory & Clinical Services (Sch O) | $7,271,278 | view vendor page |
| 2017 | EVERY CHILD SUCCEEDS INC | Staffing/Support Svcs | $1,608,496 | view vendor page |
| 2016 | UC HEALTHCARE SYSTEM | Laboratory & Clinical Services (Sch O) | $3,916,657 | view vendor page |
| 2016 | EVERY CHILD SUCCEEDS INC | Staffing/Support Svcs | $1,668,639 | view vendor page |
| 2016 | GENETIC ALLIANCE INC | RESEARCH SUPPORT | $122,042 | view vendor page |
| 2015 | UC HEALTHCARE SYSTEM | Laboratory & Clinical Services (Sch O) | $2,474,668 | view vendor page |
| 2015 | EVERY CHILD SUCCEEDS INC | Staffing/Support Svcs | $1,857,442 | view vendor page |
| 2014 | EVERY CHILD SUCCEEDS INC | Staffing/Support Svcs | $1,869,673 | view vendor page |
| 2014 | DENTAQUEST INSTITUTE INC | PROGRAM CONSULTING | $110,815 | view vendor page |
| 2012 | EVERY CHILD SUCCEEDS INC | STAFFING/SUPPORT SVCS | $2,270,749 | view vendor page |
| 2012 | ST ALOYSIUS ORPHANAGE | Psychiatry | $107,574 | view vendor page |
| 2011 | EVERY CHILD SUCCEEDS INC | Staffing & Support Services | $1,095,631 | view vendor page |
| 2011 | ST ALOYSIUS ORPHANAGE | Psychiatry | $160,948 | view vendor page |
| 2010 | CARESOURCE OHIO INC | Medical Services | $82,335,857 | view vendor page |
Who the money went to
Grants this organization reported paying: Schedule I Part II of the Form 990, or the grants-paid list on the 990-PF. Open a year for every recipient. Recipients link to their own page when the grant names an EIN we have (990-PF grants list no EIN, so those link only on an exact, unique name and state). Grants to individuals are counted; their names are not shown.
2024 · 44 grants to organizations · $2.5M
Listed grants add up to $2,499,515; the return's “grants paid” expense line says $7,673,803. Returns can differ here (grants paid vs. accrued, items listed elsewhere); check the filing.
2023 · 64 grants to organizations · $2.4M
Listed grants add up to $2,443,399; the return's “grants paid” expense line says $7,312,812. Returns can differ here (grants paid vs. accrued, items listed elsewhere); check the filing.
2022 · 58 grants to organizations · $2.6M
Listed grants add up to $2,568,531; the return's “grants paid” expense line says $7,719,351. Returns can differ here (grants paid vs. accrued, items listed elsewhere); check the filing.
2021 · 53 grants to organizations · $3.2M
Listed grants add up to $3,197,561; the return's “grants paid” expense line says $6,199,940. Returns can differ here (grants paid vs. accrued, items listed elsewhere); check the filing.
2020 · 39 grants to organizations · $2.9M
Listed grants add up to $2,863,262; the return's “grants paid” expense line says $6,789,659. Returns can differ here (grants paid vs. accrued, items listed elsewhere); check the filing.
2019 · 39 grants to organizations · $3.0M
Listed grants add up to $2,974,414; the return's “grants paid” expense line says $6,864,249. Returns can differ here (grants paid vs. accrued, items listed elsewhere); check the filing.
2018 · 41 grants to organizations · $2.5M
Listed grants add up to $2,536,234; the return's “grants paid” expense line says $9,633,252. Returns can differ here (grants paid vs. accrued, items listed elsewhere); check the filing.
2017 · 52 grants to organizations · $2.9M
Listed grants add up to $2,890,504; the return's “grants paid” expense line says $5,874,680. Returns can differ here (grants paid vs. accrued, items listed elsewhere); check the filing.
2016 · 49 grants to organizations · $1.7M
Listed grants add up to $1,672,738; the return's “grants paid” expense line says $5,100,964. Returns can differ here (grants paid vs. accrued, items listed elsewhere); check the filing.
2015 · 34 grants to organizations · $2.0M
Listed grants add up to $2,039,554; the return's “grants paid” expense line says $4,848,180. Returns can differ here (grants paid vs. accrued, items listed elsewhere); check the filing.
2014 · 16 grants to organizations · $560K
Listed grants add up to $560,321; the return's “grants paid” expense line says $2,027,513. Returns can differ here (grants paid vs. accrued, items listed elsewhere); check the filing.
2013 · 22 grants to organizations · $369K
Listed grants add up to $369,498; the return's “grants paid” expense line says $3,501,939. Returns can differ here (grants paid vs. accrued, items listed elsewhere); check the filing.
2012 · 23 grants to organizations · $530K
Listed grants add up to $530,487; the return's “grants paid” expense line says $1,244,482. Returns can differ here (grants paid vs. accrued, items listed elsewhere); check the filing.
2011 · 19 grants to organizations · $498K
Listed grants add up to $497,753; the return's “grants paid” expense line says $783,642. Returns can differ here (grants paid vs. accrued, items listed elsewhere); check the filing.
2010 · 25 grants to organizations · $1.6M
Listed grants add up to $1,592,296; the return's “grants paid” expense line says $2,110,275. Returns can differ here (grants paid vs. accrued, items listed elsewhere); check the filing.
Negative amounts are returned or refunded grants; they are listed last and left out of the totals of grants paid.
Who gave
Contributor names are not public for this form type.
Public charities filing Form 990 or 990-EZ report large donors on Schedule B, but the IRS withholds their names and addresses from public copies. Private foundations (990-PF) are different: their contributors are public.
Finances
Newest first. Each filing: its name on one row, its figures on the row beneath. Greyed filings are superseded by a later return for the same period and are left out everywhere else on this page.
| Revenue | Expenses | Assets | Net assets | Contributions | Program revenue | Officer pay | Employees | Volunteers |
|---|---|---|---|---|---|---|---|---|
| 2024 · Form 990 | ||||||||
| $3,568,680,376 | $3,363,161,573 | $10,710,948,904 | $9,098,794,045 | $489,879,227 | $2,876,835,558 | $14,574,372 | 22,512 | 465 |
| 2023 · Form 990 | ||||||||
| $3,426,543,123 | $3,205,428,772 | $10,041,775,528 | $8,358,691,220 | $480,257,641 | $2,742,648,218 | $14,526,413 | 21,943 | 450 |
| 2022 · Form 990 | ||||||||
| $3,123,028,251 | $2,972,582,848 | $9,089,728,145 | $7,412,720,391 | $414,173,321 | $2,490,304,695 | $11,879,725 | 20,881 | 456 |
| 2021 · Form 990 | ||||||||
| $2,941,412,552 | $2,794,974,659 | $8,581,156,143 | $6,893,524,785 | $392,629,936 | $2,354,617,010 | $13,059,405 | 19,987 | 400 |
| 2020 · Form 990 | ||||||||
| $2,804,594,715 | $2,526,903,482 | $8,563,028,123 | $6,865,529,878 | $414,723,376 | $2,217,297,519 | $12,198,660 | 18,712 | 400 |
| 2019 · Form 990 | ||||||||
| $2,632,357,731 | $2,477,803,190 | $6,805,886,488 | $5,272,416,000 | $366,081,052 | $2,056,160,274 | $12,397,010 | 18,848 | 610 |
| 2018 · Form 990 | ||||||||
| $2,614,076,252 | $2,504,932,768 | $6,457,499,425 | $5,190,063,000 | $296,250,819 | $2,116,146,442 | $11,013,299 | 18,318 | 690 |
| 2017 · Form 990 | ||||||||
| $2,428,973,726 | $2,350,218,945 | $5,711,861,189 | $4,445,279,000 | $295,668,368 | $2,005,054,547 | $11,642,192 | 17,946 | 720 |
| 2016 · Form 990 | ||||||||
| $2,326,190,118 | $2,199,679,665 | $5,201,204,074 | $3,862,971,000 | $265,008,163 | $1,929,601,261 | $9,774,658 | 17,771 | 780 |
| 2015 · Form 990 | ||||||||
| $2,299,158,195 | $2,114,240,096 | $4,017,211,699 | $2,552,659,000 | $254,993,626 | $1,947,623,021 | $14,857,327 | 17,604 | 803 |
| 2014 · Form 990 | ||||||||
| $2,227,579,157 | $2,039,964,371 | $3,905,798,748 | $2,519,350,000 | $261,291,939 | $1,884,757,269 | $7,680,179 | 16,766 | 775 |
| 2013 · Form 990 | ||||||||
| $2,116,496,354 | $1,975,833,461 | $3,415,522,609 | $2,409,076,000 | $219,214,533 | $1,721,234,353 | $13,072,464 | 16,202 | 770 |
| 2012 · Form 990 | ||||||||
| $1,937,816,020 | $1,802,150,625 | $3,014,071,717 | $1,966,105,000 | $227,021,993 | $1,592,946,995 | $11,106,775 | 14,837 | 724 |
| 2011 · Form 990 | ||||||||
| $1,878,608,458 | $1,729,381,098 | $2,632,830,836 | $1,476,335,000 | $228,972,104 | $1,536,030,056 | $11,800,683 | 14,096 | 737 |
| 2010 · Form 990 | ||||||||
| $1,702,991,956 | $1,651,672,224 | $2,468,439,453 | $1,533,853,802 | $242,596,688 | $1,371,019,469 | $14,835,587 | 13,637 | 620 |
| 2009 · Form 990 | ||||||||
| $1,590,398,457 | $1,512,075,251 | $2,189,842,873 | $1,196,247,205 | $213,838,287 | $1,240,716,898 | $10,500,195 | 13,082 | 601 |
Connected to
Organizations that list some of the same people on their returns (officers, directors, key employees on this organization’s latest return), and related organizations it lists on Schedule R.
- CHILDRENS HOSPITAL Cincinnati, OH · 15 people in common (Andrew Quinn, Beth Guttman, Christine Browner) · related organization (Schedule R)
- CHMC COMMUNITY HEALTH SERVICES NETWORK Cincinnati, OH · 5 people in common (Barbara Tofani, Evaline Alessandrini, Paul Jenny) · related organization (Schedule R)
- UNITED WAY OF GREATER CINCINNATI Cincinnati, OH · 4 people in common (Gary Huffman, Kay Geiger, Mark Biegger)
- CINCINNATI USA REGIONAL CHAMBER Cincinnati, OH · 4 people in common (Kay Geiger, Stacey Browning, Stephanie Ebken)
- BOY SCOUTS OF AMERICA Cincinnati, OH · 4 people in common (Darin Hall, Gary Huffman, Joel Stone)
- BOY SCOUTS OF AMERICA Pittsburg, PA · 4 people in common (Darin Hall, Gary Huffman, Joel Stone)
- GREATER CINCINNATI FOUNDATION Cincinnati, OH · 3 people in common (David Osborn, Joel Stone, Vada Hill)
- CINCINNATI BUSINESS COMMITTEE Cincinnati, OH · 3 people in common (Gary Huffman, Kay Geiger, Steve Davis)
- CINCINNATI REGIONAL BUSINESS COMMITTEE Cincinnati, OH · 3 people in common (Andrew Quinn, Steve Davis, Stuart Aitken)
- CINCINNATI MUSEUM ASSOCIATION Cincinnati, OH · 2 people in common (Andrew Quinn, Vada Hill)
- UPTOWN CONSORTIUM INC Cincinnati, OH · 2 people in common (Paul Jenny, Steve Davis)
- CINCINNATI INSTITUTE OF FINE ARTS Cincinnati, OH · 2 people in common (Joel Stone, Vada Hill)
- YWCA OF GREATER CINCINNATI INC Cincinnati, OH · 2 people in common (Beth Guttman, Liza Smitherman)
- THE HEALTH COLLABORATIVE Cincinnati, OH · 2 people in common (Stacey Browning, Tom Finn)
- CINTRIFUSE Cincinnati, OH · 2 people in common (Kay Geiger, Paul Jenny)
- OHIO CHILDRENS HOSPITAL ASSN Columbus, OH · 2 people in common (Evaline Alessandrini, Steve Davis)
- NETWORK FOR HOPE MEMORIAL FUND Cincinnati, OH · 2 people in common (Barbara Tofani, Hillary Weidner)
- COMMERCIAL CLUB OF CINCINNATI Cincinnati, OH · 2 people in common (Gary Huffman, Kay Geiger)
- WALNUT HILLS HIGH SCHOOL ASSN Cincinnati, OH · 2 people in common (Darin Hall, Susan Shelton)
- YWCA DEVELOPMENT CORPORATION Cincinnati, OH · 2 people in common (Beth Guttman, Liza Smitherman)
Funders of this organization
455 grantors reported grants to this organization, $1,986,383,913 in all, tax years 2009 to 2025; the 25 largest shown (all 455). Exact: the grantor wrote this organization's EIN. Fuzzy: the grantor wrote only a name (foundations' 990-PF has no EIN field), matched to the same or a near-identical name in the same state; the name as filed is shown. From the latest return for each grantor and year, so amended returns aren't counted twice. CSV
| Grantor | Total given | Grants | Latest year's amount | Latest year | Years given | Type | Match | Grants |
|---|---|---|---|---|---|---|---|---|
| CHILDRENS HOSPITAL | $1,479,049,433 | 17 | $186,571,039 | 2024 | 2009-2024 | Public charity | Exact | show |
| CONVALESCENT HOSPITAL FUND FOR CHILDREN | $101,609,131 | 16 | $11,711,648 | 2024 | 2009-2024 | Public charity | Exact | show |
| CYSTIC FIBROSIS FOUNDATION | $36,961,790 | 93 | $2,387,095 | 2024 | 2010-2024 | Public charity | Exact | show |
| GATES FOUNDATION | $25,605,937 | 27 | $1,803,969 | 2024 | 2011-2019, 2021-2022, 2024 | Private foundation | Fuzzy filed as “CHILDREN'S HOSPITAL MEDICAL CENTER” | show |
| THE CHILDRENS HOSPITAL OF PHILADELPHIA | $20,790,816 | 16 | $1,004,481 | 2024 | 2009-2024 | Public charity | Exact | show |
| AMERICAN HEART ASSOCIATION INC | $20,240,070 | 15 | $849,377 | 2024 | 2010-2024 | Public charity | Exact | show |
| MARCH OF DIMES INC | $17,543,021 | 27 | $500,000 | 2025 | 2010-2016, 2018-2019, 2021-2025 | Public charity | Exact | show |
| JOHN J & MARY R SCHIFF FOUNDATION | $13,100,000 | 13 | $1,500,000 | 2024 | 2012-2024 | Private foundation | Fuzzy filed as “CHILDREN'S HOSPITAL MEDICAL CENTER” | show |
| JOBSOHIO | $12,500,000 | 2 | $7,500,000 | 2021 | 2019, 2021 | Public charity | Exact | show |
| LEONA M & HARRY B HELMSLEY CHARITABLE TRUST | $11,115,672 | 18 | $3,804,472 | 2024 | 2020-2024 | Private foundation | Fuzzy filed as “CHILDREN'S HOSPITAL MEDICAL CENTER” | show |
| CYSTIC FIBROSIS FOUNDATION THERAPEUTICS INC | $10,473,854 | 33 | $3,394,916 | 2017 | 2010-2017 | Public charity | Exact | show |
| GREATER CINCINNATI FOUNDATION | $9,299,216 | 24 | $423,408 | 2024 | 2010-2024 | DAF sponsor | Exact | show |
| JOHNS HOPKINS UNIVERSITY | $8,498,607 | 15 | $1,854,161 | 2023 | 2009-2023 | DAF sponsor | Exact | show |
| CURE STARTS NOW INC | $8,323,060 | 20 | $1,590,160 | 2025 | 2010-2015, 2017-2018, 2020-2025 | Public charity | Exact | show |
| JOHNSON CHARITABLE GIFT FUND | $7,322,262 | 17 | $1,628,503 | 2024 | 2010-2011, 2013-2024 | DAF sponsor | Exact | show |
| JEWISH FEDERATION OF CINCINNATI | $7,173,588 | 15 | $5,533 | 2024 | 2010-2024 | DAF sponsor | Exact | show |
| BLOOD CANCER UNITED INC | $7,053,016 | 34 | $500,541 | 2024 | 2009-2024 | Public charity | Exact | show |
| EMORY UNIVERSITY | $6,630,157 | 19 | $466,742 | 2024 | 2009-2024 | Public charity | Exact | show |
| FIDELITY INVESTMENTS CHARITABLE GIFT FUND | $6,497,699 | 9 | $714,009 | 2024 | 2016-2024 | DAF sponsor | Exact | show |
| KIKEL CHARITABLE FOUNDATION UA 101097 | $5,953,777 | 13 | $333,268 | 2025 | 2013-2025 | Private foundation | Fuzzy filed as “CHILDREN'S HOSPITAL MEDICAL CENTER” | show |
| FARMER FAMILY FOUNDATION | $5,015,000 | 5 | $1,010,000 | 2024 | 2020-2021, 2023-2024 | Private foundation | Fuzzy filed as “CHILDREN'S HOSPITAL MEDICAL CENTER” | show |
| CONGENITAL HEART ALLIANCE OF CINCINNATI | $4,444,612 | 20 | $517,235 | 2024 | 2010-2018, 2020-2024 | Public charity | Exact | show |
| THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND | $3,903,630 | 88 | $845,959 | 2024 | 2014-2024 | Public charity | Exact | show |
| CURED NFP | $3,308,760 | 13 | $243,794 | 2024 | 2012-2024 | Public charity | Exact | show |
| NORTHWESTERN UNIVERSITY | $3,298,464 | 12 | $311,517 | 2024 | 2012, 2014-2024 | DAF sponsor | Exact | show |
Nearby + Similar BETA
Organizations like this one: what they do and who they are linked to
Same category: NTEE code and revenue
Ranked without any AI: same NTEE code first, then the same NTEE group; then revenue within 2x, 5x or 10x; then the same state; then similar name and mission text. NTEE: the IRS’s code when it lists one, otherwise FURP’s inferred code. Same state only · More (100)
| Organization | State | NTEE | Latest revenue | Latest expenses | Top-paid title | Top pay | Why similar |
|---|---|---|---|---|---|---|---|
| CHILDRENS MERCY HOSPITAL | MO | E24 | $2,340,991,656 | $2,006,474,542 | Director; President & CEO; End 1/2/25 | $1,803,068 | Same NTEE code E24, revenue within 2x, similar mission |
| COOK CHILDRENS MEDICAL CENTER | TX | E24 | $2,268,395,631 | $1,746,134,010 | CEO | $3,598,135 | Same NTEE code E24, revenue within 2x, similar name |
| TEXAS CHILDRENS HOSPITAL | TX | E24 | $4,436,955,658 | $4,105,997,047 | BOARD MEMBER, CHAIR & CEO THROUGH 10/4/24 | $13,338,019 | Same NTEE code E24, revenue within 2x, similar mission |
| SEATTLE CHILDRENS HOSPITAL | WA | E24 | $3,072,099,534 | $2,598,347,643 | FORMER OFFICER | $2,856,316 | Same NTEE code E24, revenue within 2x, similar mission |
| CHILDRENS HOSPITAL COLORADO | CO | E24 | $2,014,273,578 | $1,968,035,328 | Chief Executive Officer | $4,286,194 | Same NTEE code E24, revenue within 2x, similar mission |
| CHILDRENS HOSPITAL LOS ANGELES | CA | E24 | $1,816,852,966 | $1,930,797,327 | Director, CEO | $1,888,151 | Same NTEE code E24, revenue within 2x, similar name |
| CHILDRENS HOSPITAL CORPORATION | MA | E24 | $3,588,588,824 | $3,527,089,859 | Chief Executive Officer | $3,490,323 | Same NTEE code E24, revenue within 2x, similar name |
| ST JUDE CHILDRENS RESEARCH HOSPITAL INC | TN | E24 | $2,208,853,162 | $1,897,571,834 | PRESIDENT/CEO | $1,713,883 | Same NTEE code E24, revenue within 2x |
| CHILDRENS HOSPITAL | DC | E24 | $1,872,813,787 | $1,777,542,451 | FORMER CHIEF OPERATING OFFICER | $3,140,501 | Same NTEE code E24, revenue within 2x, similar name |
| LUCILE SALTER PACKARD CHILDRENS HOSPITAL AT STANFORD | CA | E24 | $2,890,101,302 | $2,734,866,795 | DIRECTOR | $5,385,633 | Same NTEE code E24, revenue within 2x |
| CITY OF HOPE NATIONAL MEDICAL CENTER | CA | E24 | $3,432,349,751 | $3,288,442,084 | PRESIDENT & CEO | $7,115,860 | Same NTEE code E24, revenue within 2x |
| CHILDRENS HEALTH SYSTEM OF TEXAS | TX | E24 | $2,662,618,681 | $2,449,136,918 | President CEO | $4,345,262 | Same NTEE code E24, revenue within 2x |
| H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL INC | FL | E24 | $2,640,684,525 | $2,186,992,097 | FRM HOSPITAL PRES TO 10/2021 | $2,243,616 | Same NTEE code E24, revenue within 2x |
| THE CHILDRENS HOSPITAL OF PHILADELPHIA | PA | E24 | $4,165,576,231 | $3,837,536,215 | PRESIDENT, CEO & TRUSTEE | $5,479,580 | Same NTEE code E24, revenue within 2x |
| FRED HUTCHINSON CANCER CENTER | WA | E24 | $2,532,392,907 | $2,405,985,717 | President & Director | $2,598,413 | Same NTEE code E24, revenue within 2x |
| THE NEMOURS FOUNDATION | FL | E24 | $2,357,991,833 | $2,111,711,586 | President and CEO | $3,081,278 | Same NTEE code E24, revenue within 2x |
| CHILDRENS HOSPITAL MEDICAL CENTER OF AKRON | OH | E24 | $1,540,288,244 | $1,353,888,762 | BOD/OFFICER-PRESIDENT AND CEO | $1,791,308 | Same NTEE code E24, revenue within 5x, same state, similar name |
| DAYTON CHILDRENS HOSPITAL | OH | E24 | $825,137,568 | $661,481,132 | CEO | $2,091,992 | Same NTEE code E24, revenue within 5x, same state, similar name |
| DAYTON OSTEOPATHIC HOSPITAL | OH | E24 | $870,345,091 | $740,469,688 | CEO | $2,096,364 | Same NTEE code E24, revenue within 5x, same state |
| CHILDRENS HOSPITAL & MEDICAL CENTER | NE | E24 | $774,477,317 | $685,097,245 | PRESIDENT & CEO | $2,195,461 | Same NTEE code E24, revenue within 5x, similar name |
| CHILDRENS HOSPITAL INC | LA | E24 | $737,323,254 | $521,872,985 | EXECUTIVE LEADER | $1,393,997 | Same NTEE code E24, revenue within 5x, similar name |
| CHILDRENS HOSPITAL OF WISCONSIN INC | WI | E24 | $1,016,508,622 | $971,118,396 | DIRECTOR/PRESIDENT AND CEO CHHS | $2,658,331 | Same NTEE code E24, revenue within 5x, similar mission |
| ARKANSAS CHILDRENS HOSPITAL | AR | E24 | $962,373,622 | $864,515,091 | PRESIDENT/CEO | $2,712,312 | Same NTEE code E24, revenue within 5x, similar name |
| CHILDRENS HOSPITAL & RESEARCH CENTER AT OAKLAND | CA | E24 | $916,259,379 | $686,570,664 | BOARD MEMBER/EX OFFICIO | $2,402,677 | Same NTEE code E24, revenue within 5x, similar name |
| JOHNS HOPKINS ALL CHILDRENS HOSPITAL INC | MD | E24 | $948,805,768 | $822,883,056 | TRUSTEE, CORPORATE VICE CHAIR | $2,921,520 | Same NTEE code E24, revenue within 5x, similar mission |
Who funds organizations like this
Grantors that funded the 100 most similar organizations. Ranked by total given to them. Foundations (990-PF) and donor-advised fund sponsors only. Same matching as Funders above (by EIN, or by name for foundations).
The full list · all similar organizations
Where the money went
Every expense line on each return, biggest first: Form 990 Part IX (with its program, management and fundraising columns), 990-EZ Part I, or 990-PF Part I. Event marks lines the organization itself describes as events. “Events” in each summary adds those lines, conferences and meetings, and the direct costs of fundraising events. Unusual is not the same as improper. Many of these patterns have ordinary explanations. Check the filing.
2024 · Form 990 · $3,363,161,573 spent · pay $2,167,036,814 · grants $7,673,803 · events $773,518
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $1,742,460,339 | $1,448,850,912 | $287,593,437 | $6,015,990 | 51.8% | |
| Other (as described) | PURCHASED SERVICES | $309,465,659 | $153,656,217 | $153,764,561 | $2,044,881 | 9.2% |
| Other employee benefits | $202,459,569 | $173,418,793 | $27,762,027 | $1,278,749 | 6.0% | |
| Other (as described) | DRUGS | $191,047,842 | $191,047,842 | - | - | 5.7% |
| Other (as described) | MEDICAL SUPPLIES | $190,597,189 | $190,597,189 | - | - | 5.7% |
| Depreciation and depletion | $157,524,989 | $127,076,078 | $30,026,011 | $422,900 | 4.7% | |
| All other expenses | $120,730,603 | $38,845,257 | $81,479,197 | $406,149 | 3.6% | |
| Payroll taxes | $116,367,684 | $96,970,026 | $19,000,204 | $397,454 | 3.5% | |
| Pension plan contributions | $86,829,426 | $75,664,942 | $11,164,484 | - | 2.6% | |
| Office expenses | $59,386,299 | $49,866,585 | $9,467,541 | $52,173 | 1.8% | |
| Information technology | $47,175,290 | $23,566,815 | $23,440,041 | $168,434 | 1.4% | |
| Occupancy | $34,005,405 | $29,140,009 | $4,797,821 | $67,575 | 1.0% | |
| Interest | $30,415,634 | - | $30,415,634 | - | 0.9% | |
| Insurance | $16,499,072 | $13,868,741 | $2,630,331 | - | 0.5% | |
| Pay: officers, directors, trustees, key employees | $14,574,372 | $692,164 | $13,882,208 | - | 0.4% | |
| Travel | $12,257,517 | $10,247,802 | $1,954,130 | $55,585 | 0.4% | |
| Advertising and promotion | $6,915,924 | $3,383,041 | $3,436,323 | $96,560 | 0.2% | |
| Fees: legal | $6,038,780 | - | $6,038,780 | - | 0.2% | |
| Pay: disqualified persons | $4,345,424 | $1,326,835 | $3,018,589 | - | 0.1% | |
| Grants outside the US | $3,933,654 | $3,933,654 | - | - | 0.1% | |
| Other (as described) | UBI TAXES PAID | $2,875,000 | $2,875,000 | - | - | 0.1% |
| Grants to US organizations and governments | $2,570,015 | $2,570,015 | - | - | 0.1% | |
| Fees: investment management | $1,604,572 | - | $1,604,572 | - | 0.0% | |
| Fees: accounting | $1,300,033 | - | $1,300,033 | - | 0.0% | |
| Grants to US individuals | $1,170,134 | $1,170,134 | - | - | 0.0% | |
| Fees: lobbying | $580,898 | $580,898 | - | - | 0.0% | |
| Fees: professional fundraisers | $30,250 | - | - | $30,250 | 0.0% | |
| Fundraising events Event | direct expenses; gross income $264,336 | $773,518 | reported apart | |||
| Total | $3,363,161,573 | 100% |
2023 · Form 990 · $3,205,428,772 spent · pay $2,040,347,555 · grants $7,312,812 · events $687,645
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $1,633,306,742 | $1,362,363,040 | $266,303,016 | $4,640,686 | 51.0% | |
| Other (as described) | PURCHASED SERVICES | $298,175,565 | $155,629,304 | $141,969,169 | $577,092 | 9.3% |
| Other employee benefits | $193,242,446 | $121,236,514 | $71,021,418 | $984,514 | 6.0% | |
| Other (as described) | DRUGS | $193,079,334 | $193,079,334 | - | - | 6.0% |
| Other (as described) | MEDICAL SUPPLIES | $182,196,487 | $182,196,487 | - | - | 5.7% |
| Depreciation and depletion | $151,431,719 | $116,854,470 | $34,201,977 | $375,272 | 4.7% | |
| All other expenses | $110,477,661 | $35,512,013 | $74,529,172 | $436,476 | 3.4% | |
| Payroll taxes | $108,678,902 | $90,854,002 | $17,519,588 | $305,312 | 3.4% | |
| Pension plan contributions | $86,524,462 | $64,286,514 | $22,237,948 | - | 2.7% | |
| Office expenses | $63,528,408 | $53,469,757 | $9,990,277 | $68,374 | 2.0% | |
| Information technology | $45,792,968 | $23,944,949 | $21,803,227 | $44,792 | 1.4% | |
| Interest | $32,817,311 | - | $32,817,311 | - | 1.0% | |
| Occupancy | $30,018,191 | $25,032,280 | $4,931,798 | $54,113 | 0.9% | |
| Insurance | $16,024,393 | $13,504,447 | $2,519,946 | - | 0.5% | |
| Travel | $14,819,957 | $12,437,915 | $2,330,540 | $51,502 | 0.5% | |
| Pay: officers, directors, trustees, key employees | $14,526,413 | $515,626 | $14,010,787 | - | 0.5% | |
| Advertising and promotion | $7,666,995 | $3,924,720 | $3,650,456 | $91,819 | 0.2% | |
| Fees: legal | $7,270,614 | - | $7,270,614 | - | 0.2% | |
| Pay: disqualified persons | $4,068,590 | $937,951 | $3,130,639 | - | 0.1% | |
| Grants outside the US | $4,002,212 | $4,002,212 | - | - | 0.1% | |
| Grants to US organizations and governments | $2,526,523 | $2,526,523 | - | - | 0.1% | |
| Fees: investment management | $1,955,088 | - | $1,955,088 | - | 0.1% | |
| Fees: accounting | $1,041,638 | - | $1,041,638 | - | 0.0% | |
| Other (as described) | UBI TAXES PAID | $852,000 | $852,000 | - | - | 0.0% |
| Grants to US individuals | $784,077 | $784,077 | - | - | 0.0% | |
| Fees: lobbying | $584,326 | $584,326 | - | - | 0.0% | |
| Fees: professional fundraisers | $35,750 | - | - | $35,750 | 0.0% | |
| Fundraising events Event | direct expenses; gross income $316,818 | $687,645 | reported apart | |||
| Total | $3,205,428,772 | 100% |
2022 · Form 990 · $2,972,582,848 spent · pay $1,868,955,353 · grants $7,719,351 · events $625,837
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $1,481,055,315 | $1,241,938,325 | $234,736,574 | $4,380,416 | 49.8% | |
| Other (as described) | PURCHASED SERVICES | $272,985,406 | $147,678,279 | $125,222,405 | $84,722 | 9.2% |
| Other employee benefits | $205,310,527 | $133,575,401 | $70,928,543 | $806,583 | 6.9% | |
| Other (as described) | DRUGS | $169,800,094 | $169,800,094 | - | - | 5.7% |
| Other (as described) | MEDICAL SUPPLIES | $166,273,463 | $166,273,463 | - | - | 5.6% |
| Depreciation and depletion | $148,595,215 | $114,566,785 | $33,655,136 | $373,294 | 5.0% | |
| All other expenses | $121,513,801 | $50,479,087 | $70,027,169 | $1,007,545 | 4.1% | |
| Payroll taxes | $97,059,350 | $81,571,918 | $15,203,716 | $283,716 | 3.3% | |
| Pension plan contributions | $68,045,307 | $49,755,766 | $18,289,541 | - | 2.3% | |
| Office expenses | $63,632,969 | $53,640,606 | $9,929,639 | $62,724 | 2.1% | |
| Information technology | $44,317,980 | $23,986,632 | $20,329,303 | $2,045 | 1.5% | |
| Interest | $32,530,783 | - | $32,530,783 | - | 1.1% | |
| Occupancy | $29,243,438 | $24,332,313 | $4,857,250 | $53,875 | 1.0% | |
| Insurance | $16,518,585 | $13,940,934 | $2,577,651 | - | 0.6% | |
| Travel | $13,486,859 | $11,359,321 | $2,104,564 | $22,974 | 0.5% | |
| Pay: officers, directors, trustees, key employees | $11,879,725 | $359,617 | $11,520,108 | - | 0.4% | |
| Fees: legal | $5,830,814 | - | $5,830,814 | - | 0.2% | |
| Pay: disqualified persons | $5,605,129 | $1,080,148 | $4,524,981 | - | 0.2% | |
| Advertising and promotion | $5,369,803 | $2,809,046 | $2,463,207 | $97,550 | 0.2% | |
| Grants outside the US | $4,684,861 | $4,684,861 | - | - | 0.2% | |
| Grants to US organizations and governments | $2,890,724 | $2,890,724 | - | - | 0.1% | |
| Other (as described) | UBI TAXES PAID | $2,171,428 | $2,171,428 | - | - | 0.1% |
| Fees: investment management | $2,035,338 | - | $2,035,338 | - | 0.1% | |
| Fees: accounting | $945,745 | - | $945,745 | - | 0.0% | |
| Fees: lobbying | $626,173 | $626,173 | - | - | 0.0% | |
| Grants to US individuals | $143,766 | $143,766 | - | - | 0.0% | |
| Fees: professional fundraisers | $30,250 | - | - | $30,250 | 0.0% | |
| Fundraising events Event | direct expenses; gross income $151,278 | $625,837 | reported apart | |||
| Total | $2,972,582,848 | 100% |
2021 · Form 990 · $2,794,974,659 spent · pay $1,709,079,639 · grants $6,199,940 · events $155,895
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $1,350,516,433 | $1,147,179,364 | $199,122,101 | $4,214,968 | 48.3% | |
| Other (as described) | PURCHASED SERVICES | $228,978,469 | $113,491,520 | $114,801,861 | $685,088 | 8.2% |
| Other employee benefits | $201,383,704 | $135,544,526 | $64,997,620 | $841,558 | 7.2% | |
| All other expenses | $194,963,733 | $129,338,764 | $65,216,857 | $408,112 | 7.0% | |
| Other (as described) | DRUGS | $157,847,673 | $157,847,673 | - | - | 5.6% |
| Other (as described) | MEDICAL SUPPLIES | $152,446,695 | $152,446,695 | - | - | 5.5% |
| Depreciation and depletion | $150,643,132 | $120,449,061 | $29,890,613 | $303,458 | 5.4% | |
| Payroll taxes | $88,911,919 | $75,667,007 | $12,970,359 | $274,553 | 3.2% | |
| Office expenses | $59,878,271 | $50,696,294 | $9,110,386 | $71,591 | 2.1% | |
| Pension plan contributions | $53,800,353 | $40,619,266 | $13,181,087 | - | 1.9% | |
| Information technology | $38,752,374 | $19,248,230 | $19,429,096 | $75,048 | 1.4% | |
| Interest | $30,926,151 | - | $30,926,151 | - | 1.1% | |
| Occupancy | $27,781,447 | $23,785,726 | $3,955,563 | $40,158 | 1.0% | |
| Insurance | $14,525,290 | $12,315,290 | $2,210,000 | - | 0.5% | |
| Pay: officers, directors, trustees, key employees | $13,059,405 | $798,361 | $12,261,044 | - | 0.5% | |
| Advertising and promotion | $6,833,110 | $3,286,406 | $3,425,884 | $120,820 | 0.2% | |
| Travel | $5,149,201 | $4,352,032 | $783,443 | $13,726 | 0.2% | |
| Other (as described) | UBI TAXES PAID | $5,144,112 | $5,144,112 | - | - | 0.2% |
| Grants to US organizations and governments | $3,476,274 | $3,476,274 | - | - | 0.1% | |
| Grants outside the US | $2,602,956 | $2,602,956 | - | - | 0.1% | |
| Fees: legal | $2,390,163 | - | $2,390,163 | - | 0.1% | |
| Fees: investment management | $2,206,303 | - | $2,206,303 | - | 0.1% | |
| Pay: disqualified persons | $1,407,825 | $471,204 | $936,621 | - | 0.1% | |
| Fees: accounting | $711,944 | - | $711,944 | - | 0.0% | |
| Fees: lobbying | $484,012 | $484,012 | - | - | 0.0% | |
| Grants to US individuals | $120,710 | $120,710 | - | - | 0.0% | |
| Fees: professional fundraisers | $33,000 | - | - | $33,000 | 0.0% | |
| Fundraising events Event | direct expenses; gross income $44,962 | $155,895 | reported apart | |||
| Total | $2,794,974,659 | 100% |
2020 · Form 990 · $2,526,903,482 spent · pay $1,598,073,958 · grants $6,789,659 · events $58,689
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $1,240,461,175 | $1,051,447,738 | $184,854,852 | $4,158,585 | 49.1% | |
| Other (as described) | PURCHASED SERVICES | $200,510,296 | $104,167,177 | $95,768,693 | $574,426 | 7.9% |
| Other employee benefits | $188,558,838 | $137,452,619 | $50,330,195 | $776,024 | 7.5% | |
| Other (as described) | MEDICAL SUPPLIES | $154,954,126 | $154,954,126 | - | - | 6.1% |
| Other (as described) | DRUGS | $148,384,404 | $148,384,404 | - | - | 5.9% |
| Depreciation and depletion | $137,960,805 | $110,371,843 | $27,173,048 | $415,914 | 5.5% | |
| Payroll taxes | $80,478,270 | $68,337,810 | $11,873,351 | $267,109 | 3.2% | |
| Pension plan contributions | $76,079,794 | $58,657,521 | $17,422,273 | - | 3.0% | |
| All other expenses | $73,445,165 | $22,597,611 | $50,538,063 | $309,491 | 2.9% | |
| Office expenses | $56,375,690 | $48,995,993 | $7,311,337 | $68,360 | 2.2% | |
| Other (as described) | HOSPITAL FRANCHISE FEE | $47,773,317 | $47,773,317 | - | - | 1.9% |
| Information technology | $34,303,548 | $17,904,856 | $16,384,226 | $14,466 | 1.4% | |
| Occupancy | $25,409,776 | $21,747,977 | $3,606,596 | $55,203 | 1.0% | |
| Interest | $23,249,369 | - | $23,249,369 | - | 0.9% | |
| Pay: officers, directors, trustees, key employees | $12,198,660 | $771,465 | $11,427,195 | - | 0.5% | |
| Insurance | $7,443,282 | $6,477,966 | $965,316 | - | 0.3% | |
| Advertising and promotion | $5,721,567 | $2,849,050 | $2,732,762 | $139,755 | 0.2% | |
| Grants outside the US | $3,603,216 | $3,603,216 | - | - | 0.1% | |
| Grants to US organizations and governments | $3,077,854 | $3,077,854 | - | - | 0.1% | |
| Fees: investment management | $2,191,379 | - | $2,191,379 | - | 0.1% | |
| Fees: legal | $2,171,110 | - | $2,171,110 | - | 0.1% | |
| Travel | $884,857 | $763,022 | $114,757 | $7,078 | 0.0% | |
| Fees: accounting | $772,959 | - | $772,959 | - | 0.0% | |
| Fees: lobbying | $455,215 | $455,215 | - | - | 0.0% | |
| Pay: disqualified persons | $297,221 | $250,860 | $46,361 | - | 0.0% | |
| Grants to US individuals | $108,589 | $108,589 | - | - | 0.0% | |
| Fees: professional fundraisers | $33,000 | - | - | $33,000 | 0.0% | |
| Fundraising events Event | direct expenses; gross income $30,401 | $58,689 | reported apart | |||
| Total | $2,526,903,482 | 100% |
2019 · Form 990 · $2,477,803,190 spent · pay $1,522,687,252 · grants $6,864,249 · events $722,301
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $1,190,667,461 | $1,005,619,821 | $180,811,793 | $4,235,847 | 48.1% | |
| Other (as described) | Purchased Services | $200,287,210 | $103,596,774 | $96,215,196 | $475,240 | 8.1% |
| All other expenses | $192,349,400 | $141,207,171 | $50,842,025 | $300,204 | 7.8% | |
| Other employee benefits | $179,297,955 | $131,846,512 | $46,471,602 | $979,841 | 7.2% | |
| Other (as described) | Medical Supplies | $133,538,647 | $133,538,647 | $0 | $0 | 5.4% |
| Other (as described) | Drugs | $130,522,338 | $130,522,338 | $0 | $0 | 5.3% |
| Depreciation and depletion | $130,103,806 | $105,981,079 | $23,774,177 | $348,550 | 5.3% | |
| Payroll taxes | $77,789,008 | $65,828,777 | $11,686,454 | $273,777 | 3.1% | |
| Pension plan contributions | $62,055,554 | $48,283,911 | $13,771,643 | - | 2.5% | |
| Office expenses | $45,185,429 | $38,641,293 | $6,428,434 | $115,702 | 1.8% | |
| Information technology | $32,218,576 | $16,702,569 | $15,477,357 | $38,650 | 1.3% | |
| Occupancy | $26,557,481 | $23,008,480 | $3,497,721 | $51,280 | 1.1% | |
| Interest | $24,627,214 | - | $24,627,214 | - | 1.0% | |
| Insurance | $13,880,531 | $11,905,778 | $1,974,753 | - | 0.6% | |
| Pay: officers, directors, trustees, key employees | $12,397,010 | $972,238 | $11,424,772 | - | 0.5% | |
| Travel | $7,855,761 | $6,677,118 | $1,117,622 | $61,021 | 0.3% | |
| Advertising and promotion | $5,258,180 | $2,609,777 | $2,525,957 | $122,446 | 0.2% | |
| Grants outside the US | $3,540,903 | $3,540,903 | - | - | 0.1% | |
| Grants to US organizations and governments | $3,220,544 | $3,220,544 | - | - | 0.1% | |
| Fees: legal | $2,412,667 | - | $2,412,667 | - | 0.1% | |
| Fees: investment management | $2,059,952 | - | $2,059,952 | - | 0.1% | |
| Fees: accounting | $934,579 | - | $934,579 | - | 0.0% | |
| Pay: disqualified persons | $480,264 | $256,037 | $224,227 | - | 0.0% | |
| Fees: lobbying | $424,168 | $424,168 | - | - | 0.0% | |
| Grants to US individuals | $102,802 | $102,802 | - | - | 0.0% | |
| Fees: professional fundraisers | $35,750 | - | - | $35,750 | 0.0% | |
| Fundraising events Event | direct expenses; gross income $399,637 | $722,301 | reported apart | |||
| Total | $2,477,803,190 | 100% |
2018 · Form 990 · $2,504,932,768 spent · pay $1,519,586,019 · grants $9,633,252 · events $589,526
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $1,145,916,829 | $965,177,998 | $176,815,442 | $3,923,389 | 45.7% | |
| All other expenses | $208,334,675 | $151,568,320 | $56,419,117 | $347,238 | 8.3% | |
| Other employee benefits | $196,178,751 | $153,993,528 | $41,233,270 | $951,953 | 7.8% | |
| Other (as described) | Purchased Services | $190,024,831 | $97,336,852 | $92,002,437 | $685,542 | 7.6% |
| Other (as described) | Medical Supplies | $134,395,120 | $134,395,120 | - | - | 5.4% |
| Other (as described) | Drugs | $131,992,642 | $131,992,642 | - | - | 5.3% |
| Depreciation and depletion | $129,448,051 | $105,401,871 | $23,851,736 | $194,444 | 5.2% | |
| Pension plan contributions | $90,959,349 | $70,948,187 | $20,011,162 | - | 3.6% | |
| Payroll taxes | $74,152,198 | $62,600,607 | $11,316,188 | $235,403 | 3.0% | |
| Office expenses | $50,447,645 | $42,576,464 | $7,758,408 | $112,773 | 2.0% | |
| Occupancy | $28,951,735 | $25,069,405 | $3,850,936 | $31,394 | 1.2% | |
| Information technology | $28,620,897 | $14,763,801 | $13,857,096 | - | 1.1% | |
| Interest | $27,105,906 | - | $27,105,906 | - | 1.1% | |
| Insurance | $16,939,209 | $14,334,106 | $2,605,103 | - | 0.7% | |
| Travel | $12,096,032 | $10,124,859 | $1,860,264 | $110,909 | 0.5% | |
| Pay: officers, directors, trustees, key employees | $11,013,299 | $352,350 | $10,660,949 | - | 0.4% | |
| Advertising and promotion | $9,781,277 | $4,444,118 | $4,735,704 | $601,455 | 0.4% | |
| Grants outside the US | $6,670,649 | $6,670,649 | - | - | 0.3% | |
| Fees: legal | $4,829,747 | - | $4,829,747 | - | 0.2% | |
| Grants to US organizations and governments | $2,739,699 | $2,739,699 | - | - | 0.1% | |
| Fees: investment management | $1,558,236 | - | $1,558,236 | - | 0.1% | |
| Pay: disqualified persons | $1,365,593 | $287,218 | $1,078,375 | - | 0.1% | |
| Fees: accounting | $690,645 | - | $690,645 | - | 0.0% | |
| Fees: lobbying | $469,349 | $469,349 | - | - | 0.0% | |
| Grants to US individuals | $222,904 | $222,904 | - | - | 0.0% | |
| Fees: professional fundraisers | $27,500 | - | - | $27,500 | 0.0% | |
| Fundraising events Event | direct expenses; gross income $172,176 | $589,526 | reported apart | |||
| Total | $2,504,932,768 | 100% |
2017 · Form 990 · $2,350,218,945 spent · pay $1,426,109,829 · grants $5,874,680 · events $679,047
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $1,110,607,100 | $961,712,941 | $145,156,348 | $3,737,811 | 47.3% | |
| All other expenses | $190,020,310 | $161,433,524 | $28,541,959 | $44,827 | 8.1% | |
| Other (as described) | Purchased Services | $177,782,782 | $154,546,572 | $22,602,165 | $634,045 | 7.6% |
| Other employee benefits | $162,389,153 | $141,164,891 | $21,224,262 | - | 6.9% | |
| Depreciation and depletion | $129,242,897 | $112,350,850 | $16,892,047 | - | 5.5% | |
| Other (as described) | Medical Supplies | $123,717,586 | $123,717,586 | - | - | 5.3% |
| Other (as described) | Drugs | $123,657,643 | $123,657,643 | - | - | 5.3% |
| Payroll taxes | $71,830,615 | $62,442,354 | $9,388,261 | - | 3.1% | |
| Pension plan contributions | $68,910,193 | $59,903,631 | $9,006,562 | - | 2.9% | |
| Office expenses | $50,559,528 | $43,951,398 | $6,501,889 | $106,241 | 2.2% | |
| Interest | $27,510,276 | $23,914,683 | $3,595,593 | - | 1.2% | |
| Occupancy | $27,447,616 | $23,860,213 | $3,587,403 | - | 1.2% | |
| Information technology | $26,310,547 | $22,871,759 | $3,438,788 | - | 1.1% | |
| Insurance | $25,091,877 | $21,812,369 | $3,279,508 | - | 1.1% | |
| Pay: officers, directors, trustees, key employees | $11,642,192 | - | $11,642,192 | - | 0.5% | |
| Travel | $11,283,521 | $9,808,765 | $1,370,716 | $104,040 | 0.5% | |
| Grants to US organizations and governments | $3,122,120 | $3,122,120 | - | - | 0.1% | |
| Grants outside the US | $2,678,542 | $2,678,542 | - | - | 0.1% | |
| Fees: investment management | $2,009,312 | - | $2,009,312 | - | 0.1% | |
| Fees: legal | $1,142,811 | - | $1,142,811 | - | 0.0% | |
| Advertising and promotion | $1,105,633 | $961,127 | $39,550 | $104,956 | 0.0% | |
| Pay: disqualified persons | $730,576 | $200,440 | $530,136 | - | 0.0% | |
| Fees: accounting | $713,578 | - | $713,578 | - | 0.0% | |
| Fees: lobbying | $605,519 | $605,519 | - | - | 0.0% | |
| Grants to US individuals | $74,018 | $74,018 | - | - | 0.0% | |
| Fees: professional fundraisers | $33,000 | - | - | $33,000 | 0.0% | |
| Fundraising events Event | direct expenses; gross income $184,002 | $679,047 | reported apart | |||
| Total | $2,350,218,945 | 100% |
2016 · Form 990 · $2,199,679,665 spent · pay $1,390,961,208 · grants $5,100,964 · events $911,417
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $1,082,111,476 | $943,645,738 | $134,722,879 | $3,742,859 | 49.2% | |
| Other (as described) | Purchased Services | $198,969,376 | $174,197,689 | $24,031,484 | $740,203 | 9.0% |
| Other employee benefits | $160,875,721 | $140,846,694 | $20,029,027 | - | 7.3% | |
| All other expenses | $131,094,644 | $110,208,372 | $20,574,263 | $312,009 | 6.0% | |
| Depreciation and depletion | $127,240,134 | $111,398,737 | $15,841,397 | - | 5.8% | |
| Other (as described) | Medical Supplies | $116,451,973 | $116,451,973 | - | - | 5.3% |
| Other (as described) | Drugs | $97,857,519 | $97,857,519 | - | - | 4.4% |
| Payroll taxes | $69,966,286 | $61,255,483 | $8,710,803 | - | 3.2% | |
| Pension plan contributions | $66,649,069 | $58,351,260 | $8,297,809 | - | 3.0% | |
| Office expenses | $44,745,452 | $39,174,643 | $5,442,880 | $127,929 | 2.0% | |
| Interest | $27,031,510 | $23,666,087 | $3,365,423 | - | 1.2% | |
| Other (as described) | Utilities | $20,291,177 | $17,764,925 | $2,526,252 | - | 0.9% |
| Travel | $11,065,069 | $9,687,468 | $1,279,527 | $98,074 | 0.5% | |
| Pay: officers, directors, trustees, key employees | $9,774,658 | - | $9,774,658 | - | 0.4% | |
| Information technology | $8,691,136 | $7,609,090 | $1,082,046 | - | 0.4% | |
| Insurance | $8,413,394 | $7,365,926 | $1,047,468 | - | 0.4% | |
| Occupancy | $8,166,490 | $7,149,762 | $1,016,728 | - | 0.4% | |
| Grants outside the US | $2,985,787 | $2,985,787 | - | - | 0.1% | |
| Grants to US organizations and governments | $2,087,975 | $2,087,975 | - | - | 0.1% | |
| Pay: disqualified persons | $1,583,998 | $181,876 | $1,402,122 | - | 0.1% | |
| Advertising and promotion | $1,203,174 | $1,053,379 | $77,716 | $72,079 | 0.1% | |
| Fees: accounting | $727,863 | - | $727,863 | - | 0.0% | |
| Fees: investment management | $646,357 | - | $646,357 | - | 0.0% | |
| Fees: legal | $573,145 | - | $573,145 | - | 0.0% | |
| Fees: lobbying | $409,080 | $409,080 | - | - | 0.0% | |
| Fees: professional fundraisers | $40,000 | - | - | $40,000 | 0.0% | |
| Grants to US individuals | $27,202 | $27,202 | - | - | 0.0% | |
| Fundraising events Event | direct expenses; gross income $282,669 | $911,417 | reported apart | |||
| Total | $2,199,679,665 | 100% |
2015 · Form 990 · $2,114,240,096 spent · pay $1,350,748,059 · grants $4,848,180 · events $937,118
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $1,060,275,405 | $938,337,056 | $118,092,201 | $3,846,148 | 50.1% | |
| Other (as described) | Purchased Services | $200,114,073 | $176,980,886 | $22,419,751 | $713,436 | 9.5% |
| Other employee benefits | $151,065,005 | $133,601,890 | $17,463,115 | - | 7.1% | |
| Depreciation and depletion | $124,438,610 | $110,053,507 | $14,385,103 | - | 5.9% | |
| Other (as described) | Medical Supplies | $115,020,961 | $115,020,961 | - | - | 5.4% |
| Other (as described) | Drugs | $100,580,527 | $100,580,527 | - | - | 4.8% |
| All other expenses | $87,064,624 | $77,011,570 | $9,793,104 | $259,950 | 4.1% | |
| Payroll taxes | $68,953,829 | $60,982,766 | $7,971,063 | - | 3.3% | |
| Office expenses | $50,791,608 | $44,920,098 | $5,731,306 | $140,204 | 2.4% | |
| Pension plan contributions | $50,144,029 | $44,347,379 | $5,796,650 | - | 2.4% | |
| Interest | $24,883,137 | $22,006,646 | $2,876,491 | - | 1.2% | |
| Other (as described) | Utilities | $18,537,115 | $16,394,225 | $2,142,890 | - | 0.9% |
| Pay: officers, directors, trustees, key employees | $14,857,327 | - | $14,857,327 | - | 0.7% | |
| Travel | $12,259,654 | $10,842,438 | $1,287,155 | $130,061 | 0.6% | |
| Occupancy | $7,612,123 | $6,732,162 | $879,961 | - | 0.4% | |
| Information technology | $6,981,966 | $6,174,851 | $807,115 | - | 0.3% | |
| Insurance | $6,008,000 | $5,313,475 | $694,525 | - | 0.3% | |
| Pay: disqualified persons | $5,452,464 | $255,404 | $5,197,060 | - | 0.3% | |
| Grants outside the US | $2,564,810 | $2,564,810 | - | - | 0.1% | |
| Grants to US organizations and governments | $2,234,895 | $2,234,895 | - | - | 0.1% | |
| Advertising and promotion | $1,784,608 | $1,578,308 | $109,400 | $96,900 | 0.1% | |
| Fees: accounting | $769,919 | - | $769,919 | - | 0.0% | |
| Fees: investment management | $732,899 | - | $732,899 | - | 0.0% | |
| Fees: legal | $664,854 | - | $664,854 | - | 0.0% | |
| Fees: lobbying | $362,154 | $362,154 | - | - | 0.0% | |
| Grants to US individuals | $48,475 | $48,475 | - | - | 0.0% | |
| Fees: professional fundraisers | $37,025 | - | - | $37,025 | 0.0% | |
| Fundraising events Event | direct expenses; gross income $261,187 | $937,118 | reported apart | |||
| Total | $2,114,240,096 | 100% |
2014 · Form 990 · $2,039,964,371 spent · pay $1,288,067,501 · grants $2,027,513 · events $932,154
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $1,023,694,186 | $891,383,018 | $128,483,617 | $3,827,551 | 50.2% | |
| Other (as described) | Purchased Services | $190,154,482 | $167,526,099 | $21,987,349 | $641,034 | 9.3% |
| Other employee benefits | $142,975,653 | $125,961,550 | $17,014,103 | - | 7.0% | |
| All other expenses | $117,967,817 | $104,878,933 | $12,270,670 | $818,214 | 5.8% | |
| Other (as described) | Medical Supplies | $114,401,858 | $114,401,858 | - | - | 5.6% |
| Depreciation and depletion | $110,269,968 | $97,147,842 | $13,122,126 | - | 5.4% | |
| Other (as described) | Drugs | $87,344,489 | $87,344,489 | - | - | 4.3% |
| Payroll taxes | $66,683,351 | $58,748,031 | $7,935,320 | - | 3.3% | |
| Office expenses | $52,210,429 | $45,997,388 | $5,964,409 | $248,632 | 2.6% | |
| Pension plan contributions | $46,866,168 | $41,289,094 | $5,577,074 | - | 2.3% | |
| Interest | $19,425,110 | $17,113,522 | $2,311,588 | - | 1.0% | |
| Other (as described) | Utilities | $18,987,824 | $16,748,273 | $2,239,551 | - | 0.9% |
| Travel | $12,884,482 | $11,351,229 | $1,394,716 | $138,537 | 0.6% | |
| Occupancy | $8,005,015 | $7,052,418 | $952,597 | - | 0.4% | |
| Pay: officers, directors, trustees, key employees | $7,680,179 | - | $7,680,179 | - | 0.4% | |
| Information technology | $6,774,104 | $5,967,986 | $806,118 | - | 0.3% | |
| Insurance | $6,509,719 | $5,735,300 | $774,419 | - | 0.3% | |
| Advertising and promotion | $1,685,124 | $1,245,869 | $200,530 | $238,725 | 0.1% | |
| Grants outside the US | $1,456,922 | $1,456,922 | - | - | 0.1% | |
| Fees: investment management | $1,052,463 | - | $1,052,463 | - | 0.1% | |
| Fees: accounting | $870,042 | - | $870,042 | - | 0.0% | |
| Fees: legal | $805,567 | - | $805,567 | - | 0.0% | |
| Grants to US organizations and governments | $570,591 | $570,591 | - | - | 0.0% | |
| Fees: lobbying | $424,739 | $424,739 | - | - | 0.0% | |
| Pay: disqualified persons | $167,964 | $43,220 | $124,744 | - | 0.0% | |
| Fees: professional fundraisers | $96,125 | - | - | $96,125 | 0.0% | |
| Fundraising events Event | direct expenses; gross income $372,930 | $932,154 | reported apart | |||
| Total | $2,039,964,371 | 100% |
2013 · Form 990 · $1,975,833,461 spent · pay $1,242,767,804 · grants $3,501,939 · events $836,151
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $968,784,346 | $847,732,689 | $117,537,846 | $3,513,811 | 49.0% | |
| Office expenses | $217,324,381 | $187,686,381 | $29,469,186 | $168,814 | 11.0% | |
| Other (as described) | PURCHASED SERVICES | $146,302,567 | $125,973,936 | $19,838,628 | $490,003 | 7.4% |
| Other employee benefits | $129,748,767 | $113,270,674 | $16,478,093 | - | 6.6% | |
| Depreciation and depletion | $109,187,656 | $94,381,810 | $14,805,846 | - | 5.5% | |
| All other expenses | $87,754,607 | $75,228,896 | $12,181,766 | $343,945 | 4.4% | |
| Pension plan contributions | $68,017,003 | $58,793,897 | $9,223,106 | - | 3.4% | |
| Payroll taxes | $62,929,079 | $54,395,896 | $8,533,183 | - | 3.2% | |
| Other (as described) | MEDICAL SUPPLIES | $53,270,415 | $46,046,947 | $7,223,468 | - | 2.7% |
| Insurance | $38,516,141 | $33,293,352 | $5,222,789 | - | 1.9% | |
| Other (as described) | UTILITIES | $17,642,754 | $15,250,397 | $2,392,357 | - | 0.9% |
| Travel | $15,935,152 | $13,676,129 | $2,160,807 | $98,216 | 0.8% | |
| Interest | $14,169,946 | $12,248,501 | $1,921,445 | - | 0.7% | |
| Pay: officers, directors, trustees, key employees | $13,072,464 | - | $13,072,464 | - | 0.7% | |
| Occupancy | $9,822,853 | $8,487,726 | $1,331,979 | $3,148 | 0.5% | |
| Other (as described) | DIETARY | $8,250,688 | $7,131,895 | $1,118,793 | - | 0.4% |
| Information technology | $7,071,970 | $6,113,011 | $958,959 | - | 0.4% | |
| Grants outside the US | $3,132,441 | $3,132,441 | - | - | 0.2% | |
| Advertising and promotion | $2,417,346 | $1,771,829 | $327,792 | $317,725 | 0.1% | |
| Fees: accounting | $795,986 | $688,050 | $107,936 | - | 0.0% | |
| Fees: legal | $575,400 | $497,376 | $78,024 | - | 0.0% | |
| Fees: lobbying | $387,412 | $334,879 | $52,533 | - | 0.0% | |
| Grants to US organizations and governments | $369,498 | $369,498 | - | - | 0.0% | |
| Pay: disqualified persons | $216,145 | $216,145 | - | - | 0.0% | |
| Fees: professional fundraisers | $138,444 | - | - | $138,444 | 0.0% | |
| Fundraising events Event | direct expenses; gross income $195,731 | $836,151 | reported apart | |||
| Total | $1,975,833,461 | 100% |
2012 · Form 990 · $1,802,150,625 spent · pay $1,158,516,702 · grants $1,244,482 · events $565,572
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $876,638,942 | $762,282,218 | $111,333,144 | $3,023,580 | 48.6% | |
| Office expenses | $200,814,670 | $175,201,637 | $25,503,463 | $109,570 | 11.1% | |
| Other (as described) | PURCHASED SERVICES | $182,904,512 | $159,557,142 | $23,228,873 | $118,497 | 10.1% |
| Other employee benefits | $119,929,371 | $104,698,341 | $15,231,030 | - | 6.7% | |
| Depreciation and depletion | $110,364,186 | $96,347,934 | $14,016,252 | - | 6.1% | |
| Pension plan contributions | $93,110,829 | $81,285,754 | $11,825,075 | - | 5.2% | |
| All other expenses | $63,056,685 | $54,907,154 | $7,917,196 | $232,335 | 3.5% | |
| Payroll taxes | $57,529,620 | $50,223,358 | $7,306,262 | - | 3.2% | |
| Other (as described) | UTILITIES | $15,508,582 | $13,538,992 | $1,969,590 | - | 0.9% |
| Interest | $14,247,432 | $12,438,008 | $1,809,424 | - | 0.8% | |
| Travel | $14,050,195 | $12,186,822 | $1,784,375 | $78,998 | 0.8% | |
| Pay: officers, directors, trustees, key employees | $11,106,775 | - | $11,106,775 | - | 0.6% | |
| Occupancy | $9,766,793 | $8,525,905 | $1,240,383 | $505 | 0.5% | |
| Other (as described) | DIETARY | $7,555,884 | $6,596,287 | $959,597 | - | 0.4% |
| Insurance | $7,126,160 | $6,221,138 | $905,022 | - | 0.4% | |
| Information technology | $6,613,616 | $5,773,687 | $839,929 | - | 0.4% | |
| Other (as described) | DUES & SUBSCRIPTIONS | $5,338,659 | $4,660,649 | $678,010 | - | 0.3% |
| Advertising and promotion | $2,257,749 | $1,745,988 | $286,734 | $225,027 | 0.1% | |
| Fees: legal | $1,189,888 | $1,038,772 | $151,116 | - | 0.1% | |
| Fees: accounting | $834,781 | $728,764 | $106,017 | - | 0.0% | |
| Grants outside the US | $713,995 | $713,995 | - | - | 0.0% | |
| Grants to US organizations and governments | $530,487 | $530,487 | - | - | 0.0% | |
| Fees: lobbying | $446,716 | $389,983 | $56,733 | - | 0.0% | |
| Fees: professional fundraisers | $312,933 | - | - | $312,933 | 0.0% | |
| Pay: disqualified persons | $201,165 | $201,165 | - | - | 0.0% | |
| Fundraising events Event | direct expenses; gross income - | $565,572 | reported apart | |||
| Total | $1,802,150,625 | 100% |
2011 · Form 990 · $1,729,381,098 spent · pay $1,070,652,468 · grants $783,642 · events $516,050
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $822,955,742 | $715,478,624 | $104,515,379 | $2,961,739 | 47.6% | |
| Office expenses | $179,849,228 | $156,913,137 | $22,840,852 | $95,239 | 10.4% | |
| Other (as described) | PURCHASED SERVICES | $164,531,017 | $143,379,886 | $20,895,439 | $255,692 | 9.5% |
| Depreciation and depletion | $119,571,015 | $104,385,496 | $15,185,519 | - | 6.9% | |
| Other employee benefits | $115,575,616 | $100,897,513 | $14,678,103 | - | 6.7% | |
| Pension plan contributions | $65,803,152 | $57,446,152 | $8,357,000 | - | 3.8% | |
| All other expenses | $61,982,813 | $53,780,613 | $7,871,815 | $330,385 | 3.6% | |
| Payroll taxes | $53,679,930 | $46,862,579 | $6,817,351 | - | 3.1% | |
| Other (as described) | BAD DEBT EXPENSE | $40,934,574 | $40,934,574 | $0 | - | 2.4% |
| Other (as described) | UTILITIES | $16,717,922 | $14,594,746 | $2,123,176 | - | 1.0% |
| Insurance | $16,098,265 | $14,053,785 | $2,044,480 | - | 0.9% | |
| Interest | $15,926,250 | $13,903,616 | $2,022,634 | - | 0.9% | |
| Travel | $14,942,471 | $13,044,777 | $1,897,694 | - | 0.9% | |
| Pay: officers, directors, trustees, key employees | $11,800,683 | - | $11,800,683 | - | 0.7% | |
| Occupancy | $9,470,629 | $8,207,639 | $1,202,770 | $60,220 | 0.5% | |
| Other (as described) | DIETARY | $7,450,843 | $6,504,586 | $946,257 | - | 0.4% |
| Information technology | $6,483,869 | $5,660,418 | $823,451 | - | 0.4% | |
| Advertising and promotion | $1,789,413 | $1,423,176 | $227,255 | $138,982 | 0.1% | |
| Fees: accounting | $873,605 | $762,657 | $110,948 | - | 0.1% | |
| Pay: disqualified persons | $837,345 | $837,345 | - | - | 0.0% | |
| Fees: legal | $667,202 | $582,467 | $84,735 | - | 0.0% | |
| Grants to US organizations and governments | $497,753 | $497,753 | - | - | 0.0% | |
| Fees: lobbying | $439,433 | $383,625 | $55,808 | - | 0.0% | |
| Grants outside the US | $285,889 | $285,889 | - | - | 0.0% | |
| Fees: professional fundraisers | $216,439 | - | - | $216,439 | 0.0% | |
| Fundraising events Event | direct expenses; gross income - | $516,050 | reported apart | |||
| Total | $1,729,381,098 | 100% |
2010 · Form 990 · $1,651,672,224 spent · pay $1,032,000,932 · grants $2,110,275 · events $470,588
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $780,225,992 | $678,207,789 | $99,088,701 | $2,929,502 | 47.2% | |
| Other (as described) | PURCHASED SERVICES | $164,927,982 | $143,746,674 | $20,945,854 | $235,454 | 10.0% |
| Office expenses | $158,325,879 | $138,157,391 | $20,107,387 | $61,101 | 9.6% | |
| Other employee benefits | $114,189,449 | $99,687,389 | $14,502,060 | - | 6.9% | |
| Depreciation and depletion | $110,704,675 | $96,645,181 | $14,059,494 | - | 6.7% | |
| Pension plan contributions | $70,226,119 | $61,307,402 | $8,918,717 | - | 4.3% | |
| Payroll taxes | $51,717,161 | $45,149,082 | $6,568,079 | - | 3.1% | |
| Other (as described) | BAD DEBT EXPENSE | $49,531,569 | $49,531,569 | - | - | 3.0% |
| All other expenses | $35,856,590 | $30,932,707 | $4,553,784 | $370,099 | 2.2% | |
| Insurance | $20,027,990 | $17,484,435 | $2,543,555 | - | 1.2% | |
| Other (as described) | UTILITIES | $17,855,674 | $15,588,003 | $2,267,671 | - | 1.1% |
| Interest | $16,103,740 | $14,058,565 | $2,045,175 | - | 1.0% | |
| Pay: officers, directors, trustees, key employees | $14,835,587 | - | $14,835,587 | - | 0.9% | |
| Travel | $14,097,070 | $12,306,742 | $1,790,328 | - | 0.9% | |
| Other (as described) | DIETARY | $6,983,317 | $6,096,436 | $886,881 | - | 0.4% |
| Occupancy | $6,206,341 | $5,357,916 | $788,205 | $60,220 | 0.4% | |
| Information technology | $5,932,733 | $5,179,276 | $753,457 | - | 0.4% | |
| Other (as described) | DUES AND SUBSCRIPTIONS | $4,829,050 | $4,215,761 | $613,289 | - | 0.3% |
| Advertising and promotion | $2,729,945 | $2,240,764 | $346,703 | $142,478 | 0.2% | |
| Fees: legal | $2,140,739 | $1,868,865 | $271,874 | - | 0.1% | |
| Grants to US organizations and governments | $1,592,296 | $1,592,296 | - | - | 0.1% | |
| Fees: accounting | $822,525 | $718,064 | $104,461 | - | 0.0% | |
| Pay: disqualified persons | $806,624 | $806,624 | - | - | 0.0% | |
| Grants outside the US | $517,979 | $517,979 | - | - | 0.0% | |
| Fees: lobbying | $485,198 | $423,578 | $61,620 | - | 0.0% | |
| Fundraising events Event | direct expenses; gross income - | $470,588 | reported apart | |||
| Total | $1,651,672,224 | 100% |
2009 · Form 990 · $1,512,075,251 spent · pay $932,128,826 · grants $0 · events $426,317
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $713,387,958 | $626,916,836 | $83,466,391 | $3,004,731 | 47.2% | |
| Other (as described) | PURCHASED SERVICES | $161,412,885 | $142,407,620 | $18,885,308 | $119,957 | 10.7% |
| Office expenses | $152,242,737 | $134,341,228 | $17,812,400 | $89,109 | 10.1% | |
| Other employee benefits | $105,086,513 | $92,791,391 | $12,295,122 | - | 6.9% | |
| Depreciation and depletion | $105,078,555 | $92,784,364 | $12,294,191 | - | 6.9% | |
| Pension plan contributions | $53,256,506 | $47,025,495 | $6,231,011 | - | 3.5% | |
| Payroll taxes | $49,157,212 | $43,405,818 | $5,751,394 | - | 3.3% | |
| Other (as described) | BAD DEBT EXPENSE | $39,613,627 | $39,613,627 | - | - | 2.6% |
| All other expenses | $36,952,087 | $32,294,789 | $4,323,395 | $333,903 | 2.4% | |
| Other (as described) | UTILITIES | $17,449,247 | $15,407,685 | $2,041,562 | - | 1.2% |
| Interest | $15,729,237 | $13,888,916 | $1,840,321 | - | 1.0% | |
| Insurance | $12,240,496 | $10,808,358 | $1,432,138 | - | 0.8% | |
| Pay: officers, directors, trustees, key employees | $10,500,195 | - | $10,500,195 | - | 0.7% | |
| Travel | $10,328,340 | $9,119,924 | $1,208,416 | - | 0.7% | |
| Occupancy | $6,882,219 | $6,024,008 | $805,220 | $52,991 | 0.5% | |
| Information technology | $6,863,760 | $6,060,700 | $803,060 | - | 0.5% | |
| Other (as described) | dietARY | $6,146,813 | $5,427,636 | $719,177 | - | 0.4% |
| Other (as described) | DUES AND SUBSCRIPTIONS | $4,657,106 | $4,112,225 | $544,881 | - | 0.3% |
| Advertising and promotion | $2,153,439 | $1,746,422 | $251,952 | $155,065 | 0.1% | |
| Fees: legal | $889,654 | $785,564 | $104,090 | - | 0.1% | |
| Fees: accounting | $805,053 | $710,862 | $94,191 | - | 0.1% | |
| Pay: disqualified persons | $740,442 | $740,442 | - | - | 0.0% | |
| Fees: lobbying | $493,105 | $435,412 | $57,693 | - | 0.0% | |
| Fees: professional fundraisers | $8,065 | - | - | $8,065 | 0.0% | |
| Fundraising events Event | direct expenses; gross income - | $426,317 | reported apart | |||
| Total | $1,512,075,251 | 100% |
Federal grants and contracts
Awards from USAspending.gov to a recipient with this organization's name and zip code. Obligations by federal fiscal year (October to September); each award links to its page on usaspending.gov.
| Fiscal year | Grants and other assistance | Contracts | Awards |
|---|---|---|---|
| 2026 | $189,751,387 | $98,562 | 424 |
| 2025 | $191,562,291 | $218,307 | 416 |
| 2024 | $188,003,282 | $1,236,905 | 472 |
| 2023 | $198,054,188 | $2,661,544 | 445 |
| 2022 | $199,882,069 | -$531,842 | 500 |
| 2021 | $188,685,436 | $3,587,513 | 443 |
| 2020 | $195,188,230 | $1,284,081 | 435 |
| 2019 | $161,505,814 | $7,954,866 | 425 |
| 2018 | $139,198,284 | $2,221,402 | 414 |
| 2017 | $133,006,181 | $13,865,288 | 392 |
| 2016 | $130,786,155 | $2,182,765 | 306 |
| 2015 | $116,756,064 | $2,993,675 | 292 |
| 2014 | $114,420,873 | $5,622,009 | 288 |
| 2013 | $115,618,862 | $12,040,177 | 287 |
| 2012 | $118,325,561 | $7,135,447 | 276 |
| 2011 | $112,518,326 | $10,957,315 | 280 |
| 2010 | $141,141,294 | $2,690,480 | 318 |
| 2009 | $110,425,254 | $3,693,500 | 299 |
| 2008 | $52,899,350 | $1,463,065 | 157 |
| 2007 | $48,568,232 | $2,519,837 | 156 |
Largest awards · 200 shown
| Year | Agency | Kind | Program | Description | Obligated |
|---|---|---|---|---|---|
| 2026 | Health Resources and Services Administration | Grant or other assistance | CHILDREN'S HOSPITALS GRADUATE MEDICAL EDUCATION PAYMENT PROGRAM 93.255 | CHILDREN'S HOSPITALS GRADUATE MEDICAL EDUCATION PAYMENT PROGRAM | $11,624,896 |
| 2026 | National Institutes of Health | Grant or other assistance | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853 | THE IMPACT OF COVID-19 ON PEOPLE LIVING WITH RARE DISEASES AND THEIR FAMILIES | $6,837,569 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | DATA COORDINATING CENTER: B2B CHANGE COHORT - PROJECT ABSTRACT CONGENITAL HEART DISEASE (CHD) OCCURS IN APPROXIMATELY 40,000 INFANTS IN THE UNITED STATES EACH Y | $6,452,040 |
| 2026 | National Institutes of Health | Grant or other assistance | TRANS-NIH RESEARCH SUPPORT 93.310 | RANDOMIZED CONTROL TRIAL OF OXYGEN THERAPY IN CHILDREN AND ADOLESCENTS WITH DOWN SYNDROME AND OBSTRUCTIVE SLEEP APNEA - ABSTRACT: A LARGE PERCENTAGE OF CHILDREN | $3,919,962 |
| 2026 | National Institutes of Health | Grant or other assistance | TRANS-NIH RESEARCH SUPPORT 93.310 | PATIENT-SPECIFIC, COMBINATORIAL NAMS FOR GASTROINTESTINAL DISEASES AND DRUG RESPONSE PREDICTION - ABSTRACT MILLIONS OF PEOPLE IN THE US ARE IMPACTED BY GASTROI | $3,240,000 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | TRANSPIRE: A PROSPECTIVE COHORT STUDY OF LUNG INJURY AFTER HEMATOPOIETIC STEM CELL TRANSPLANT IN CHILDREN. - PROJECT SUMMARY HEMATOPOIETIC STEM CELL TRANSPLANT | $2,595,280 |
| 2026 | National Institutes of Health | Grant or other assistance | TRANS-NIH RESEARCH SUPPORT 93.310 | 4/6 HBCD PRENATAL EXPERIENCES AND LONGITUDINAL DEVELOPMENT (PRELUDE) CONSORTIUM - PROJECT SUMMARY/ABSTRACT BRAIN DEVELOPMENT OCCURS AT A RAPID PACE PRENATALLY A | $2,413,640 |
| 2026 | National Institutes of Health | Grant or other assistance | DRUG USE AND ADDICTION RESEARCH PROGRAMS 93.279 | BIOPSYCHOSOCIAL DETERMINANTS OF PEDIATRIC-ONSET CHRONIC MUSCULOSKELETAL PAIN - ABSTRACT PEDIATRIC-ONSET CHRONIC MUSCULOSKELETAL PAIN DISORDERS ARE COMMON, BUT T | $2,086,466 |
| 2026 | National Institutes of Health | Grant or other assistance | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853 | A PHASE 3 CLINICAL TRIAL OF AN E-HEALTH BEHAVIORAL INTERVENTION TO IMPROVE EXECUTIVE FUNCTIONING IN ADOLESCENTS WITH EPILEPSY - EPILEPSY IS A COMMON PEDIATRIC N | $1,913,604 |
| 2026 | National Institutes of Health | Grant or other assistance | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853 | MECHANISTIC AND TRANSLATIONAL MEDICINE STUDIES OF BRAIN NEUROPHYSIOLOGY AND PHENOTYPIC HETEROGENEITY IN FRAGILE X SYNDROME - THE DEVELOPMENT OF NEXT-GENERATION | $1,881,985 |
| 2026 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | EPITHELIAL GENES IN ALLERGIC INFLAMMATION | $1,872,275 |
| 2026 | National Institutes of Health | Grant or other assistance | CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH 93.865 | XENBASE: A XENOPUS MODEL ORGANISM DATABASE | $1,756,854 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | THE LUNGMAP DATA COORDINATION CENTER FOR NEXT GEN SYSTEMS BIOLOGY OF RESPIRATION | $1,719,766 |
| 2026 | National Institutes of Health | Grant or other assistance | NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES 93.350 | CONSORTIUM OF EOSINOPHILIC GASTROINTESTINAL DISEASE RESEARCHERS | $1,715,910 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | NON-INVASIVELY QUANTIFYING ALVEOLAR REMODELING IN CYSTIC FIBROSIS LUNG DISEASE - FORMERLY FATAL, PEDIATRIC CONDITIONS SUCH AS CYSTIC FIBROSIS (CF), HAVE BEEN TR | $1,601,013 |
| 2026 | National Institutes of Health | Grant or other assistance | CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH 93.865 | DEVELOPMENTAL MECHANISMS OF TRACHEA-ESOPHAGEAL BIRTH DEFECTS | $1,598,939 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | INTRAMUSCULAR VS. ENTERAL PENICILLIN PROPHYLAXIS TO PREVENT PROGRESSION OF LATENT RHEUMATIC HEART DISEASE: A NON-INFERIORITY RANDOMIZED TRIAL. (GOALIE) - PROJEC | $1,522,366 |
| 2026 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER VACCINE AND TREATMENT EVALUATION UNITS (UM1 CLINICAL TRIAL REQUIRED) | $1,354,230 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | HPV AND HOST FACTORS IN JUVENILE ONSET RECURRENT RESPIRATORY PAPILLOMATOSIS - ABSTRACT. PATIENTS WITH JUVENILE-ONSET RECURRENT RESPIRATORY PAPILLOMATOSIS (JORRP | $1,340,183 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | REALIZING EFFECTIVENESS ACROSS CONTINENTS WITH HYDROXYUREA(REACH): A PHASE I/II PILOT STUDY OF HYROXYUREA FOR CHILDREN WITH SICKLE CELL ANEMIA | $1,266,339 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | EPIGENETIC REGULATION OF INTESTINAL TUFT CELLS - INTESTINAL EPITHELIAL CELLS RESIDE AT THE DIRECT INTERFACE BETWEEN THE MICROBIOTA AND MAMMALIAN HOST, AND ARE T | $1,255,082 |
| 2026 | National Institutes of Health | Grant or other assistance | TRANS-NIH RESEARCH SUPPORT 93.310 | PERSONALIZED CYSTIC FIBROSIS THERAPY AND RESEARCH CENTER | $1,231,361 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | DIGESTIVE HEALTH CENTER: BENCH TO BEDSIDE RESEARCH IN PEDIATRIC DIGESTIVE DISEASE | $1,192,500 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | TRANSCRIPTIONAL AND EPIGENETIC MECHANISMS OF ALVEOLOGENESIS AND RE-ALVEOLOGENESIS - PROJECT SUMMARY LUNG DISEASES IMPACTING THE GAS EXCHANGE ALVEOLI, INCLUDING | $1,099,905 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | THE MICROENVIRONMENT IN BONE MARROW HEMATOPOIESIS - ABSTRACT: BLOOD CELL PRODUCTION TAKES PLACE VIA STEPWISE DIFFERENTIATION FROM HEMATOPOIETIC STEM CELLS INTO | $1,077,597 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | DECODING INNATE IMMUNE SIGNALING IN NORMAL AND MYELODYSPLASTIC HEMATOPOIESIS - ABSTRACT MYELODYSPLASTIC SYNDROMES (MDS) ARE HETEROGENOUS AND POORLY UNDERSTOOD H | $1,057,623 |
| 2026 | Health Resources and Services Administration | Grant or other assistance | SICKLE CELL TREATMENT DEMONSTRATION PROGRAM 93.365 | THE SICKLE CELL DISEASE REGIONAL QUALITY CARE PROGRAM (SORCE-Q) - NEEDS ADDRESSED: IN THE MIDWESTERN REGION (INDIANA, ILLINOIS, KENTUCKY, MICHIGAN, MINNESOTA, N | $950,000 |
| 2026 | Defense Health Agency | Grant or other assistance | MILITARY MEDICAL RESEARCH AND DEVELOPMENT 12.420 | DEFINING THE CONTEMPORARY NATURAL HISTORY AND THERAPEUTICS IMPACT ON CARDIOMYOPATHY IN DUCHENNE MUSCULAR DYSTROPHY. | $910,000 |
| 2026 | National Institutes of Health | Grant or other assistance | TRANS-NIH RESEARCH SUPPORT 93.310 | COGNITIVE OUTCOME MEASURES IN SCHOOL AGE CHILDREN WITH DOWN SYNDROME | $878,666 |
| 2026 | National Institutes of Health | Grant or other assistance | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853 | MECHANISMS OF FOCAL EPILEPTOGENESIS IN MTOROPATHIES - PROJECT SUMMARY THE GOAL OF THIS R35 APPLICATION IS TO CAPITALIZE ON NEW MOUSE MODELS OF EPILEPSY THAT MY | $870,682 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | MECHANISMS REGULATING COMPETENCY OF HEPATOCYTE PLASTICITY - PROJECT ABSTRACT INTRAHEPATIC BILE DUCT (IHBD) PAUCITY IS A MAJOR CAUSE OF PEDIATRIC LIVER DISEASE, | $851,275 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | IMPLEMENTATION OF SHARED DECISION-MAKING FOR SICKLE CELL DISEASE (IMPLEMENT-SDM STUDY) - MODIFIED PROJECT SUMMARY/ABSTRACT SECTION SICKLE CELL DISEASE (SCD) IS | $830,260 |
| 2026 | National Institutes of Health | Grant or other assistance | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853 | A NEW MODEL TO IDENTIFY PRETERM NEONATES AT HIGH-RISK FOR COGNITIVE DEFICITS | $826,976 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | CINCINNATI CHILDREN'S CLINICAL CENTER FOR TARGETING THE PATHOPHYSIOLOGY OF YOUTH-ONSET TYPE 2 DIABETES - PROJECT SUMMARY FOR MORE THAN TWO DECADES THROUGH LOCAL | $824,771 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | FROM REAL-WORLD EVIDENCE TO SYSTEMS PHARMACOLOGY: A COMPREHENSIVE APPROACH TO DRUG-INDUCED PANCREATIC INJURY - SUMMARY DRUG-INDUCED PANCREATIC INJURY (DIPI) IS | $824,078 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | THE ROLE OF MACROPHAGES IN STEATOTIC LIVER DISEASE - PROJECT SUMMARY/ABSTRACT MACROPHAGES PLAY CRITICAL ROLES IN THE PATHOPHYSIOLOGY OF STEATOTIC LIVER DISEASE | $822,411 |
| 2026 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | IMPACT OF CIRCADIAN MISALIGNMENT FOR ADOLESCENTS WITH ADHD: OBSERVATIONAL AND MECHANISTIC DATA - PROJECT SUMMARY DURING ADOLESCENCE, INDIVIDUALS WITH ATTENTION- | $820,196 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | IMMUNOPATHOGENESIS OF NON-ALCOHOLIC FATTY LIVER DISEASE | $817,650 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | EXPLORING THE LINK BETWEEN EXTRACELLULAR VESICLE-ASSOCIATED INFLAMMATION IN OBESITY AND SEPSIS OUTCOMES - SUMMARY OBESITY, NOW AT PANDEMIC LEVELS, SIGNIFICANTLY | $815,858 |
| 2026 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | VIRUS-DRIVEN HUMAN GENE MISREGULATION IN DISEASE - THOUSANDS OF GENETIC VARIANTS HAVE BEEN ESTABLISHED FOR HUNDREDS OF HUMAN DISEASES. LIKEWISE, ENVIRONMENTAL F | $809,922 |
| 2026 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | EVALUATION OF A PAN-FILOVIRUS VIRUS-LIKE PARTICLE (VLP) VACCINE. - PROJECT SUMMARY SINCE FIRST DISCOVERED IN 1967, MEMBERS OF THE FILOVIRIDAE FAMILY (EBOLAVIRUS | $808,811 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | PATHOGENESIS AND TREATMENT OF KAPOSIFORM LYMPHANGIOMATOSIS - KAPOSIFORM LYMPHANGIOMATOSIS (KLA) IS A DEVASTATING CONGENITAL LYMPHATIC ANOMALY WITH A 51% SURVIVA | $808,579 |
| 2026 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | COGNITIVE DISENGAGEMENT SYNDROME: A TRANSDIAGNOSTIC PREDICTOR OF PSYCHOPATHOLOGY ACROSS ADOLESCENCE - PROJECT SUMMARY/ABSTRACT COGNITIVE DISENGAGEMENT SYNDROME | $802,494 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | A MECHANISTIC 3D AI-POWERED MAP OF GENETIC CHILD - ABSTRACT/SUMMARY LEVERAGING THE TECHNOLOGIES AND INFRASTRUCTURE IN OUR PREVIOUS LUNGMAP PHASES, WE WILL CONST | $786,450 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | UTE MRI TO MONITOR CF LUNG DISEASE AND RESPONSE TO CFTR MODULATION IN YOUNG CHILDREN | $784,505 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | CALCULATING THE COMPONENTS OF WORK OF BREATHING IN NEONATES WITH BRONCHOPULMONARY DYSPLASIA - PROJECT SUMMARY NEONATES CAN NOW SURVIVE PREMATURE BIRTH FROM AS E | $781,677 |
| 2026 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | PREGNANCY INDUCED DEACETYLATION OF SIALYLATED GLYCOPROTEINS - PREGNANCY INDUCED DEACETYLATION OF SIALYLATED GLYCOPROTEINS ABSTRACT. PREGNANCY CONFERS SUSCEPTIBI | $777,106 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | MRI PHENOTYPING OF EARLY BPD AND PREDICTION OF OUTCOMES | $776,191 |
| 2026 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | MULTI-OMICS OF THE FREQUENT EXACERBATOR ASTHMATIC - ABSTRACT ASTHMA IS A COMMON, COMPLEX AND COSTLY PEDIATRIC CHRONIC CONDITION IN THE U.S., RESULTING IN NEARLY | $775,331 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | DELINEATING THE IMPACT OF BEIGE ADIPOCYTES IN THE METABOLISM - PROJECT SUMMARY IN THIS PROPOSAL, WE ADDRESS A CRITICAL GAP IN OUR UNDERSTANDING OF ADIPOSE TISSU | $771,701 |
| 2026 | National Institutes of Health | Grant or other assistance | CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH 93.865 | SCREEN SMART: USING DIGITAL HEALTH TO IMPROVE HIV SCREENING AND PREVENTION FOR ADOLESCENTS IN THE EMERGENCY DEPARTMENT - PROJECT SUMMARY: ADOLESCENTS AND YOUNG | $769,815 |
| 2026 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | COMMENSAL CANDIDA ALBICANS PRIMED TH17 IMMUNITY - ABSTRACT. THE HUMAN INTESTINE HARBORS AN ESTIMATED 100 TRILLION MICROBES THAT ARE INCREASINGLY RECOGNIZED TO P | $765,377 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | THE ROLES OF MRP9 IN CHOLANGIOCYTE METABOLISM - PROJECT SUMMARY/ABSTRACT CHOLANGIOPATHIES ARE LIVER DISORDERS THAT PRIMARILY INJURE THE CHOLANGIOCYTES, LEADING | $763,829 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | TRAJECTORIES OF REGIONAL CARDIOPULMONARY STRUCTURE AND FUNCTION IN A LONGITUDINAL COHORT OF EXTREMELY PRETERM INFANTS - ABSTRACT PREMATURE BIRTH IS THE LEADING | $760,764 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | CARDIAC FIBROBLASTS IN POSTNATAL DEVELOPMENT AND ADULT INJURY RESPONSE | $760,670 |
| 2026 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | SYNDROME OF UNDIFFERENTIATED RECURRENT FEVERS: UNDERSTANDING PHENOTYPES (SURFS-UP) - PROJECT SUMMARY / ABSTRACT PERIODIC RECURRENT FEVER SYNDROMES RESULT FROM A | $758,906 |
| 2026 | Food and Drug Administration | Grant or other assistance | FOOD AND DRUG ADMINISTRATION RESEARCH 93.103 | ABATACEPT FOR THE TREATMENT OF COMMON VARIABLE IMMUNODEFICIENCY WITH INTERSTITIAL LUNG DISEASE (ABCVILD) IND #152820 9/2/20 - COMMON VARIABLE IMMUNODEFICIENCY | $756,873 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | ENGINEERING STRUCTURE AND FUNCTION OF HUMAN KIDNEY ORGANOIDS - PROJECT SUMMARY THE KIDNEY IS RESPONSIBLE FOR MAINTAINING AN OVERALL STATE OF HOMEOSTASIS, WHICH | $750,253 |
| 2026 | Defense Health Agency | Grant or other assistance | MILITARY MEDICAL RESEARCH AND DEVELOPMENT 12.420 | TARGETING EPIGENETIC MECHANISMS THAT DRIVE TRIPLE-NEGATIVE BREAST CANCER | $750,000 |
| 2026 | Health Resources and Services Administration | Grant or other assistance | EMERGENCY MEDICAL SERVICES FOR CHILDREN 93.127 | EMERGENCY MEDICAL SERVICES FOR CHILDREN: NETWORK DEVELOPMENT DEMONSTRATION PROJECT | $750,000 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | MECHANISMS UNDERLYING NEONATAL INTESTINAL IMMUNITY - PROJECT SUMMARY DESPITE MODERN THERAPEUTIC DEVELOPMENTS AND PROPHYLACTIC USE OF ANTIBIOTICS DURING BIRTH OR | $749,140 |
| 2026 | National Institutes of Health | Grant or other assistance | ARTHRITIS, MUSCULOSKELETAL AND SKIN DISEASES RESEARCH 93.846 | CINCINNATI RHEUMATIC DISEASES RESOURCE CENTER | $743,603 |
| 2026 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | GENE REGULATORY NETWORK MODELING OF DISEASE-ASSOCIATED DNA METHYLATION PERTURBATIONS - PROJECT SUMMARY SOMATIC MUTATIONS IN DNMT3A AND TET2 ARE COMMON IN THE HE | $740,330 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | ROLE OF ALVEOLAR FIBROBLASTS IN EXTRACELLULAR MATRIX ORGANIZATION AND ALVEOLAR TYPE 1 CELL DIFFERENTIATION - ABSTRACT: AN IN-DEPTH UNDERSTANDING OF THE MECHANIS | $740,079 |
| 2026 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | STUDYING FXS-ASSOCIATED HYPERVASCULARIZATION AND BBB DEFECTS USING BBB ASSEMBLOIDS: UNVEILING THE UNDERLYING MOLECULAR MECHANISMS - FRAGILE X SYNDROME (FXS) IS | $723,817 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER CAUSE AND PREVENTION RESEARCH 93.393 | A TAILORED MEDICATION ADHERENCE-PROMOTION INTERVENTION FOR ADOLESCENTS AND YOUNG ADULTS WITH CANCER - UP TO 60% OF ADOLESCENTS AND YOUNG ADULTS (AYAS) WITH CANC | $718,279 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | THE IMPACT OF SLC26A9 ON RESPONSE TO CFTR CORRECTION - PROJECT ABSTRACT / SUMMARY ALTHOUGH CFTR MODULATOR THERAPIES HAVE IMPROVED RESPIRATORY OUTCOMES FOR THE C | $717,742 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | REGULATION OF LONG-LASTING HEMATOPOIETIC MULTIPOTENT PROGENITORS - PROJECT DESCRIPTION THE DYNAMICS OF THE HEMATOPOIETIC FLUX RESPONSIBLE FOR BLOOD HOMEOSTASIS | $715,504 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | REGULATORY CD4+ T (TREG) CELLS DYNAMICS IN THE PATHOGENESIS OF METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD) - PROJECT SUMMARY METABOLIC DYSF | $714,898 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | MECHANISMS OF GRANULOCYTE HOMEOSTASIS | $714,156 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | MEOX2: A CRITICAL REGULATOR OF ALVEOLAR FIBROBLAST FUNCTION - ABSTRACT: AN IN-DEPTH UNDERSTANDING OF THE MECHANISMS THAT REGULATE ALVEOLAR SEPTATION AND SEPTAL | $707,389 |
| 2026 | National Institutes of Health | Grant or other assistance | CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH 93.865 | FX ENTRAIN: PERTURBATION OF NEURODYNAMICS UNDERLYING SENSORY HYPERAROUSAL AND STATISTICAL LEARNING IN YOUTH WITH FXS - CONTACT PI/PD: PEDAPATI, ERNEST PROJECT S | $706,917 |
| 2026 | National Institutes of Health | Grant or other assistance | CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH 93.865 | MACROPHAGE INTERACTIONS UNDERLYING ADULT TESTICULAR FUNCTION - PROJECT SUMMARY/ABSTRACT MALE HYPOGONADISM, CHARACTERIZED BY LOW TESTOSTERONE, PROFOUNDLY IMPACTS | $705,341 |
| 2026 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | ROLE OF CLIC/GEEC PATHWAY IN VCC FORMATION AND HIV-1 TRANSMISSION FROM MACROPHAGES - SUMMARY MYELOID CELLS CAPTURE FREE HIV-1 PARTICLES VIA INTERACTIONS BETWEEN | $703,409 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | CELLULAR DETERMINANTS OF RESPONSIVENESS TO MTOR INHIBITORS IN LAM - PROJECT SUMMARY ABSTRACT LYMPHANGIOLEIOMYOMATOSIS (LAM) IS A DESTRUCTIVE LUNG DISEASE ASSOCI | $702,302 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | CINCINNATI COOPERATIVE CENTER OF EXCELLENCE IN HEMATOLOGY - SUMMARY/ABSTRACT: THE LONG-TERM GOAL OF THE CINCINNATI COOPERATIVE CENTER OF EXCELLENCE IN HEMATOLOG | $700,000 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | IMPROVING MEDICATION ADHERENCE USING AN ADAPTIVE MHEALTH INTERVENTION IN ADOLESCENTS WITH ASTHMA - ASTHMA AFFECTS OVER 10 MILLION YOUTH IN THE UNITED STATES AND | $699,807 |
| 2026 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | LEVERAGING MULTI-OMICS TO MAXIMIZE THE SCIENTIFIC VALUE OF PEDIATRIC SEPSIS BIOREPOSITORY AND ADVANCE PATIENT ENDOTYPING - LEVERAGING MULTI-OMICS TO MAXIMIZE TH | $697,828 |
| 2026 | National Institutes of Health | Grant or other assistance | CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH 93.865 | PREVENTION OF BEHAVIOR PROBLEMS AMONG PRESCHOOL CHILDREN IN FOSTER CARE THROUGH GROUP-BASED FOSTER CAREGIVER TRAINING AT THE TIME OF PLACEMENT - PROJECT SUMMARY | $695,864 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER CAUSE AND PREVENTION RESEARCH 93.393 | BIOMARKER LEVELS AND ILLNESSES ASSOCIATED WITH EXPOSURE TO NONCOMBUSTIBLE AND COMBUSTIBLE TOBACCO PRODUCTS IN YOUNG CHILDREN - PROJECT SUMMARY UP TO ONE IN SIX | $694,182 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | EARLY DETECTION OF PULMONARY COMPLICATIONS OF HEMATOPOIETIC STEM-CELL TRANSPLANTATION IN CHILDREN USING HYPERPOLARIZED XENON MRI - PROJECT SUMMARY/ABSTRACT LATE | $691,296 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | CONCOMITANT INHIBITION OF VAV3 AND ERA TO TREAT HIGH-RISK B-ALL - PROJECT ABSTRACT B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL) REMAIN POOR PROGNOSIS DISEASES, E | $683,698 |
| 2026 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | GENETIC AND IMMUNOLOGICAL DISSECTION OF EOSINOPHILIC ESOPHAGITIS | $678,808 |
| 2026 | National Institutes of Health | Grant or other assistance | CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH 93.865 | FOOD-BASED RANDOMIZED TRIAL FOR ENHANCING SUPPORT OF HOSPITALIZED CHILDREN AND THEIR FAMILIES (FRESH) - PROJECT SUMMARY NATIONALLY, 1 IN 7 FAMILIES WITH CHILDRE | $673,002 |
| 2026 | National Institutes of Health | Grant or other assistance | CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH 93.865 | ACHIEVING INDEPENDENCE AND MASTERY IN SCHOOLS – AN RCT FOR MIDDLE-SCHOOLERS WITH AUTISM - PROJECT SUMMARY/ABSTRACT CHILDREN WITH AUTISM SPECTRUM DISORDERS (ASD) | $670,800 |
| 2026 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | KRUPPEL-LIKE FACTOR-2 CD4+ T CELLS AND INTESTINAL INFLAMMATION - ABSTRACT MUCOSAL TISSUES LIKE THE INTESTINE HARBOR TRILLIONS OF ANTIGENICALLY FOREIGN MICROBES. | $670,547 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | EFFECT OF REPRODUCTIVE HISTORY ON LONGITUDINAL CHANGE IN CARDIAC, VASCULAR AND LIPID PARAMETERS - ABSTRACT PREGNANCY IS OFTEN DESCRIBED AS A PHYSIOLOGIC “STRESS | $663,889 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | REGULATORY MECHANISMS OF HEMATOPOIETIC STEM CELL FUNCTIONS POST-TRANSPLANT - ABSTRACT HEMATOPOIETIC STEM CELLS (HSC) SUSTAIN THE PRODUCTION OF ALL BLOOD AND IMM | $663,697 |
| 2026 | National Institutes of Health | Grant or other assistance | TRANS-NIH RESEARCH SUPPORT 93.310 | BEHAVIOR MEASURE FOR CHILDREN AND ADOLESCENTS WITH DOWN SYNDROME - PROJECT SUMMARY THERE IS A FUNDAMENTAL GAP IN THE AVAILABILITY OF BEHAVIORAL OUTCOME MEASURES | $663,512 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | INITIATORS OF THROMBOTIC MICROANGIOPATHY - PROJECT SUMMARY/ABSTRACT THROMBOTIC MICROANGIOPATHY (TMA) OCCURS IN 20% OF CHILDREN AFTER HEMATOPOIETIC STEM CELL TRA | $659,088 |
| 2026 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | NAIVE CD8 T CELL FUNCTIONAL HETEROGENEITY - PROJECT SUMMARY THERE HAS BEEN CONSIDERABLE PROGRESS IN IDENTIFYING SUBSETS IN EFFECTOR, MEMORY, AND EXHAUSTED CD8 T | $658,849 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | GENETIC AND SMALL MOLECULE REGULATION OF MECHANISMS OF CROHN’S DISEASE STRICTURE FORMATION - THE LONG-TERM GOAL OF OUR RESEARCH PROGRAM IS TO DEFINE MECHANISMS | $658,456 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | PRECISE INFLIXIMAB EXPOSURE AND PHARMACODYNAMIC CONTROL TO ACHIEVE DEEP REMISSION IN PEDIATRIC CROHN'S DISEASE - PROJECT SUMMARY/ABSTRACT CROHN'S DISEASE IS A C | $655,158 |
| 2026 | National Institutes of Health | Grant or other assistance | ORAL DISEASES AND DISORDERS RESEARCH 93.121 | MOLECULAR REGULATION OF PALATE DEVELOPMENT - ABSTRACT SUBMUCOUS CLEFT PALATE (SMCP), DEFINED BY ABNORMAL ATTACHMENT OF PALATAL MUSCLES WITH INTACT ORAL AND NAS | $654,625 |
| 2026 | National Institutes of Health | Grant or other assistance | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853 | SUPRASPINAL PROCESSING OF SENSORY ASPECTS OF PAIN | $651,737 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | ROLE OF APOE IN HDL-MEDIATED ENHANCED SURVIVAL OF HUMAN REGULATORY T-CELLS - ABSTRACT REGULATORY T CELLS (TREGS) MEDIATE ANTI-INFLAMMATORY FUNCTIONS AND HAVE B | $649,387 |
| 2026 | National Institutes of Health | Grant or other assistance | CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH 93.865 | A MULTISITE RCT OF A DAILY LIVING SKILLS INTERVENTION FOR AUTISTIC ADOLESCENTS PRIOR TO THE TRANSITION TO ADULTHOOD - PROJECT SUMMARY/ABSTRACT: DAILY LIVING SKI | $648,898 |
| 2026 | National Institutes of Health | Grant or other assistance | CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH 93.865 | "IMPROVING ADHD TEEN DRIVING" | $646,695 |
| 2026 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | THE EFFECT OF DDX41 MUTATIONS ON HEMATOPOIESIS DURING AGING - MYELODYSPLASTIC SYNDROMES (MDS) ARE A GROUP OF BONE MARROW FAILURE DISORDERS CAUSED BY CLONAL EXPA | $645,245 |
| 2026 | National Institutes of Health | Grant or other assistance | NURSING RESEARCH 93.361 | A SOCIO-ECOLOGICAL APPROACH FOR IMPROVING SELF-MANAGEMENT IN ADOLESCENTS WITH SCD - PROJECT SUMMARY SICKLE CELL DISEASE (SCD), THE MOST COMMON LIFE-SHORTENING G | $643,900 |
| 2026 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | ANTIBIOTICS, INNATE IMMUNITY, AND DYSBIOSIS IN PEDIATRIC URTICARIAL REACTIONS - PROJECT SUMMARY ANTIBIOTIC ASSOCIATED REACTIONS (AAR) OCCUR IN 5-10% OF CHILDREN | $643,833 |
| 2026 | National Institutes of Health | Grant or other assistance | VISION RESEARCH 93.867 | INTEGRATIVE NEURODEVELOPMENTAL APPROACH TO CVI: SCREENING AND SUBTYPING IN EARLY CHILDHOOD - PROJECT SUMMARY/ABSTRACT CEREBRAL VISUAL IMPAIRMENT (CVI) IS THE LE | $642,491 |
| 2026 | National Institutes of Health | Grant or other assistance | ORAL DISEASES AND DISORDERS RESEARCH 93.121 | THE ROLE OF PRIMARY CILIA AND C2CD3 IN CRANIOFACIAL SKELETOGENESIS - ABSTRACT: PRIMARY CILIA ARE UBIQUITOUS, MICROTUBULE-BASED EXTENSIONS THAT TRANSDUCE MOLECUL | $642,392 |
| 2026 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | SIALYLATED ANTIBODY DEFENSE AGAINST INTRACELLULAR INFECTIONS - SIALYLATED ANTIBODY DEFENSE AGAINST INTRACELLULAR INFECTIONS ABSTRACT. DIVISION OF LABOR BETWEEN | $642,356 |
| 2026 | National Institutes of Health | Grant or other assistance | CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH 93.865 | LEVERAGING THE ELECTRONIC HEALTH RECORD TO CHARACTERIZE AND OPTIMIZE CARE DELIVERY FOR CHILDREN WITH CEREBRAL PALSY. - ABSTRACT/SUMMARY LEVERAGING THE ELECTRONI | $638,743 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | SUBCLINICAL KIDNEY AND CARDIOVASCULAR INDICATORS OF TRANSPLANT-ASSOCIATED THROMBOTIC MICROANGIOPATHY (TMA) - PROJECT SUMMARY/ABSTRACT TRANSPLANT-ASSOCIATED THRO | $638,652 |
| 2026 | National Institutes of Health | Grant or other assistance | CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH 93.865 | EVALUATING ADDITIVE EFFECTS OF INCLUDING CANINES IN REGULATING TOGETHER: A GROUP TREATMENT TO ADDRESS EMOTION DYSREGULATION IN YOUTH WITH AUTISM SPECTRUM DISORD | $638,363 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | DISSECTING INNATE IMMUNE SIGNALING IN PRE-LEUKEMIA EVOLUTION - ABSTRACT CLONAL HEMATOPOIESIS (CH) IS AN AGING ASSOCIATED CONDITION CHARACTERIZED BY THE CLONAL O | $638,243 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | ALLOGENEIC VIRUS-SPECIFIC T-CELL THERAPY AFTER HEMATOPOIETIC STEM CELL TRANSPLANT: DETERMINANTS OF TREATMENT SUCCESS AND FAILURE - ABSTRACT: INFECTIONS CAUSED B | $633,324 |
| 2026 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | PARITY, PATERNITY AND PREGNANCY OUTCOMES - ABSTRACT. PREMATURITY REMAINS THE LEADING CAUSE OF INFANT MORTALITY, RESPONSIBLE FOR WELL OVER 1 MILLION DEATHS EACH | $627,048 |
| 2026 | National Institutes of Health | Grant or other assistance | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853 | BINDING OF EPSTEIN BARR VIRUS EBNA2 UNIFIES MULTIPLE SCLEROSIS GENETIC MECHANISMS | $626,015 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | CELL-CELL SIGNALING DRIVING HPV-INDUCED RESPIRATORY DISEASE AND VACCINE RESPONSE - ABSTRACT THIS PATIENT-CENTRIC COLLABORATIVE TRANSLATIONAL RESEARCH PROJECT WI | $625,733 |
| 2026 | National Institutes of Health | Grant or other assistance | CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH 93.865 | DOSING AND PILOT EFFICACY OF 2'-FUCOSYLLACTOSE IN INFLAMMATORY BOWEL DISEASE | $623,628 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | THE ROLE OF DNAJB1-PKAC-?-CATENIN AXIS IN FIBROLAMELLAR HCC - ABSTRACT THIS MULTIPLE-PI APPLICATION PROPOSES INVESTIGATIONS OF CELLULAR AND MOLECULAR MECHANISMS | $622,939 |
| 2026 | National Institutes of Health | Grant or other assistance | ORAL DISEASES AND DISORDERS RESEARCH 93.121 | GENOMIC AND DEVELOPMENTAL MECHANISMS OF SIX2-RELATED FRONTONASAL DYSPLASIA - ABSTRACT ON AVERAGE, A HUMAN GENOME HARBORS ~27,000 STRUCTURAL VARIATIONS (SVS), I | $620,039 |
| 2026 | National Institutes of Health | Grant or other assistance | CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH 93.865 | THE ROLE OF HLA-C IN CHRONIC CHORIOAMNIONITIS - CHRONIC INFLAMMATION OF THE PLACENTAL MEMBRANES (CHRONIC CHORIOAMNIONITIS (CCA)) OCCURS FREQUENTLY AND INVOLVES | $614,982 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | MECHANISMS OF ARYL HYDROCARBON RECEPTOR CONTROL OF EOSINOPHILIC ESOPHAGITIS - PROJECT SUMMRAY EOSINOPHILIC ESOPHAGITIS (EOE) IS AN ALLERGIC DISEASE OF THE ESOPH | $611,916 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | MECHANISMS GOVERNING THE DIFFERENTIATION AND MAINTENANCE OF ATRIAL IDENTITY - PROJECT SUMMARY/ABSTRACT APPROPRIATE DIFFERENTIATION AND MAINTENANCE OF CELLULAR I | $611,409 |
| 2026 | National Institutes of Health | Grant or other assistance | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853 | ADVANCING CNS DRUG DELIVERY VIA EPIGENETIC MODULATION - ABSTRACT LYSOSOMAL STORAGE DISORDERS (LSDS) ARE A GROUP OF INHERITED DISEASES CHARACTERIZED BY DYSFUNCT | $609,073 |
| 2026 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | VIRAL AND CELLULAR DETERMINANTS OF HIV-1 ASSEMBLY - THE MAJOR GOAL OF THIS APPLICATION IS TO DEFINE VIRAL INTERACTIONS WITH HOST PATHWAYS THAT ARE ESSENTIAL FOR | $609,012 |
| 2026 | National Institutes of Health | Grant or other assistance | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853 | SYSTEMIC ENZYME DELIVERY BY A BRAIN TARGETED SAPC-DOPS NANOCARRIER FOR TREATMENT OF NEURONOPATHIC GAUCHER DISEASE - SUMMARY GAUCHER DISEASE (GD) IS A COMMON LYS | $608,491 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | IKEGAMI - R01 - NUCLEAR RUPTURE AND REPAIR IN LAMIN-ASSOCIATED CARDIOMYOPATHY - PROJECT SUMMARY LMNA-ASSOCIATED DILATED CARDIOMYOPATHY (LMNA-DCM) IS A FATAL GEN | $608,215 |
| 2026 | National Institutes of Health | Grant or other assistance | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853 | MITOGENIC ACTIVITIES IN NEUROFIBROMATOSIS | $607,383 |
| 2026 | Food and Drug Administration | Grant or other assistance | FOOD AND DRUG ADMINISTRATION RESEARCH 93.103 | SIROLIMUS TSC EPILEPSY PREVENTION STUDY (STEPS) IND#145820 11/8/2019 - SUMMARY/ABSTRACT EPILEPSY IS VERY PREVALENT AND HIGHLY REFRACTORY TO CURRENTLY AVAILABLE | $605,876 |
| 2026 | National Institutes of Health | Grant or other assistance | ORAL DISEASES AND DISORDERS RESEARCH 93.121 | REGULATION OF PALATE DEVELOPMENT AND INNERVATION - ABSTRACT CLEFT PALATE AFFECTS MORE THAN 1 IN 1,000 CHILDREN AND CAUSES SIGNIFICANT PROBLEMS IN FEEDING, SPEE | $605,123 |
| 2026 | National Institutes of Health | Grant or other assistance | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853 | ROLES OF GSX FACTORS IN BASAL GANGLIA DEVELOPMENT - NORMAL BRAIN FUNCTION RELIES ON THE CORRECT ASSEMBLY OF NEURAL CIRCUITS DURING DEVELOPMENT. THIS PROCESS STA | $602,583 |
| 2026 | National Science Foundation | Grant or other assistance | ENGINEERING 47.041 | CAREER: BIOENGINEERING OF A HUMAN BLOOD-SPINAL CORD BARRIER-ON-A-CHIP -THE HUMAN BODY HAS A PROTECTIVE SHIELD BETWEEN THE BLOODSTREAM AND THE CENTRAL NERVOUS SY | $600,000 |
| 2026 | National Institutes of Health | Grant or other assistance | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853 | DISRUPTED SPATIAL AND TEMPORAL NOCICEPTIVE FILTERING IN ADOLESCENTS WITH AND RISK FOR OVERLAPPING PAIN CONDITIONS - PROJECT ABSTRACT WHILE LOCALIZED PRIMARY PAI | $599,831 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | CLINICAL CENTER FOR BILIARY ATRESIA: ETIOPATHOGENESIS A* | $599,685 |
| 2026 | National Institutes of Health | Grant or other assistance | DRUG USE AND ADDICTION RESEARCH PROGRAMS 93.279 | MODELING HIV AND METHAMPHETAMINE-INDUCED NEUROINFLAMMATION IN CEREBRAL ORGANOIDS - COMBINATION ANTIRETROVIRAL THERAPY (CART) HAS LED TO DRAMATIC INCREASES IN LI | $598,811 |
| 2026 | National Institutes of Health | Grant or other assistance | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853 | IDENTIFICATION OF GERMLINE MODIFIERS OF NEUROFIBROMATOSIS TYPE 1 TUMORS - ABSTRACT NEUROFIBROMATOSIS TYPE 1 (NF1) IS A GENETIC DISORDER THAT OCCURS IN ABOUT 1: | $597,257 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | THROMBOSPONDIN1-REGULATED ATROPHY IN THE HEART - ABSTRACT LIKE SKELETAL MUSCLE MYOFIBERS, CARDIOMYOCYTES IN THE HEART CONSTANTLY ADJUST THEIR SIZE BASED ON PERC | $595,777 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | RATIONAL TARGETING OF CDC42 TO BENEFIT IMMUNOTHERAPY - ABSTRACT T CELLS PLAY IMPORTANT ROLE IN CANCER CELL IMMUNOSUPPRESSION. CANCER CELLS CAN INTERACT WITH IMM | $594,402 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | ORGANOID-GUIDED PRECISION HEPATOLOGY FOR STEATOHEPATITIS - PROJECT SUMMARY NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) AFFECTS BILLIONS OF PEOPLE. NAFLD WAS FIRST | $589,780 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | RNA SILENCING MACHINERY IN EXTRACELLULAR VESICLE-MEDIATED IMMUNOMETABOLIC REGULATION - PROJECT SUMMARY OBESITY HAS SOLID INFLAMMATORY UNDERPINNINGS, WHICH ARE R | $584,778 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | THROMBOSPONDIN 4 REGULATES ADAPTIVE ER STRESS RESPONSE | $584,016 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | DEVELOPING DWORF GENE THERAPY TO TREAT HEART FAILURE AND MUSCULAR DYSTROPHY - PROJECT SUMMARY CALCIUM IS AN ESSENTIAL REGULATOR OF MUSCLE FUNCTION AND ITS DYSRE | $581,971 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | PATHOGENESIS OF VASCULAR ANOMALIES WITH GNAQ MUTATIONS - PROJECT SUMMARY/ ABSTRACT: HYPERACTIVE, POSTZYGOTIC MUTATIONS IN THE GNAQ GENE (ENCODING FOR GAQ PROTEI | $581,713 |
| 2026 | National Institutes of Health | Grant or other assistance | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853 | CELL TYPE-SPECIFIC EPIGENETIC CONTROL OF BRAIN FUNCTION - SUMMARY: THERE ARE NO EFFECTIVE TREATMENTS FOR THE MAJORITY OF BRAIN DISORDERS. EVEN DISEASES LIKE EPI | $579,294 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | DEFINING PRC2 COMPLEX EPIGENOMIC CONTROL IN ALVEOLAR PROGENITOR CELLS - PROJECT SUMMARY THE ALVEOLAR REGION OF THE MAMMALIAN LUNG IS A COMPLEX, PRECISELY STRUCT | $569,920 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | ACCELERATING DELIVERY OF RHEUMATIC HEART DISEASE PREVENTIVE INTERVENTIONS IN UGANDA (ADUNU) - PROJECT SUMMARY ABSTRACT RHEUMATIC HEART DISEASE (RHD) IS THE MOST | $569,747 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | CUTANEOUS BIOMARKERS OF PEDIATRIC NON-ALCOHOLIC FATTY LIVER DISEASE - PROJECT SUMMARY/ABSTRACT THE OBJECTIVE OF THIS MULTICENTER STUDY IS TO DEVELOP AND VALIDAT | $569,533 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | THE ROLE OF SERPINS AND LRP1 IN THE ESOPHAGEAL EPITHELIUM DURING EOSINOPHILIC ESOPHAGITIS - PROJECT SUMMRAY EOSINOPHILIC ESOPHAGITIS (EOE) IS A CHRONIC ALLERGIC | $563,828 |
| 2026 | National Institutes of Health | Grant or other assistance | VISION RESEARCH 93.867 | OPTIMIZING METHOTREXATE USE FOR THE MANAGEMENT OF CHRONIC PEDIATRIC NON-INFECTIOUS UVEITIS - PROJECT SUMMARY PEDIATRIC CHRONIC NON-INFECTIOUS UVEITIS (NIU) IS A | $560,861 |
| 2026 | National Institutes of Health | Grant or other assistance | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853 | MOLECULAR MECHANISMS OF OLIGODENDROCYTE MYELINATION AND REMYELINATION - SUMMARY OF PROPOSED RESEARCH DEMYELINATING DISEASES OF THE CENTRAL NERVOUS SYSTEM, SUCH | $557,941 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | MOLECULAR MECHANISMS OF ATRIAL DEVELOPMENT AND REGENERATION | $555,341 |
| 2026 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | BLOCKING GRANZYME-MEDIATED IMMUNE SUPPRESSION TO ENHANCE HIV VACCINE EFFICACY - SUMMARY IMMUNIZATION REPRESENTS ONE OF THE MOST SUCCESSFUL PUBLIC HEALTH INTERVE | $550,847 |
| 2026 | Centers for Disease Control and Prevention | Grant or other assistance | INJURY PREVENTION AND CONTROL RESEARCH AND STATE AND COMMUNITY BASED PROGRAMS 93.136 | RFA-CE-23-008, DEVELOPMENT OF A MENTAL HEALTH OUTCOMES SCREENING TOOL (MOST) AFTER MILD TBI IN ADOLESCENTS: THE MOST-MTBI STUDY | $550,000 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | THROMBOSIS RISK IN TRANSGENDER ADOLESCENTS AND YOUNG ADULTS STARTING GENDER-AFFIRMING HORMONE THERAPY - PROJECT SUMMARY GENDER-AFFIRMING HORMONE THERAPY (GAHT) | $544,227 |
| 2026 | National Institutes of Health | Grant or other assistance | ARTHRITIS, MUSCULOSKELETAL AND SKIN DISEASES RESEARCH 93.846 | THE PEDIATRIC LUPUS NEPHRITIS MYCOPHENOLATE MOFETIL (PLUMM) STUDY - TITLE EFFICACY & SAFETY OF PHARMACOKINETICALLY-DRIVEN DOSING OF MYCOPHENOLATE MOFETIL FOR TH | $534,933 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | THE ROLE OF REGULATORY T CELLS IN BILIARY ATRESIA | $533,386 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | PROTEIN GLUTATHIONYLATION IS ESSENTIAL FOR LEUKEMIA INITIATING CELL SURVIVAL. - PROJECT SUMMARY THE GOAL OF THIS PROJECT IS TO DEVELOP A STRATEGY TO EFFECTIVELY | $533,245 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | TARGETING POLYAMINE METABOLISM IN RELAPSED ACUTE MYELOID LEUKEMIA STEM CELLS - PROJECT SUMMARY THE OVERALL GOAL OF THIS PROJECT IS TO TARGET AND MECHANISTICALLY | $530,106 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | PEDIATRIC GASTROENTEROLOGY AND NUTRITION TRAINING GRANT | $522,425 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | NON-CANONICAL BRAF MUTATIONS IN AML DEVELOPMENT AND THERAPEUTIC RESPONSE - PROJECT SUMMARY/ABSTRACT ACUTE MYELOID LEUKEMIA (AML), THE MOST COMMON TYPE OF ADULT | $522,196 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | ACETYLATION REGULATES YAP SUBCELLULAR LOCALIZATION AND CARDIAC REGENERATION - PROJECT SUMMARY ISCHEMIC HEART DISEASES, WHICH INCLUDE HEART FAILURE, ARE LINKED T | $515,218 |
| 2026 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | THE TNF SUPERFAMILY CONTROL OF PATHOLOGICAL REMODELING ASSOCIATED WITH SEVERE ASTHMA - PROJECT SUMMARY/ABSTRACT A SEVERE ASTHMA ENDOTYPE INVOLVING NEUTROPHILS I | $515,000 |
| 2026 | Health Resources and Services Administration | Grant or other assistance | NATIONAL RESEARCH SERVICE AWARD IN PRIMARY CARE MEDICINE 93.186 | NATIONAL RESEARCH SERVICE AWARD | $512,172 |
| 2026 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | MECHANISMS OF HOMEODOMAIN TRANSCRIPTION FACTOR SPECIFICITY - PROGRAM SUMMARY/ABSTRACT: THE GOAL OF MY RESEARCH PROGRAM IS TO DETERMINE HOW HOMEODOMAIN (HD) TRAN | $510,390 |
| 2026 | National Institutes of Health | Grant or other assistance | ARTHRITIS, MUSCULOSKELETAL AND SKIN DISEASES RESEARCH 93.846 | MECHANISMS OF SKELETAL MUSCLE CELL FUSION - PROJECT SUMMARY/ABSTRACT SKELETAL MUSCLE FORMATION, GROWTH, AND ADAPTATION DEPEND ON CELL FUSION REACTIONS THAT OCCU | $510,175 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | SKELETAL HETEROGENEITY OF BONE MARROW STRESS RESPONSES. - ABSTRACT: DEFINING HOW THE BONE MARROW FUNCTIONS UNDER STRESS IS INDISPENSABLE TO UNDERSTAND HEMATOPOI | $503,478 |
| 2026 | National Institutes of Health | Grant or other assistance | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853 | IDENTIFICATION OF NOVEL PATHWAYS CAUSING NF1-DRIVEN SCHWANN CELL TUMORS - ABSTRACT THE NF1 GENE PRODUCT, NEUROFIBROMIN, WAS IDENTIFIED IN 1990, YET FUNDAMENTAL | $500,637 |
| 2026 | Agency for Healthcare Research and Quality | Grant or other assistance | RESEARCH ON HEALTHCARE COSTS, QUALITY AND OUTCOMES 93.226 | DIGITAL INNOVATION, SIMULATION, AND COLLABORATION USING VIRTUAL ENVIRONMENT REALITIES (DISCOVER) FOR PEDIATRIC DIAGNOSTIC - PROJECT SUMMARY MORE THAN A THIRD OF | $500,000 |
| 2026 | National Institutes of Health | Grant or other assistance | ARTHRITIS, MUSCULOSKELETAL AND SKIN DISEASES RESEARCH 93.846 | DEVELOPMENT AND OPTIMIZATION OF SKELETAL MUSCLE DELIVERY VEHICLES - PROJECT SUMMARY/ABSTRACT CORRECTION OF GENETIC MUSCLE DISEASES, SUCH AS THE MUSCULAR DYSTROP | $498,796 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | COMPARATIVE STUDY OF GENE REGULATORY AND STRUCTURAL MECHANISMS IN LAMIN-RELATED CARDIOMYOPATHY - PROJECT SUMMARY LMNA-RELATED DILATED CARDIOMYOPATHY (LMNA-DCM) | $496,085 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | CYST INDUCTION AND GROWTH IN ADPKD - ABSTRACT: AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD) IS ONE OF THE WORLD’S MOST COMMON LIFE-THREATENING GENETIC D | $490,868 |
| 2026 | National Institutes of Health | Grant or other assistance | HUMAN GENOME RESEARCH 93.172 | CISBP AND CISBP-RNA: WEB RESOURCES FOR PROTEIN-DNA AND PROTEIN-RNA BINDING MODELS - PROJECT SUMMARY AND ABSTRACT THE PROCESSES UNDERLYING HUMAN HEALTH AND DISEA | $488,769 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | HOST INTEGRATION OF COMMENSAL AND PATHOGENIC BACTERIAL-DERIVED SIGNALS | $488,159 |
| 2026 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | RIBOREGULATION OF INNATE IMMUNE SIGNALING - PROJECT SUMMARY INNATE IMMUNE SIGNALING PATHWAYS ARE ESSENTIAL FOR HOST DEFENSE BUT MUST BE TIGHTLY REGULATED TO PRE | $486,000 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | CONTRIBUTIONS OF THE ENTEROCYTE BRUSH BORDER TO INTESTINAL HEALTH AND DISEASE - THE LUMINAL SURFACE OF EACH EPITHELIAL CELL IS COVERED BY SEVERAL THOUSAND BRIST | $481,632 |
| 2026 | National Institutes of Health | Grant or other assistance | ORAL DISEASES AND DISORDERS RESEARCH 93.121 | ARID1 PROTEINS ORCHESTRATE CRANIAL NEURAL CREST DIFFERENTIATION - PROJECT SUMMARY (ABSTRACT) CRANIAL NEURAL CREST CELLS (CNCCS) ARE A UNIQUE, MULTIPOTENT, MIGRA | $477,779 |
| 2026 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | INNATE MECHANISMS OF REGULATION OF MEMORY TH17 CELL RESPONSES | $477,000 |
| 2026 | National Institutes of Health | Grant or other assistance | ARTHRITIS, MUSCULOSKELETAL AND SKIN DISEASES RESEARCH 93.846 | PATHOGENESIS OF SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS-ASSOCIATED LUNG DISEASE - PROJECT SUMMARY / ABSTRACT SEVERE LUNG DISEASE IS AN INCREASINGLY RECOGNIZED LI | $474,257 |
| 2026 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | LOGIC-GATED CARS TO TARGET PHENOTYPIC RATHER THAN VIRAL FEATURES OF LATENT HIV RESERVOIRS - ABSTRACT ANTIRETROVIRAL THERAPY (ART) IS REMARKABLY SUCCESSFUL AT PR | $473,491 |
| 2026 | Department of Education | Grant or other assistance | RESEARCH IN SPECIAL EDUCATION 84.324 | IDENTIFYING SOCIAL EXPERIENCES LINKED TO ACADEMIC OUTCOMES OF MIDDLE AND HIGH SCHOOL STUDENTS WITH ASD IN GENERAL EDUCATION CLASSROOMS: LAYING THE GROUNDWORK FO | $463,074 |
| 2026 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | STUDY OF ALZHEIMER'S DISEASE RISK GENES USING BLOOD-BRAIN BARRIER ASSEMBLOIDS - ABSTRACT THE BLOOD-BRAIN BARRIER (BBB) PLAYS AN ESSENTIAL ROLE IN MAINTAINING C | $462,593 |
| 2026 | National Institutes of Health | Grant or other assistance | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853 | UNDERSTANDING THE IMPACT OF YOUTH ONSET OBESITY AND TYPE 2 DIABETES ON THE NEUROVASCULAR UNIT - PROJECT SUMMARY THERE IS A CRITICAL NEED TO DETERMINE WHETHER P | $451,149 |
| 2026 | Health Resources and Services Administration | Grant or other assistance | AUTISM COLLABORATION, ACCOUNTABILITY, RESEARCH, EDUCATION, AND SUPPORT 93.877 | TRANSITION FOR YOUTH WITH AUTISM AND/OR EPILEPSY DEMONSTRATION PROJECTS - UNIVERSITY OF CINCINNATI CENTER FOR EXCELLENCE IN DEVELOPMENTAL DISABILITIES (UCCEDD) | $450,000 |
| 2026 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | PROTEOMIC IDENTIFICATION OF NUCLEAR RUPTURE-ASSOCIATED PROTEINS IN LAMINOPATHY HEARTS - PROJECT SUMMARY THE NUCLEAR ENVELOPE CAN RUPTURE IN VARIOUS AGE-ASSOCIAT | $445,500 |
| 2026 | National Institutes of Health | Grant or other assistance | CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH 93.865 | DEFINING HOW DOMINANT-NEGATIVE RBPJ DISEASE ALLELES IMPACT NOTCH OUTCOMES - PROJECT SUMMARY. THE NOTCH PATHWAY IS A HIGHLY CONSERVED CELL SIGNALING PATHWAY THAT | $445,500 |
| 2026 | National Institutes of Health | Grant or other assistance | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853 | GENETIC DISSECTION OF THE RASOPATHY GENE NF1 AND MAPK PATHWAY ACTIVATION IN CORTICAL CELL FATE - ABSTRACT GLIOGENESIS AND NEUROGENESIS IN THE DEVELOPING CORTEX | $445,500 |
| 2026 | National Institutes of Health | Grant or other assistance | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853 | MICRORNA-MEDIATED REGULATION OF IL17A-ASSOCIATED NEURODEVELOPMENTAL DEFECTS INDUCED BY MATERNAL IMMUNE ACTIVATION - SUMMARY: ONE OF THE BIGGEST OBSTACLES PREVEN | $445,500 |
| 2026 | National Institutes of Health | Grant or other assistance | CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH 93.865 | LEVERAGING LONG-READ SEQUENCING TO PREDICT DISEASE SEVERITY IN FRAGILE X SYNDROME - PROJECT SUMMARY FRAGILE X SYNDROME (FXS) IS THE MOST COMMON INHERITED MONOGE | $445,500 |
| 2026 | National Institutes of Health | Grant or other assistance | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853 | PHENOTYPE-GENOTYPE RELATIONSHIPS IN TUBEROUS SCLEROSIS - SUMMARY TUBEROUS SCLEROSIS (TS) IS A RARE GENETIC DISORDER ASSOCIATED WITH BENIGN TUMORS AND NEUROLOGIC | $445,500 |
| 2026 | National Institutes of Health | Grant or other assistance | CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH 93.865 | TARGETING UNDRUGGABLE LUNG VASCULAR ENHANCERS WITH COMPACT AAV-CAS12F CRISPR ACTIVATION - PROJECT SUMMARY REGULATORY DNA ELEMENTS CONTROL CELL- AND TISSUE- SPE | $445,500 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | ROLE OF ETV4 AND ETV5 IN THE SELF-RENEWAL AND DIFFERENTIATION OF NEPHRON PROGENITORS - ABSTRACT: ETV4 AND ETV5 (ETV4/5) ARE TWO TRANSCRIPTION FACTORS EXPRESSED | $445,399 |
| 2026 | National Institutes of Health | Grant or other assistance | CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH 93.865 | PEDIATRIC CENTER FOR GENE EXPRESSION AND DEVELOPMENT | $444,598 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | PEDIATRIC HEART NETWORK JOINT HEART PROGRAM CONSORTIUM - THIS APPLICATION REPRESENTS A NEW CLINICAL RESEARCH CENTER CONSORTIUM THAT WILL STRENGTHEN THE PEDIATRI | $443,588 |
| 2026 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | MOLECULAR BASIS OF CIRCADIAN AND SENSORY INTEGRATION IN NEURONAL CLOCKS - MOLECULAR BASIS OF CIRCADIAN AND SENSORY INTEGRATION IN NEURONAL CLOCKS IN LIVING ORGA | $439,880 |
| 2026 | National Institutes of Health | Grant or other assistance | CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH 93.865 | MOLECULAR SIGNALING IN UTERINE RECEPTIVITY TO IMPLANTATION | $439,064 |
| 2026 | National Institutes of Health | Grant or other assistance | HUMAN GENOME RESEARCH 93.172 | POLYGENIC RISK SCORES FOR HEALTHIER AFRICAN AMERICAN FAMILIES | $438,114 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | DIABETIC MEMORY IN HEMATOPOIETIC STEM CELLS - PROJECT DESCRIPTION ONE IN SIX PREGNANCIES IS AFFECTED BY SOME FORM OF GESTATIONAL DIABETES (GD), A PREVALENCE THA | $436,663 |
| 2026 | Health Resources and Services Administration | Grant or other assistance | POISON CENTER SUPPORT AND ENHANCEMENT GRANT 93.253 | POISON CONTROL STABILIZATION AND ENHANCEMENT PROGRAM | $432,598 |
| 2026 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | MYONUCLEAR DYNAMICS DURING SKELETAL MUSCLE AGING - PROJECT SUMMARY/ABSTRACT SARCOPENIA IS A DEVASTATING SKELETAL MUSCLE CONDITION THAT OCCURS IN ADVANCED AGE AN | $423,410 |
| 2026 | National Institutes of Health | Grant or other assistance | CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH 93.865 | DETERMINING THEMECHANISM OF MATERNAL IL-10 RESTRICTION OF FETAL EMERGENCY MYELOPOIESIS TO IMPROVE NEONATALOUTCOMES - PROJECT SUMMARY/ABSTRACT MATERNAL INFECTIO | $417,462 |
| 2026 | National Institutes of Health | Grant or other assistance | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853 | SENSITIZATION OF DEVELOPING SENSORY NEURONS AFTER INCISION | $413,504 |
| 2026 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | REGULATORY MECHANISMS OF GASDERMIN-MEDIATED PYROPTOSIS - PROJECT SUMMARY THE HIGHLY INFLAMMATORY PROGRAMMED CELL DEATH, PYROPTOSIS, IS MEDIATED BY THE GASDERMIN | $405,000 |
| 2026 | National Institutes of Health | Grant or other assistance | CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH 93.865 | UNDERSTANDING FUNCTIONS OF LTR RETROTRANSPOSON ACTIVATION IN PREIMPLANTATION DEVELOPMENT - UNDERSTANDING THE FUNCTIONS OF LTR RETROTRANSPOSON ACTIVATION IN PREI | $401,927 |
| 2026 | National Institutes of Health | Grant or other assistance | VISION RESEARCH 93.867 | MELANOPSIN-DEPENDENT LIGHT-EVOKED DEVELOPMENT OF ROD PHOTORECEPTORS - IT HAS BEEN KNOWN FOR SOME TIME THAT DEVELOPMENT OF THE VISUAL SYSTEM CAN BE AN ADAPTIVE P | $401,250 |
| 2026 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | POST-TRANSCRIPTIONAL REGULATION OF STEM AND PROGENITOR CELL FUNCTION - ABSTRACT THE GENOME IS TRANSMITTED FROM ONE GENERATION TO THE NEXT BY TWO HIGHLY SPECIALI | $401,250 |
State business registration
- CHILDREN'S HOSPITAL MEDICAL CENTER OH, Employee benefit plan sponsor (Form 5500), Filed for plan year 2025
- AGENTPOINT LLC FL, Florida limited liability company (FLAL), Inactive, formed 2011-01-24
The same business name in the same state, from the state’s official registry data.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Plan sponsor | CHILDREN'S HOSPITAL MEDICAL CENTER | OH | Form 5500 (employee benefit plans) | EIN (EXACT) |
| Payment recipient | Childrens Hospital Medical Center | OH | Open Payments (drug and device company payments) | name and state |
| Payment recipient | Childrens Hospital Medical Center | OH | Open Payments (drug and device company payments) | name and state |
| Payment recipient | Childrens Hospital Medical Center | OH | Open Payments (drug and device company payments) | name and state |
| Payment recipient | Childrens Hospital Medical Center | OH | Open Payments (drug and device company payments) | name and state |
| Payment recipient | Childrens Hospital Medical Center | OH | Open Payments (drug and device company payments) | name and state |
| Payment recipient | Childrens Hospital Medical Center | OH | Open Payments (drug and device company payments) | name and state |
| Payment recipient | Childrens Hospital Medical Center | OH | Open Payments (drug and device company payments) | name and state |
| Payment recipient | Childrens Hospital Medical Center | OH | Open Payments (drug and device company payments) | name and state |
| Payment recipient | Childrens Hospital Medical Center | OH | Open Payments (drug and device company payments) | name and state |
| Payment recipient | CHILDRENS HOSPITAL MEDICAL CENTER | OH | Open Payments (drug and device company payments) | name and state |
| Payment recipient | CHILDRENS HOSPITAL MEDICAL CENTER | OH | Open Payments (drug and device company payments) | name and state |
| Payment recipient | CHILDRENS HOSPITAL MEDICAL CENTER | OH | Open Payments (drug and device company payments) | name and state |
| Payment recipient | CHILDRENS HOSPITAL MEDICAL CENTER | OH | Open Payments (drug and device company payments) | name and state |
| Payment recipient | CHILDRENS HOSPITAL MEDICAL CENTER | OH | Open Payments (drug and device company payments) | name and state |
Matched by name (and state) or EIN only; a shared name is not proof of the same person or organization.
Comments